WO2016129087A1 - Living body management system and living body management method - Google Patents

Living body management system and living body management method Download PDF

Info

Publication number
WO2016129087A1
WO2016129087A1 PCT/JP2015/053860 JP2015053860W WO2016129087A1 WO 2016129087 A1 WO2016129087 A1 WO 2016129087A1 JP 2015053860 W JP2015053860 W JP 2015053860W WO 2016129087 A1 WO2016129087 A1 WO 2016129087A1
Authority
WO
WIPO (PCT)
Prior art keywords
unit
user
biological
magnetic field
management system
Prior art date
Application number
PCT/JP2015/053860
Other languages
French (fr)
Japanese (ja)
Inventor
秀文 伊達
信 薮上
木村 光照
Original Assignee
学校法人東北学院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 学校法人東北学院 filed Critical 学校法人東北学院
Priority to PCT/JP2015/053860 priority Critical patent/WO2016129087A1/en
Priority to JP2016574584A priority patent/JP6516229B2/en
Publication of WO2016129087A1 publication Critical patent/WO2016129087A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • Embodiments described herein relate generally to a biological management system and a biological management method.
  • preemptive medicine is to prevent or delay the onset by predicting onset or making a diagnosis before onset with high accuracy before the onset of the disease, and implementing therapeutic intervention at an appropriate time before onset.
  • individualization prevention means prevention of the disease suitable for each individual.
  • the present invention has been made in view of the above, and an object of the present invention is to provide a biological management system and a biological management method that can detect biological substances with high accuracy.
  • the biological management system includes a reception unit, a measurement unit, a prediction unit, a determination unit, and a display unit.
  • the said reception part is the fixture installed in a toilet or a washroom, Comprising: The said user's body substance taken out from the fixture used by a user is received.
  • the measurement unit measures information indicating characteristics of the biological material from the body material received by the reception unit by a sensor provided in the fixture.
  • the prediction unit predicts a biological material contained in the user's body based on information measured by the measurement unit.
  • the determination unit determines the health state of the user from the biological material predicted by the prediction unit.
  • the display unit displays advice to the user based on the health state determined by the determination unit.
  • the biological management system includes a reception unit, a measurement unit, and a prediction unit.
  • the said reception part receives the waste_water
  • the measurement unit measures a magnetic field generated from a mixture of a waste material received by the reception unit and a reactive substance, which is an antibody or an antigen, and magnetic beads, using a magnetic field sensor.
  • the prediction unit predicts a biological material contained in the user's body based on the magnetic field measured by the measurement unit.
  • the biological management system includes a reception unit, a temperature measurement unit, and a prediction unit.
  • the said reception part receives the said internal body material of the said user taken out from the fixture which a user uses.
  • the temperature measuring unit measures a temperature change based on a thermal reaction between the in-vivo substance received by the receiving unit and a predetermined reactant.
  • the prediction unit predicts a biological material contained in the user's body based on the temperature change measured by the temperature measurement unit.
  • FIG. 1 is a diagram for explaining an example of an embodiment.
  • FIG. 2 is a diagram illustrating an example of a biological management system according to the embodiment.
  • FIG. 3 is a diagram illustrating an example of a smart brush system according to the first embodiment.
  • FIG. 4 is a top view showing the magnetic field sensor according to the first embodiment.
  • FIG. 5 is a schematic cross-sectional view taken along the line AA in FIG.
  • FIG. 6 is a top view showing another magnetic field sensor according to the first embodiment.
  • FIG. 7 is a diagram illustrating another example of the magnetic field sensor according to the first embodiment.
  • FIG. 8 is a diagram illustrating an example of a processing circuit according to the first embodiment.
  • FIG. 9 is a diagram illustrating an example of a home server according to the first embodiment.
  • FIG. 9 is a diagram illustrating an example of a home server according to the first embodiment.
  • FIG. 10 is a diagram illustrating an example of a user information storage unit according to the first embodiment.
  • FIG. 11 is a diagram illustrating a display example in the first embodiment.
  • FIG. 12 is a diagram showing a display example in the first embodiment.
  • FIG. 13 is a sequence diagram illustrating a processing procedure performed by the smart brush system according to the first embodiment.
  • FIG. 14 is a diagram for explaining a cleaning process according to the first embodiment.
  • FIG. 15 is a diagram showing a display example in the first embodiment.
  • FIG. 16 is a diagram illustrating an example of a smart sync system according to the first embodiment.
  • FIG. 17 is a diagram illustrating an example of a smart toilet system according to the first embodiment.
  • FIG. 18 is a diagram illustrating an example of a smart toilet system according to the second embodiment.
  • FIG. 19 is a diagram illustrating an example of a measuring apparatus according to the second embodiment.
  • FIG. 20 is a diagram illustrating an example of a sensor chip according to the second embodiment.
  • FIG. 21 is a diagram illustrating an example of an enzyme and a coenzyme according to the second embodiment.
  • FIG. 22 is a diagram for explaining an example of processing by the measurement control unit in the second embodiment.
  • FIG. 23 is a diagram showing a display example in the second embodiment.
  • FIG. 24 is a diagram illustrating an example of a sensor chip according to a modification of the second embodiment. 25 is a schematic cross-sectional view taken along the line BB in FIG. 24.
  • FIG. 26 is a diagram illustrating an example of a relationship between environmental temperature and output voltage.
  • FIG. 20 is a diagram illustrating an example of a sensor chip according to the second embodiment.
  • FIG. 21 is a diagram illustrating an example of an enzyme and a coenzyme according to the second embodiment.
  • FIG. 22 is a diagram
  • FIG. 27 is a view for explaining a handy type sensor according to the second embodiment.
  • FIG. 28 is a diagram illustrating an example of a urine sugar test using an oxidation-reduction current.
  • FIG. 29 is a diagram illustrating a hardware configuration of the home server according to the embodiment.
  • FIG. 30 is a diagram for explaining the society realized by the embodiment.
  • the biological management system detects a biological substance by a plurality of methods (for example, a magnetic method, a thermal method, etc.), but the plurality of methods are not necessarily realized. Is not a required configuration.
  • the living body management system and the measurement device may be configured to realize a part of the plurality of methods.
  • the biological material that is sensing data includes biological information such as a material contained in the living body, a biological material, a part of the living body, and a substance that is a constituent element of the living body.
  • biological substances include bacteria, fungi, viruses, proteins, amino acids, vitamins, enzymes, DNA (deoxyribonucleic acid), RNA (ribonucleic acid), organic substances, sugars, salts, stomach acids, pesticides, microorganisms, and environmental substances.
  • a toilet here is a toilet bowl installed in a washroom (sink), a toilet installed in a toilet, etc., for example.
  • a toothbrush washing machine etc. which are installed in a washroom correspond, for example.
  • FIG. 1 is a diagram for explaining an example of an embodiment.
  • FIG. 1 shows a state of the future home where the daily human dock is utilized.
  • users such as a grandfather, father, mother, eldest daughter, and eldest son live in the house and a grandmother lives in another house.
  • biological substances such as bacteria and biological substances contained in the user's body are predicted from the user's internal substances.
  • the substance in the user here refers to a substance obtained from the user, and includes, for example, “saliva”, “sweat”, “exhaust such as urine and stool”, “saliva, sweat, urine, stool, etc.” "Washed water”, "blood obtained from the body”, and the like.
  • the toothbrush or the interdental brush for cleaning the teeth or the tongue brush for cleaning the tongue
  • the biological material contained in the body is predicted from the washing water in which the anus or the like is washed.
  • health information based on the collected biological material is fed back to the user.
  • health information information such as “there is a possibility of tooth decay”
  • health information information such as “health”
  • health information is displayed on the mobile terminal device for the father who owns the mobile terminal device.
  • health information information such as “there is a risk of influenza”
  • the wearable information terminal when the daily human dock according to the embodiment is applied to a separate house where the grandmother lives, the health information of the grandmother transmitted from the separate house is also displayed on a predetermined display device. In the case of the example in FIG.
  • the health information of the entire family including the grandmother and advice to the user predicted from the health information are displayed on the monitor (display) placed in the living room 40.
  • Such biological substance prediction processing and health information display processing are realized by a biological management system built in the house.
  • the biological material prediction process is performed based on information detected by a sensor incorporated in a toothbrush washing machine installed in a washroom, or information detected by a sensor incorporated in a toilet installed in a toilet. Based on information detected by a sensor incorporated in a measurement measurement of a handy type (small portable type).
  • the living body management system displays advice such as “consult with a doctor” on the monitor based on the urine sugar value which is health information.
  • the living body management system can also display an advance when the urine sugar value becomes a predetermined value (for example, 80 [mg / dl]) or more.
  • the biological management system displays an advice “Go to the hospital”.
  • the biological management system may display strong instructional advice such as “Please go to the hospital immediately!”.
  • the mother brushes his teeth brush and a specific fungus for example, a caries fungus such as mutans or Lactobacillus
  • a specific fungus for example, a caries fungus such as mutans or Lactobacillus
  • the biological management system displays advice such as “Please go to the hospital!” on the monitor.
  • the eldest son has been prescribed a medicine from the hospital with symptoms of a cold, and has continued to take medicine and is absent from school.
  • the detection amount of pathogenic bacteria in the toilet 33 at home is a threshold value.
  • the living body management system displays an advice such as “Good school from tomorrow!” On the monitor.
  • the biological management system can display not only the current state of health of the user but also advice for the next action based on the current state of health.
  • enterohemorrhagic Escherichia coli infectious disease O-157 is known as a representative disease that is suspended from school (so-called infectious disease).
  • infectious disease enterohemorrhagic Escherichia coli infectious disease
  • the biological management system is based on the bacteria detected by the user. By displaying advice such as “Good school from tomorrow!”, It can also serve as a tool to prevent the spread of infection.
  • the biological management system may realize a display that can reflect the intention of each user as well as allowing the user to see the detection result and advice in each home.
  • the message sent to each individual can be determined based on the results of tests on biological substances such as pathogens and biological substances, the presence or absence of detection of specific bacteria and viruses, the amount of biological substances and the tendency to increase daily quantities, etc.
  • advice is displayed on the monitor so that appropriate judgment based on the test result can be made instead of individual judgment. By doing in this way, it becomes a message display of a user-friendly expression, and it is possible to prevent fear of the test result.
  • the requested information may be displayed. For example, necessary information may be displayed on a monitor in an interactive manner with a computer by voice recognition.
  • the biological material contained in each user's body is predicted, and health information based on the prediction result is fed back to the daily life. Realize daily human docks as if they were carried out every day in life.
  • FIG. 2 is a diagram illustrating an example of a biological management system according to the embodiment.
  • a smart brush system 1 including a washing machine 101 for washing a toothbrush and the like, a home server 50 installed in a home, and a display device 60, a sink 201 of a wash basin, and a home server Smart sink system 2 including 50 and display device 60, and smart toilet system 3 including toilet bowl 301, home server 50, and display device 60.
  • the smart brush system 1, the smart sink system 2, and the smart toilet system 3 can predict a biological material contained in the user's body by a magnetic technique or a thermal technique.
  • the smart brush system 1 measures the magnetic field caused by the magnetic beads or the like bound to the antibody of the biological substance in the body substance contained in the washing water in which the toothbrush is washed.
  • Antigens for example, bacteria
  • the smart sink system 2 predicts an antigen contained in the user's body by measuring a magnetic field caused by a substance in the body contained in water or the like exhaled by the user after gargle.
  • the smart toilet system 3 predicts an antigen contained in the user's body by measuring a magnetic field caused by a substance in the body contained in washing water that has washed the anus after defecation.
  • the in-home server 50 transmits information related to the predicted biological material of each user to various display devices 60.
  • the display device 60 can notify the health information to the user in the home by displaying the information regarding the biological material received from the home server 50.
  • Examples of the display device 60 include a home monitor, a bathroom mirror, a portable terminal device, a wearable information terminal, and a wearable terminal.
  • the smart brush system 1 measures the calorific value at the time of a catalytic reaction between a substance in the toothbrush washing water and a predetermined enzyme, thereby providing a living body contained in the user's body. Predict substances.
  • the smart sink system 2 measures the amount of heat generated during the catalytic reaction between water and the enzyme after gargle.
  • the smart toilet system 3 measures the amount of heat generated during the catalytic reaction between the washing water such as the anus and the enzyme.
  • the subsequent processing by the home server 50 is the same as the processing described in the magnetic method described above.
  • a PHR processing device 20 that is a server device may be constructed in a cloud formed on a network outside the user's home (hereinafter sometimes referred to as “healthcare cloud”).
  • the PHR processing device 20 collects and stores biometric information of each individual from the home server 50. At this time, the PHR processing device 20 may collect and accumulate life log information in association with each individual's biological information and behavior information. Then, the PHR processing device 20 centrally manages PHR big data obtained by integrating a large amount of biological information and life log information collected in time series for a plurality of users on the healthcare cloud.
  • the PHR processing device 20 may analyze the PHR big data to analyze the risk of developing the disease in the future, the amount of meal, the amount of exercise, or the response response of the body to the exercise load in an advanced and detailed manner. Eventually, it will be possible to design daily life aiming at an ideal image, such as the risk of disease onset, signs of seizures, personal constitution, diet content optimal for lifestyle, exercise, lifestyle, selection of medicines and supplements, etc.
  • the PHR processing device 20 can feed back such information to a medical institution as well as to the user. Based on the analysis results fed back from the PHR processing device 20, the doctor recognizes, for example, a high-risk disease onset army and actively accesses these persons as necessary.
  • the sensing data transmitted from the user is also useful for detecting abnormalities in the user's body.
  • the PHR processing device 20 constantly monitors sensing data transmitted every day for users of high-risk disease-causing reserves, and when an abnormality is detected therein, immediately feeds back to a medical institution or the like.
  • the PHR processing apparatus 20 can contribute to the use of various services and the creation of new industries by providing the results of PHR big data analysis to medical institutions and various companies.
  • the in-home server 50 transmits information related to the biological material to the display device 60, but the PHR processing device 20 may transmit information related to the biological material to the display device 60.
  • the in-home server 50 plays a role as a relay device that relays information on the biological substance to the PHR processing device 20.
  • FIG. 3 is a diagram illustrating an example of the smart brush system 1 according to the first embodiment.
  • the smart brush system 1 includes a washing machine 101, a concentrating device 102, and a measuring device 103.
  • the concentration device 102 and the measurement device 103 are externally attached to the washing machine 101 is shown, but the concentration device 102 and the measurement device 103 may be incorporated in the washing machine 101.
  • the washing machine 101 is a washing device for washing a toothbrush (or an interdental brush, a tongue brush, or the like) that is a washing tool for washing a user.
  • the cleaning machine 101 has a container for containing cleaning water and a drain outlet for draining the cleaning water in the container to the concentrating device 102.
  • the cleaning machine 101 has a function of ultrasonic cleaning.
  • the cleaning machine 101 cleans the toothbrush by generating an ultrasonic wave when a predetermined cleaning start button is pressed in a state where the toothbrush is immersed in the cleaning water contained in the container.
  • the washing machine 101 drains the washing water that may contain the in-vivo substance to the concentration device 102.
  • the cleaning machine 101 is provided with an authentication unit 101a.
  • the authentication unit 101a is, for example, a sensor that reads a user's fingerprint and the like. The authentication process using the authentication unit 101a will be described later.
  • the concentrating device 102 performs a concentration process for removing moisture from the cleaning water, which is a drainage material drained from the cleaning machine 101. Then, the concentrating device 102 discharges the concentrated cleaning water to the measuring device 103. In FIG. 3, the concentrating device 102 is shown, but the smart brush system 1 may not include the concentrating device 102. In this case, the washing water drained from the washing machine 101 flows into the measuring device 103 without being concentrated.
  • the measuring apparatus 103 includes a communication unit 103a (an example of a transmission unit) that performs wireless communication or wired communication with the home server 50.
  • the measuring device 103 mixes magnetic beads and an antibody as a reactive substance that reacts with a biological substance in the washing water discharged from the concentrating device 102, and measures a magnetic field generated from the mixed mixture.
  • the measuring apparatus 103 transmits the measurement result of a magnetic field to the home server 50 via the communication part 103a.
  • the internal configuration of the measuring apparatus 103 is shown in a broken-line rectangle in FIG.
  • the measuring apparatus 103 includes a first flow path 104, second flow paths 105 1 to 105 n , a mixing section 106, a DC magnetic field generation section 107, an AC magnetic field generation section 108, and a magnetic field.
  • the sensor 110, the processing circuit 120, and the measurement control unit 130 are included.
  • the wash water containing the body substance drained from the concentrator 102 flows.
  • the connection portion with the concentrating device 102 corresponds to a reception unit that receives the cleaning water drained from the concentrating device 102 (that is, the cleaning water drained from the cleaning machine 101).
  • the second flow paths 105 1 to 105 n are flow paths branched from the first flow path 104, and the washing water flowing from the first flow path 104 flows therethrough. In the case of the example in FIG. 3, it is assumed that the wash water flows through the second flow paths 105 1 to 105 n from the left side where the first flow path 104 is located toward the right side where the mixing unit 106 is located.
  • the mixing unit 106 is provided upstream of the second flow path 105 1. Then, the mixing unit 106 has accumulated magnetic beads specific antibody is bound, to inject the magnetic beads in the second flow path 105 1. Accordingly, the mixing unit 106, the washing water flowing in the second flow path 105 1, mixing the magnetic beads to which the antibody is bound. As described above, the washing water flowing through the second flow path 105 1 may include internal substances obtained from the user. Therefore, when a specific antigen (in this example, oral bacteria) is contained in the body substance and an antibody that causes an antigen-antibody reaction with the specific antigen is bound to the magnetic beads, The antigen is bound to the magnetic bead by binding to the antibody injected by the mixing unit 106 through an antigen-antibody reaction. On the other hand, when an antibody that causes an antigen-antibody reaction with an antigen contained in a substance in the body is not bound to the magnetic bead, there is no antibody bound to the magnetic bead. Does not cause antibody reaction.
  • a specific antigen in this example, oral bacteria
  • the mixing unit 106 also provided in the second flow path 105 2 ⁇ 105 n.
  • the mixing part 106 provided for every 2nd flow path accumulate
  • a specific antigen in this example, oral bacteria
  • that causes an antigen-antibody reaction with the antibody injected by the mixing unit 106 passes through the antibody. Bind with magnetic beads.
  • the second flow path 105 1 antibody A1 to cause antigen B1 and antigen-antibody reaction is injected into the 2 second flow path 105, an antibody causing antigen B2 and antigen-antibody reaction A2 is injected into the second flow path 105 3, it is assumed that the antibody A3 to cause antigen B3 antigen-antibody reaction is injected.
  • the washing water flowing through the second flow paths 105 1 to 105 3 includes antigens B1, B2, and B3.
  • antigen B1 binds to the magnetic beads via an antibody A1
  • antigens B2 are bound to magnetic beads via an antibody A2
  • the antigen B3 binds to the magnetic beads via an antibody A3.
  • a different antigen binds to the magnetic bead via the antibody for each second channel.
  • magnetic beads to which antigens such as oral bacteria are bound may be referred to as “bound beads”, and magnetic beads to which antigens are not bound may be denoted as “unbound beads”.
  • Direct current magnetic field generator 107 than mixing unit 106 disposed downstream of the second flow path 105 1, generates a DC magnetic field.
  • the DC magnetic field generator 107 such that the second flow path 105 1 is positioned in the magnetic field generated from the direct current magnetic field generator 107, is provided in the vicinity of the second channel 105 1.
  • the DC magnetic field generator 107 is formed of a magnetized coil, and generates a DC magnetic field by applying a voltage to the magnetized coil.
  • the DC magnetic field generator 107 may be a permanent magnet or an electromagnet that generates a DC magnetic field.
  • Such direct current magnetic field generator 107 by generating a DC magnetic field, magnetized magnetic beads flowing through the second flow path 105 1.
  • AC magnetic field generation unit 108 rather than direct current magnetic field generator 107 is provided downstream of the second flow path 105 1, generates an AC magnetic field.
  • the AC magnetic field generation unit 108 as the second flow path 105 1 is located in the magnetic field generated from the alternating magnetic field generating unit 108, is provided in the vicinity of the second channel 105 1.
  • the AC magnetic field generation unit 108 is formed of a coil, and generates an AC magnetic field by applying a voltage to the coil. This has been described as an example 1 second flow path 105, the AC magnetic field generation unit 108 is also provided in the second flow path 105 2 ⁇ 105 n.
  • FIG. 3 shows an example where magnetic beads 109 3 is included in the wash water antigen 109 1 is attached via the antibody 109 2.
  • the antigen that causes an antigen-antibody reaction with the antibody injected by the mixing unit 106 is not contained in the washing water, magnetic beads to which no antigen is bound are contained in the washing water. Become. Even if the antigen that causes an antigen-antibody reaction with the antibody is contained in the washing water, if the amount of the antigen is less than the amount of the antibody, the antigen is bound to the magnetic beads to which the antigen is bound.
  • Unwashed magnetic beads will be contained in the washing water.
  • Such magnetic beads rotate due to the Brownian relaxation phenomenon when an alternating magnetic field is applied by the alternating magnetic field generator 108.
  • the speed (frequency) of Brownian rotational movement due to this Brownian relaxation phenomenon depends on the mass of the magnetic beads. Specifically, the bound bead is heavier in mass by the antigen than the unbound bead, and the turning radius of the Brownian rotational motion is increased. For this reason, the Brownian rotational motion of the bonded beads is slower than the Brownian rotational motion of the unbound beads.
  • the bonded beads having a relatively higher mass than the unbound beads resonate with the AC magnetic field and generate a larger magnetic field.
  • an unbound bead having a lighter weight than the bound bead resonates with the alternating magnetic field and generates a larger magnetic field if the frequency of the alternating magnetic field generated from the alternating magnetic field generator 108 is high. . That is, by generating an alternating magnetic field having a frequency corresponding to the Brownian rotational motion from the alternating magnetic field generator 108, it is possible to increase the magnetic field generated from the coupled beads or to increase the magnetic field generated from the unbound beads. .
  • the magnetic field sensor 110 and the processing circuit 120 measure the magnetic field generated from the bound beads and unbound beads to which an alternating magnetic field is applied by the alternating magnetic field generator 108.
  • the magnetic field sensor 110 and the processing circuit 120 will be described later.
  • the measurement control unit 130 is realized by an integrated circuit such as ASIC (Application Specific Integrated Circuit) or FPGA (Field Programmable Gate Array). Further, for example, the measurement control unit 130 is realized by executing various programs using a RAM (Random Access Memory) as a work area by a CPU (Central Processing Unit), an MPU (Micro Processing Unit), or the like.
  • ASIC Application Specific Integrated Circuit
  • FPGA Field Programmable Gate Array
  • Such a measurement control unit 130 corresponds to a measurement unit that controls processing by the measurement apparatus 103. Specifically, the measurement control unit 130 transmits the fingerprint image read by the authentication unit 101 a to the home server 50. In this case, the home server 50 performs user authentication based on the image received from the measurement control unit 130 and notifies the measurement control unit 130 of the authentication result. At this time, if the authentication is successful, the home server 50 notifies the measurement control unit 130 of the user ID for identifying the user together with the authentication result.
  • the measurement control unit 130 does not inject the antibody and the magnetic beads into the mixing unit 106 and does not generate the DC magnetic field at the DC magnetic field generation unit 107.
  • the AC magnetic field generator 108 does not generate an AC magnetic field, and the processing circuit 120 does not perform the magnetic field measurement process. Thereby, the measurement control unit 130 can perform the sensing process only when the user authentication is successful.
  • the measurement control unit 130 causes the mixing unit 106 to inject antibodies and magnetic beads, causes the DC magnetic field generation unit 107 to generate a DC magnetic field, and causes the AC magnetic field generation unit 108 to generate an AC magnetic field.
  • the processing circuit 120 to perform magnetic field measurement processing.
  • the magnitude of the magnetic field generated from the bound and unbound beads depends on the frequency of the alternating magnetic field. Therefore, the measurement control unit 130 can control the frequency of the AC magnetic field generated from the AC magnetic field generation unit 108 to increase the magnetic field generated from the bound beads or increase the magnetic field generated from the unbound beads. it can.
  • the measurement control unit 130 measures the magnetic field in a state where the magnetic field generated from the bonded beads is increased, or measures the magnetic field in a state where the magnetic field generated from the unbound beads is increased. And the measurement control part 130 measures a magnetic field in such various states for every 2nd flow path, and transmits the measurement result for every 2nd flow path to the home server 50.
  • FIG. the measurement control unit 130 measures state information identifying the measurement state, antibody information identifying the antibody injected into the second flow path (or information identifying the second flow path), and magnetic field measurement. The combination with the result is transmitted to the home server 50.
  • the home server 50 described later obtains the amount of bound beads contained in the wash water and the relative amount of bound and unbound beads based on the magnetic field measurement result. Thereby, the in-home server 50 predicts the amount and concentration of the antigen (in this example, oral bacteria) contained in the user's body.
  • valves that can be opened and closed may be provided in the second flow paths 105 1 to 105 n shown in FIG.
  • a valve is provided between the position where the mixing unit 106 is provided and the position where the DC magnetic field generation unit 107 is provided, or between the position where the DC magnetic field generation unit 107 is provided and the position where the AC magnetic field generation unit 108 is provided. May be.
  • the measurement control unit 130 may control the valve to be closed until the time required for the antigen-antibody reaction elapses, and may control the valve to be opened after the time required for the antigen-antibody reaction elapses. .
  • the magnetic field sensor 110 has a magnetic body whose permeability changes as a function of the magnetic field when an external magnetic field is applied, and has a phase of a current (carrier) supplied to a transmission line provided in the vicinity of the magnetic body. Based on this, it is a sensor for detecting a magnetic field applied to a magnetic body. In addition, it can be said that the electric current which flows through a transmission line has the characteristic which changes with the influence of the magnetic field in a magnetic body, and this characteristic shows the characteristic of the antigen contained in a user's body.
  • FIG. 4 is a top view showing the magnetic field sensor 110 according to the first embodiment.
  • FIG. 5 is a schematic sectional view taken along the line AA in FIG.
  • the magnetic field sensor 110 includes a substrate 111, a CoNbZr (cobalt niobium zirconium) thin film 112, a SrTiO (strontium titanate) thin film 113, and Cu (copper) thin films 114 1 to 114 3 .
  • the substrate 111 is formed of glass such as potash glass or soda lime glass, for example.
  • the dimension H1 in the short direction on the surface of the substrate 111 on which the CoNbZr thin film 112 and the SrTiO thin film 113 are laminated is 1.15 [mm], for example, and the dimension H2 in the longitudinal direction is 12 [mm], for example. ].
  • the thickness H3 of the substrate 111 is, for example, 1 [mm].
  • the material and dimensions of the substrate 111 are not limited to this example.
  • the CoNbZr thin film 112 is amorphous, and is formed as a magnetic film having a magnetic impedance effect on the substrate 111 on which a resist pattern is formed by a high frequency sputtering method or the like.
  • the thickness of the CoNbZr thin film 112 is, for example, 5 [ ⁇ m].
  • the resist film is peeled off after the CoNbZr thin film 112 is formed, whereby a magnetic film pattern is obtained.
  • the CoNbZr thin film 112 is given magnetic anisotropy in a predetermined axial direction by heat treatment in a magnetic field or the like. In this example, the CoNbZr thin film 112 is given a short direction magnetic anisotropy.
  • the SrTiO thin film 113 is a ferroelectric film as an insulating layer, and is formed on the substrate 111 on which the CoNbZr thin film 112 is formed by high frequency sputtering or the like.
  • the thickness of the SrTiO thin film 113 is, for example, 6 [ ⁇ m] or less.
  • the Cu thin films 114 1 to 114 3 are formed on the SrTiO thin film 113 on which a resist pattern for forming a coplanar line is formed by a high frequency sputtering method or the like. Specifically, Cr (chromium) having a thickness of about 0.2 [ ⁇ m] is formed on the SrTiO thin film 113 as a base for improving the adhesion of the film. Then, the Cu thin films 114 1 to 114 3 are formed on the Cr thin film by a high frequency sputtering method or the like. The thickness of the Cu thin films 114 1 to 114 3 is, for example, 4 [ ⁇ m].
  • a coplanar line pattern By removing the resist after the Cu thin films 114 1 to 114 3 are formed, a coplanar line pattern can be obtained.
  • the interval H4 between adjacent Cu thin films is, for example, 0.05 [mm].
  • the dimension H5 in the short direction of the coplanar line is, for example, 0.3 [mm].
  • the processing circuit 120 described later measures the magnetic field generated from the coupled beads and unbound beads by detecting the phase difference of the current flowing through the coplanar line of the magnetic field sensor 110.
  • FIG. 4 and 5 show a linear coplanar line
  • the coplanar line is not limited to a linear shape.
  • FIG. 6 is a top view showing another magnetic field sensor according to the first embodiment.
  • coplanar lines 114a, 114b, 114c, 114d, 114e, and 114f are formed.
  • the coplanar line is not limited to a linear shape, but may be a meander shape (zigzag shape).
  • the example is not limited to the example illustrated in FIG. 6, and the coplanar line may have a spiral shape.
  • FIG. 6 shows an example in which magnetic thin films 113a, 113b, 113c, 113d, 113e, and 113f are further provided on the magnetic field sensors 110a, 110b, 110c, 110d, 110e, and 110f.
  • it is good also as a structure which pinches
  • any of the magnetic field sensor 110 shown in FIG. 4 and the magnetic field sensors 110a, 110b, 110c, 110d, 110e, and 110f shown in FIG. 6 may be adopted.
  • the longer the coplanar line that overlaps the magnetic thin film the more sensitive the magnetic field can be detected while the S / N ratio tends to deteriorate. For this reason, it is desirable to employ any one of the magnetic field sensors depending on the balance between the detection accuracy and the SN ratio.
  • the coplanar line is formed in the magnetic field sensor 110.
  • the magnetic field sensor 110 may be formed with a microstrip line or a triplate line.
  • FIG. 7 is a diagram illustrating another example of the magnetic field sensor according to the first embodiment.
  • the magnetic field sensor 110 g includes a ground plane 115, an insulating film 116, a conductor 117, and a magnetic thin film 118.
  • An insulating film 116 and a conductor 117 are sequentially stacked on the ground plane 115.
  • the conductor 117 forms a microstrip line as a transmission line through which a current flows.
  • the magnetic thin film 118 is placed on the microstrip line.
  • a soft magnetic film such as CoNbZr or NiFe (nickel alloy) is used.
  • the magnetic thin film 118 is assumed to have magnetic anisotropy in a direction orthogonal to the microstrip line.
  • a magnetic field sensor 110g illustrated in FIG. 7 may be used.
  • FIG. 7 shows a linear microstrip line
  • the microstrip line may have a meander shape (zigzag shape) or a spiral shape.
  • the magnetic field sensor 110g may be formed with a coplanar line or a triplate line instead of the microstrip line.
  • the processing circuit 120 measures the magnetic field generated from the mixture (bound beads or unbound beads) flowing through the second flow path based on the signal input to the magnetic field sensor 110 and the signal output from the magnetic field sensor 110. To do. For example, the processing circuit 120 measures the magnetic field by a DMTD (Dual Mixer Time Difference) method or the like.
  • DMTD Direct Mixer Time Difference
  • FIG. 8 is a diagram illustrating an example of the processing circuit 120 according to the first embodiment. As shown in FIG. 8, the processing circuit 120 includes an oscillator 121, a phase shifter 122, an oscillator 123, mixers 124a and 124b, amplifiers 125a and 125b, and band pass filters (BPFs) 126a and 126b. And comparators 127a and 127b and a counter 128.
  • a magnetic field sensor 110 is provided between the oscillator 121 and the mixer 124a.
  • Oscillator 121 generates a first repetitive signal having a predetermined frequency f 1.
  • the oscillator 121 supplies an AC current of 2 to 3 [GHz] to the circuit.
  • the first repetitive signal generated from the oscillator 121 is distributed to the magnetic field sensor 110 and the phase shifter 122.
  • the first repetitive signal distributed to the magnetic field sensor 110 is transmitted by the coplanar line of the magnetic field sensor 110.
  • the magnetic field sensor 110 changes the impedance of the transmission line by applying an external magnetic field generated from the coupled beads or the unbound beads. For this reason, when an external magnetic field is applied to the magnetic field sensor 110, the phase of the first repetitive signal is modulated.
  • the first repetitive signal distributed to the phase shifter 122 is attenuated and phase shifted by the phase shifter 122.
  • the first repetitive signal output from the phase shifter 122 does not pass through the magnetic field sensor 110, it is not affected by the external magnetic field generated from the bound beads or unbound beads. For this reason, the phase of the first repetitive signal output from the phase shifter 122 is not modulated.
  • Oscillator 123 generates a second repetitive signal of a different frequency f 2 to the frequency f 1 of the first repetitive signal.
  • the second repetitive signal generated from the oscillator 123 is distributed to the mixer 124a and the mixer 124b.
  • the mixer 124 a mixes the second repetitive signal generated from the oscillator 123 and the output signal from the magnetic field sensor 110. Further, the mixer 124 b mixes the second repetitive signal generated from the oscillator 123 and the output signal from the phase shifter 122. For example, the mixers 124a and 124b down-convert a repetitive signal of 2 to 3 [GHz] to about 5 [kHz].
  • the signal output from the mixer 124a is amplified by the amplifier 125a, only the component of the predetermined frequency is passed by the band-pass filter 126a, and is converted into a rectangular wave by the comparator 127a.
  • the signal output from the mixer 124b is amplified by the amplifier 125b, only the component of the predetermined frequency is passed through the band-pass filter 126b, and is converted into a rectangular wave by the comparator 127b.
  • the counter 128 measures the phase difference between the output signal from the comparator 127a as shown by the signal waveform 129a and the output signal from the comparator 127b as shown by the signal waveform 129b as a time difference.
  • the magnetic field sensor 110 has a magnetic material (for example, the CoNbZr thin film 112) whose permeability changes as a function of the magnetic field when an external magnetic field is applied. That is, the counter 128 can measure the magnetic field applied to the magnetic field sensor 110 based on the measured phase difference, that is, the magnetic field generated from the bound beads and unbound beads.
  • the processing circuit 120 illustrated in FIG. 8 since the magnetic field is detected based on the phase difference of the output signal, the restriction of the SN ratio due to the thermal noise of the magnetic field sensor 110 and each circuit element is eliminated.
  • a sensitive magnetic sensor unit can be constructed. Further, according to the processing circuit 120 shown in FIG. 8, the S / N ratio can be improved by amplifying the output signals from the mixers 124a and 124b by the amplifiers 125a and 125b, respectively.
  • the home server 50 is a management device that is provided in the user's home and manages various types of information related to the user.
  • FIG. 9 is a diagram illustrating an example of the home server 50 according to the first embodiment. As shown in FIG. 9, the home server 50 includes a communication unit 51, a user information storage unit 52, an authentication unit 53, a reception unit 54, a prediction unit 55, a display control unit 56, and a transmission unit 57. Have.
  • the communication unit 51 performs wireless communication or wired communication with the communication unit 103a of the measurement apparatus 103.
  • the communication unit 51 receives, from the communication unit 103a, an authentication fingerprint image acquired by the authentication unit 101a and information on the magnetic field measured by the measurement device 103.
  • the user information storage unit 52 stores various types of information related to the user.
  • the user information storage unit 52 stores information on a family located in the house or a family living in another house.
  • FIG. 10 shows an example of the user information storage unit 52 according to the first embodiment.
  • the user information storage unit 52 includes items such as “user ID”, “date and time”, and “antigen”.
  • “User ID” indicates identification information for identifying a user. “Date and time” indicates the date and time when a biological substance such as oral bacteria was sensed by the user. “Antigen” indicates the amount of antigen contained in the user's body.
  • FIG. 10 shows “Porphynomonas gingivalis” and “Prevotella Intel Media” known as anaerobic bacteria that cause periodontal disease, the present invention is not limited thereto.
  • the user information storage unit 52 includes “Actinobacillus actinomycetemcomitans”, “Porphyromonas gingivalis”, “Fusobacterium nucleatum”, and “Trepone madenticola”. Etc. may be stored. Further, the user information storage unit 52 may store caries causing bacteria (for example, “mutans bacteria” or “Lactobacillus bacteria”).
  • M11 Porphynomonas gingivalis
  • N11 Prevoterra Intel Media
  • the authentication unit 53 performs user authentication processing based on the fingerprint image for authentication received from the measurement apparatus 103.
  • the user information storage unit 52 stores a fingerprint image registered in advance by each user.
  • the authentication unit 53 performs authentication processing by comparing the fingerprint image for authentication with the registered fingerprint image.
  • the authentication unit 53 notifies the measurement device 103 of the authentication result via the communication unit 51.
  • the home server 50 notifies the measurement control unit 130 of the user ID together with the authentication result.
  • the receiving unit 54 receives the measurement result of the magnetic field from the measuring device 103 via the communication unit 51. For example, the receiving unit 54 receives a combination of state information for identifying a measurement state, antibody information for identifying an antibody injected into the second flow path, and a magnetic field measurement result from the measurement device 103.
  • the predicting unit 55 is an antigen that causes an antigen-antibody reaction with each antibody mixed by the mixing unit 106 based on the measurement result of the magnetic field received by the receiving unit 54. Predict antigens involved. Specifically, the prediction unit 55 identifies the type of antigen based on the antibody information transmitted from the measurement device 103. Then, the prediction unit 55 predicts the amount of bound beads and the amount of unbound beads based on the state information transmitted from the measuring apparatus 103 and the measurement result of the magnetic field. For example, the predicting unit 55 predicts the amount of bound beads based on the magnetic field measured by the measuring device 103 in a state where the magnetic field generated from the bound beads is increased, so that the amount of antigen bound to the bound beads. Predict.
  • the prediction unit 55 may predict the amount of unbound beads based on the magnetic field measured by the measurement device 103 in a state where the magnetic field generated from the unbound beads is increased. Then, the prediction unit 55 may predict the relative amount of the bound bead and the unbound bead. Note that the measuring device 103 may measure the magnetic field only in a state where the magnetic field generated from the binding beads is increased. In this case, the prediction unit 55 may predict only the amount of bound beads. The predicting unit 55 may predict the concentration of the antigen contained in the wash water from the amount of the bound beads when the amount of the wash water flowing through the second flow path is determined in advance.
  • the prediction unit 55 predicts the type and amount of antigen (in this example, oral bacteria) included in the user's body. Then, the prediction unit 55 stores the amount of antigen as a prediction result in the user information storage unit 52 in association with the user ID.
  • the prediction result by the prediction part 55 is a detection result of the kind and quantity of the antigen contained in a user's body. That is, it can be said that the prediction unit 55 detects the type and amount of the antigen.
  • the prediction unit 55 may simply predict whether or not a predetermined antigen is contained in the user's body without predicting the amount of antigen contained in the user's body.
  • the prediction unit 55 may function as a determination unit that determines a user's health state from a biological material such as an antigen that is a prediction result. For example, the prediction unit 55 may determine the health state of the user based on the amount of antigen that is the prediction result. That is, the prediction unit 55 may predict a disease that the user is suffering from or a disease that the user is likely to suffer in the future. To explain with an example, it is assumed that the predicting unit 55 predicts that a causative agent for caries is included in the user's body. At this time, the prediction unit 55 determines that the user is suffering from caries or that there is a possibility of suffering from caries when the predicted amount of the causative agent for caries is greater than a predetermined amount.
  • the display control unit 56 displays the prediction result by the prediction unit 55 on the display device 60a.
  • the display control unit 56 causes the display device 60a to display the prediction result by transmitting the prediction result from the prediction unit 55 to the display device 60a.
  • FIG. 11 shows a display example in the first embodiment.
  • FIG. 11 shows an example in which the causative causative bacteria are predicted to be included in the user's body by the prediction unit 55.
  • FIG. 11 shows an example in which the bathroom mirror is a display device 60a having a display function.
  • Such a display device 60a is realized, for example, by attaching a transparent member (for example, glass) whose surface facing the user is specially processed like a mirror to the display surface of the display display.
  • the display device 60a is assumed to have a wireless communication function.
  • the display control unit 56 performs display control on the display device 60 a to the effect that the causative causative fungus has been found. Specifically, the display control unit 56 sends a message to the display device 60a that a causative agent for caries has been found. Accordingly, the display device 60a displays a message (for example, “Caries fungus has been found”) indicating that a causative agent for caries has been found.
  • the display control unit 56 may display and control information on the amount of carious causative bacteria on the display device 60a.
  • the display device 60a displays a message related to the amount of caries-causing bacteria (for example, “20 caries were found”).
  • the display control unit 56 may display and control a message related to the health state on the display device 60a.
  • the display device 60 a controls display of messages related to the danger of caries (for example, “there is a possibility of caries”, “the possibility of caries is low”).
  • the display control unit 56 may display the prediction results by the prediction unit 55 on the display device 60a in time series. For example, the display control unit 56 obtains the amount of antigen collected in a predetermined period (for example, one week or one month) from the user information storage unit 52, and relates to a graph showing the relationship between the amount of antigen and the sensing date and time. Information is transmitted to the display device 60a. At this time, the display control unit 56 may include a message regarding the danger of tooth decay on the graph. In this case, for example, the display device 60a controls display of a message (for example, “low risk” and “high risk”) regarding the danger of dental caries together with a graph indicating the relationship between the amount of antigen and the sensing date and time. In the example of FIG.
  • the amount of the causative causative bacteria in the display device 60a is in a low risk range from 30 days to 20 days ago, but the amount of the caries causative bacteria is in a high risk range from 10 days ago to today. Display. Thereby, the user can look back on the life so far and can improve future lifestyle habits by grasping the risk of disease displayed in time series.
  • the display control unit 56 advises according to the amount of antigen predicted by the prediction unit 55 as described with reference to FIG. Let's brush dentition ") on the display.
  • the home server 50 holds a health state table in which the antigen amount threshold value, the user's health state, and advice are associated with each other.
  • the prediction unit 55 determines that the health state corresponding to the threshold in the health state table is the user's state.
  • the display control part 56 may display the advice corresponding to a user's health condition on a display apparatus in a health condition table.
  • a plurality of threshold values may be stored for the same antigen.
  • the health status table information that associates the threshold value “T 1 [units / dl]” of antigen A with the health status “no tooth decay” and advice “well brushed” and antigen A
  • the prediction unit 55 when the amount of the antigen A is a prediction result is less than the thresholds T 1 determines the health condition of the user is "no caries”. Then, the display control unit 56 causes the display device to display the advice “I have brushed my teeth well” (or the health condition “No tooth decay”). Also, the prediction unit 55, when the amount of the antigen A is a prediction result is thresholds T 1 or more and less than the threshold T 2 are, determines the health status of the user that "there is a possibility to become a dental caries”. Then, the display control unit 56 displays the advice “Let's brush your teeth three times a day” on the display device.
  • the prediction unit 55 when the amount of the antigen A is a prediction result is the threshold value T 3 or more, determines the health status of the user is a "likely caries". Then, the display control unit 56 displays the advice “Please go to the dentist!” On the display device.
  • the health state table stores information in which a health state (such as diabetes) and advice are associated with each predictable biological material. Further, the display control unit 56 may vary the advice displayed at the present time in accordance with the advice displayed so far. For example, it is assumed that the display control unit 56 has continued to display advice such as “Don't go to school” so far, because the prediction unit 55 has predicted that the pathogen of the infectious disease is in the user's body. .
  • the display control unit 56 may display an advice such as “You can go to school” on the first day when the prediction unit 55 no longer predicts that the infectious disease pathogen is in the user's body.
  • the display control unit 56 for example, “today” unless the prediction unit 55 predicts that the pathogen of the infectious disease is in the user's body from the next day when “you can go to school” is displayed. "I am healthy too”.
  • the home server 50 may acquire advice from a doctor via the PHR processing device 20 by transmitting the prediction result by the prediction unit 55 to the PHR processing device 20.
  • the display control unit 56 may display advice from the doctor on the display device.
  • FIG. 12 is a diagram illustrating a display example in the first embodiment.
  • a smart brush system 1 shown in FIG. 12 includes a projector 70.
  • the projector 70 is attached to the ceiling or wall of a washroom, and has a wireless communication function with the in-home server 50. Then, the projector 70 projects various messages received from the home server 50 on the mirror 60b of the washstand so as to be visible. As described above, various messages may be displayed on the mirror by the projector 70.
  • the display control unit 56 includes a home monitor, a mobile terminal device, Various messages may be displayed on a display device such as a wearable information terminal or a wearable terminal.
  • the home server 50 transmits various messages to the display device 60a.
  • the home server 50 may transmit various messages to the measurement device 103.
  • the measuring device 103 displays various messages received from the home server 50 on a display device associated with the own device (measuring device 103) in advance.
  • the display device 60a provided in the mirror of the washstand is associated with the measuring device 103 of the washing machine 101 disposed in the washroom.
  • the measuring apparatus 103 displays various messages on the display device 60a.
  • the home server 50 can display various messages for the user on the display device in the vicinity of the user.
  • the transmission unit 57 transmits the prediction result by the prediction unit 55 to the PHR processing device 20.
  • the transmission unit 57 transmits the user ID and the prediction result to the PHR processing device 20 every time the prediction process by the prediction unit 55 is performed.
  • the transmission unit 57 periodically acquires various information stored in the user information storage unit 52 and transmits the acquired various information to the PHR processing device 20.
  • the PHR processing device 20 collects and accumulates each individual's biometric information from the home server installed in each home, and centrally manages the PHR big data integrated for a plurality of users on the healthcare cloud. .
  • FIG. 13 is a sequence diagram illustrating a processing procedure performed by the smart brush system 1 according to the first embodiment.
  • the cleaning machine 101 performs ultrasonic cleaning in accordance with a user operation (step S101).
  • the cleaning water used for the ultrasonic cleaning is drained to the measuring device 103 (step S102).
  • the washing water that has flowed into the measuring device 103 flows through the second flow paths 105 1 to 105 n branched from the first flow path 104. Although omitted here, the washing water may be drained to the measuring device 103 after being concentrated by the concentrating device 102.
  • the measuring apparatus 103 injects magnetic beads, to which a specific antibody is bound, into the washing water for each second flow path (step S103). And the measuring apparatus 103 measures the magnetic field which generate
  • the home server 50 predicts an antigen contained in the body based on the magnetic field measurement result received from the measurement device 103 (step S107).
  • the in-home server 50 predicts oral bacteria contained in the body.
  • the home server 50 feeds back information (for example, the amount of antigen, user health information) based on the prediction result to the user (step S108).
  • the cleaning machine 101 described above may be used by a plurality of users.
  • the predetermined user uses the washing machine 101, there is a possibility that the internal substance and the binding beads of the predetermined user remain in the first flow path 104 and the second flow paths 105 1 to 105 n. . Therefore, the smart brush system 1 may have a cleaning function for cleaning the first channel 104 and the second channels 105 1 to 105 n .
  • FIG. 14 is a diagram for explaining the cleaning process according to the first embodiment.
  • the cleaning machine 101 shown in FIG. 14 is provided with a cleaning button 101b.
  • the cleaning button 101b notifies the measurement control unit 130 to perform the cleaning process.
  • the measurement control unit 130 receives a notification that the cleaning process is to be performed, the antibody and the magnetic beads are not injected into the mixing unit 106, the DC magnetic field generation unit 107 is not generated with a DC magnetic field, and the AC magnetic field generation unit An AC magnetic field is not generated in 108, and a magnetic field measurement process is not performed in the processing circuit 120.
  • the first flow path 104 and the second flow paths 105 1 to 105 n are cleaned by the flow of water contained in the container of the cleaning machine 101.
  • antigens contained in the user's body can be predicted with high accuracy.
  • the smart brush system 1 may perform a prediction process for predicting the cleaning state of the cleaning machine 101.
  • the measurement control unit 130 sends an AC magnetic field to the AC magnetic field generation unit 108 in a state where water flows through the first flow path 104 and the second flow paths 105 1 to 105 n in the above-described cleaning process.
  • the processing circuit 120 to perform magnetic field measurement processing.
  • the amount of antigen remaining in the second flow paths 105 1 to 105 n after washing is predicted by the prediction unit 55 of the home server 50.
  • the predicting unit 55 predicts that the washing is sufficient when the predicted amount of the antigen is equal to or less than the predetermined threshold, and the washing is not performed when the amount of the antigen is larger than the predetermined threshold. Predict that it is sufficient.
  • the display control unit 56 may display-control information related to the prediction result of the cleaning state on the display device 60a.
  • the prediction unit 55 predicts that the cleaning is insufficient.
  • the display control unit 56 causes the display device 60a to display a message indicating that the cleaning is insufficient (for example, “Please clean again!”). It is assumed that the cleaning is performed again in this state and the prediction unit 55 predicts that the cleaning is sufficient. In this case, as shown on the right side of FIG. 14, the display control unit 56 displays a message that is determined to be sufficient for cleaning (for example, “I was able to clean cleanly”).
  • the user can use the sufficiently cleaned washer 101, so that the antigen contained in the user's body can be predicted with higher accuracy. it can.
  • the antigen-antibody reaction described above may take about 30 to 60 minutes. Therefore, as described above, it has been described that a valve that can be opened and closed may be provided in the second flow paths 105 1 to 105 n of the measuring apparatus 103.
  • the antigen-antibody reaction in all antigens does not take about 30 to 60 minutes uniformly, and some antigens may cause an antigen-antibody reaction immediately. Therefore, in the smart brush system 1 described above, immediately after the user uses the washing machine 101, “whether or not an antigen is contained in the body” is predicted, and a sufficient time required for the antigen-antibody reaction (for example, 30 minutes to 60 minutes). “Amount of antigen contained in the body” may be predicted after a minute).
  • FIG. 15 is a diagram showing a display example in the first embodiment.
  • the cleaning machine 101 is used by the user at 7:00.
  • the measuring apparatus 103 may be used after an arbitrary time has elapsed since the antibody and magnetic beads were mixed with the washing water flowing from the washing machine 101 (for example, immediately after mixing, after 1 minute has elapsed, or after 5 minutes have elapsed). ), The magnetic field measurement process described above is performed.
  • the home server 50 predicts whether or not an antigen is contained in the user body based on the measurement result, and the prediction result (for example, “the causative causative fungus has been found. .. ”) is displayed on the display device 60a.
  • the measurement apparatus 103 performs the above-described magnetic field measurement process again after a time (for example, 30 minutes) longer than the above-described arbitrary time has elapsed. Then, the home server 50 predicts the amount of antigen contained in the user's body based on the measurement result, and displays information (for example, “... not a dangerous amount”) based on the prediction result on the display device 60a. To display. As described above, in the smart brush system 1, even if it takes time for the antigen-antibody reaction, the presence or absence of the causative agent of the disease can be immediately fed back to the user.
  • the measuring apparatus 103 described above may be controlled so as not to inject the antibody and the magnetic beads using the predetermined second channel among the second channels 105 1 to 105 n for comparison.
  • the in-home server 50 generates a comparison magnetic field measured in the second flow path where the antibody and the magnetic beads are not injected, and a magnetic field measured in the second flow path where the antibody and the magnetic beads are injected.
  • a prediction result can be obtained with high accuracy and speed.
  • the prediction unit 55 determines that the body contains an antigen. Predict.
  • the prediction unit 55 can predict the presence or absence of an antigen as soon as possible by using the magnetic field for comparison.
  • the predicting unit 55 can predict the amount of the antigen with high accuracy even after the time required for the antigen-antibody reaction has elapsed, based on the difference between the two magnetic fields.
  • FIG. 16 is a diagram illustrating an example of the smart sync system 2 according to the first embodiment.
  • the smart sync system 2 includes a sink 201, a concentration device 202, and a measurement device 203.
  • the sink 201 is a fixture that discharges the user's discharge and drains the discharge.
  • the sink 201 drains, to the concentrator 202, water discharged when the user gargles, water discharged when the user brushes his teeth, or water used by the user to wash his hands and face.
  • an oral cleaning device is also known that cleans the oral cavity (teeth, interdental teeth and gums) with high-pressure water flow or pneumatic pressure.
  • the sink 201 drains water that is discharged when the oral cleaning device is used and cleaning water that cleans the oral cleaning device.
  • the water drained by such a sink 201 may contain body substances.
  • the concentrator 202 performs the same processing as the concentrator 102 shown in FIG.
  • the measuring device 203 performs the same processing as that of the measuring device 103 shown in FIG.
  • the authentication unit 201a provided in the sink 201 performs the same processing as the authentication unit 101a illustrated in FIG.
  • description of processing by the concentrating device 202, the measuring device 203, and the authentication unit 201a is omitted.
  • FIG. 17 is a diagram illustrating an example of the smart toilet system 3 according to the first embodiment.
  • the smart toilet system 3 includes a toilet 301, a concentrating device 302, and a measuring device 303.
  • the toilet bowl 301 drains the substance discharged from the user.
  • the toilet 301 is provided with a nozzle for washing the anus and the like, and a tray 301b is provided at the tip of the nozzle.
  • the wash water obtained by washing the user's anus and the like is received by the tray 301 b, and the received wash water is collected by a vacuum suction method or the like and drained to the concentrator 302.
  • the concentrator 302 performs the same processing as the concentrator 102 shown in FIG.
  • the measuring device 303 performs the same processing as the measuring device 103 shown in FIG. Further, the authentication unit 301a provided in the toilet bowl 301 performs the same processing as the authentication unit 101a illustrated in FIG. Here, description of processing by the concentrating device 302, the measuring device 303, and the authentication unit 301a is omitted.
  • Such a smart toilet system 3 can detect enteric bacteria in the daily life of the user. Bacteria that lead to infectious diseases are also known among intestinal bacteria, but in smart toilet system 3, it is possible to prevent the spread of infectious diseases by displaying the detected intestinal bacteria on a home display device. it can. Examples of enteric bacteria detected by the smart toilet system 3 include norovirus and Campylobacter, which have a high incidence in modern society, Salmonella, Vibrio parahaemolyticus, Staphylococcus aureus, and Clostridium botulinum that have a low incidence in modern society. Can be mentioned.
  • the home server 50 may predict an antibody (for example, an immune substance such as a protein) contained in the body based on the measurement result of the magnetic field by the measurement devices 103, 203, and 303. In this case, the home server 50 may predict that the user is healthy if the antibody contained in the body is a normal value, and may display the prediction results on various display devices.
  • an antibody for example, an immune substance such as a protein
  • the magnetic field generated from the mixture can be accurately measured by the magnetic field sensor 110 described above, the biological material contained in the user's body can be accurately detected. Furthermore, according to the first embodiment, since different antibodies and antigens are injected for each second flow path, a plurality of items of antigens and antibodies can be detected in a single process. In the daily human dock described above, since a sensor is provided in a toothbrush washing machine or the like, this daily human dock can be realized by using the measuring device 103 capable of detecting many items.
  • FIG. 18 is a diagram illustrating an example of the smart toilet system 4 according to the second embodiment.
  • the smart toilet system 4 includes a toilet 401, a home server 50, and a display device 60.
  • the toilet bowl 401 is provided with an authentication unit 401a and a measuring device 410.
  • the authentication unit 401a corresponds to a sensor that reads a user's fingerprint and the like, like the authentication unit 101a illustrated in FIG.
  • the measuring device 410 is installed behind the toilet seat of the toilet 401 or in the toilet seat. Further, the measuring device 410 is attached with an arm 410a formed in a hollow cylindrical shape. One end of the arm 410 a is attached to the measuring device 410. In addition, a receiving tray is provided at the other end of the arm 410a, and a liquid detection sensor for detecting contact with the liquid is provided on the receiving tray. Further, as shown in FIG. 18, the arm 410 a can swing with one end attached to the measuring device 410 as a fulcrum. In addition, when the toilet bowl 401 is not utilized by the user, the arm 410a is accommodated in the back side of the toilet seat or in the toilet seat.
  • Such a measuring device 410 can be used by swinging the arm 410a when the user uses the toilet bowl 401 (for example, when the toilet seat lid is opened or when authentication through the authentication unit 401a is successful).
  • the urine discharged from the user is brought into contact with the arm 410a.
  • the measuring device 410 swings the arm 410a until the liquid detection sensor of the arm 410a detects contact with the liquid, and stops the arm 410a when contact with the liquid is detected.
  • emitted from the user enters into the saucer of the arm 410a.
  • the measuring device 410 causes such urine and a predetermined enzyme to undergo a catalytic reaction, measures the amount of heat generated in the catalytic reaction, and transmits the measurement result to the home server 50.
  • the home server 50 predicts a biological material such as a substrate (for example, glucose: urine sugar) contained in urine based on the measurement result of the calorific value. Then, the home server 50 transmits the prediction result to the PHR processing device 20 and various display devices 60. Thereby, the PHR processing apparatus 20 accumulate
  • FIG. 19 is a diagram illustrating an example of the measurement apparatus 410 according to the second embodiment.
  • the measurement device 410 includes a communication unit 411, a sensor chip 420, and a measurement control unit 430.
  • the communication unit 411 performs wireless communication or wired communication with the home server 50.
  • the communication unit 411 corresponds to a transmission unit that transmits the fingerprint image for authentication acquired by the authentication unit 401 a and the measurement result of the calorific value measured by the measurement control unit 430 described later to the in-home server 50.
  • the sensor chip 420 measures a temperature change due to a catalytic reaction between a user's urine flowing through the arm 410a and a predetermined enzyme.
  • the sensor chip 420 may be fixed to the measurement device 410 or may be removable from the measurement device 410.
  • the sensor chip 420 will be described later.
  • the measurement control unit 430 is realized by an integrated circuit such as ASIC or FPGA, for example. Further, for example, the measurement control unit 430 is realized by executing various programs using the RAM as a work area by a CPU, an MPU, or the like.
  • Such a measurement control unit 430 corresponds to a measurement unit that controls processing by the measurement apparatus 410. Specifically, when the authentication result notified from the in-home server 50 indicates success, the measurement control unit 430 swings the arm 410a stored in the toilet seat, and the urine discharged from the user and the arm 410a is brought into contact. In this case, the measurement control unit 430 calculates the amount of heat generated by the catalytic reaction between urine and the enzyme based on the temperature change detected by the sensor chip 420, and the calculated amount of generated heat is transmitted to the home server 50 via the communication unit 411. Send to.
  • the measurement control unit 430 does not allow the arm 410a to contact the urine discharged from the user by keeping the arm 410a in the toilet seat without swinging. In this case, the measurement control unit 430 does not perform a heat generation amount calculation process or a process for transmitting the heat generation amount to the home server 50.
  • the measurement control unit 430 performs processing for cleaning the sensor chip 420.
  • the toilet 401 illustrated in FIG. 18 includes a water discharge unit 403 that discharges water. Then, the measurement control unit 430 discharges water when a predetermined time has elapsed since the toilet 401 was used by the user, or when a predetermined time has elapsed since the liquid detection sensor of the arm 410a detected contact with the liquid.
  • the water discharge part 403 is controlled so that water is discharged from the part 403 to the tray of the arm 410a. Thereby, the water discharged
  • the sensor chip 420 is a calorimetric sensor that uses a temperature change caused by a thermal reaction between a biological material and an enzyme to identify the type and amount of the biological material even at normal temperature and low power consumption.
  • FIG. 20 is a diagram illustrating an example of a sensor chip 420 according to the second embodiment. As shown in FIG. 20, the sensor chip 420 includes a substrate 421, an absolute temperature sensor 422 as a first temperature sensor, a sample injection hole 423, flow paths 424 1 to 424 3 and reaction units 425 1 to 425. 3 , temperature sensors 426 1 to 426 3 as second temperature sensors, electrodes 427 1 to 427 3, and a common electrode 428.
  • the substrate 421 is, for example, a semiconductor silicon single crystal substrate.
  • the absolute temperature sensor 422 is a pn junction diode, for example, and is provided on the substrate 421. The absolute temperature sensor 422 measures the absolute temperature of the substrate 421.
  • a sample such as urine is injected into the sample injection hole 423 through the arm 410a.
  • Channels 424 1 to 424 3 are branched channels branched from the sample injection hole 423 and extend from the sample injection hole 423 to the discharge portion.
  • the flow paths 424 1 to 424 3 correspond to, for example, a microcapillary or a microchannel, and move urine or the like injected into the sample injection hole 423 toward the discharge portion by capillary action. Note that the flow paths 424 1 to 424 3 are not limited to this example, and urine or the like injected into the sample injection hole 423 may be moved toward the discharge portion by electrophoresis or dielectrophoresis.
  • the discharge unit is connected to the drainage channel of the toilet 401 and discharges urine, water, and the like injected into the sample injection hole 423 to the drainage channel.
  • the sample injection hole 423 corresponds to a reception unit that receives urine discharged from the toilet 401.
  • the measurement control unit 430 described above cleans the sensor chip 420 by controlling the water discharge unit 403. At this time, urine already injected into the sensor chip 420 is washed away to the discharge portion by the wash water from the water discharge portion 403. As a result, the sensor chip 420 can be easily washed and can be used repeatedly.
  • the reaction units 425 1 to 425 3 are respectively provided in the flow paths 424 1 to 424 3 between the sample injection hole 423 and the discharge unit.
  • a sample holder into which urine moving through the channels 424 1 to 424 3 enters is formed.
  • an enzyme having a catalytically active functional site with respect to a specific substrate is immobilized in the reaction units 425 1 to 425 3 .
  • a specific enzyme is fixed to the reaction units 425 1 to 425 3 by attaching a mixture of an enzyme solution and a photocrosslinkable polyvinyl alcohol resin.
  • a coenzyme that activates the catalytic reaction may be fixed to the reaction units 425 1 to 425 3 together with the enzyme.
  • FIG. 21 shows an example of an enzyme and a coenzyme in the second embodiment.
  • FIG. 21 shows specific examples of various substrates and enzymes and coenzymes corresponding to the substrates.
  • the substrate “glucose” and the enzyme “glucose oxidase” undergo a catalytic reaction.
  • the reaction units 425 1 to 425 3 for example, a cavity is formed in the substrate 421 facing the reaction units 425 1 to 425 3 and a part of the flow paths 424 1 to 424 3 before and after the reaction units 425 1 to 425 3.
  • a cross-linked structure in which can be formed can be employed.
  • a cantilever structure disclosed in Patent Document 5 can be adopted as the reaction units 425 1 to 425 3 .
  • the reaction units 425 1 to 425 3 may be provided with a heating unit (for example, a thin film heater) that keeps the sample holder at a predetermined temperature (for example, 38 [° C.]).
  • a heating unit for example, a thin film heater
  • the sample holder can be kept at a temperature suitable for the catalytic reaction (for example, 38 [° C.]), and the sample holder can be kept in the same environment. Can be measured.
  • reaction units 425 1 to 425 3 different enzymes are immobilized on the reaction units 425 1 to 425 3 , respectively. That is, of the various substrates contained in the urine moving through the channels 424 1 to 424 3 , only a specific substrate undergoes a catalytic reaction with the enzyme immobilized on the reaction units 425 1 to 425 3 .
  • a substrate SU1 enzyme E1 which catalyzes the reaction is fixed, the reaction unit 425 2, a substrate SU2 and enzyme E2 to catalyze the reaction is fixed, the reaction unit 425 3 Assumes that the enzyme E3 that catalyzes the substrate SU3 is immobilized.
  • the urine moving through the channels 424 1 to 424 3 includes the substrates SU1, SU2, and SU3.
  • the reaction part 425 1 a substrate SU1 enzymes E1 and catalyze the reaction
  • the reaction part 425 2 a substrate SU2 enzyme E2 and catalyze the reaction
  • the reaction part 425 3 substrate SU3 to enzyme E3 and catalysis .
  • a specific substrate can be selectively reacted with an enzyme for each reaction part (that is, for each flow path).
  • the temperature sensors 426 1 to 426 3 are provided on the substrate 421 similarly to the absolute temperature sensor 422. Specifically, the temperature sensors 426 1 to 426 3 are provided in the reaction units 425 1 to 425 3 , respectively.
  • the temperature sensors 426 1 to 426 3 are thin film thermocouples. That is, the temperature sensors 426 1 to 426 3 generate voltages according to temperature changes in the reaction units 425 1 to 425 3 .
  • the electrodes 427 1 to 427 3 are for taking out the thermoelectromotive force based on the thermal reaction from each of the temperature sensors 426 1 to 426 3 under the control of the measurement control unit 430.
  • the absolute temperature sensor 422 and the temperature sensors 426 1 to 426 3 (or the absolute temperature sensor 422, the temperature sensors 426 1 to 426 3 and the electrodes 427 1 to 427 3 ) are moved to the reaction units 425 1 to 425 3 . It can be said that this is a temperature measurement unit that measures a temperature change based on the thermal reaction between the body substance and the enzyme.
  • the number of flow paths formed in the sensor chip 420 is not limited to the example shown in FIG.
  • one or two flow paths may be formed in the sensor chip 420, or four or more flow paths may be formed.
  • the measurement control unit 430 shown in FIG. 19 uses the temperature measured by the absolute temperature sensor 422 as a reference and the temperature difference (from the output voltage of the temperature sensors 426 1 to 426 3 taken out by the electrodes 427 1 to 427 3 ( That is, the temperature rise due to the catalytic reaction) is measured. And the measurement control part 430 measures the emitted-heat amount in each reaction part based on the temperature change which is a measurement result. Then, the measurement control unit 430 transmits the measurement result for each reaction unit to the home server 50. For example, the measurement control unit 430 transmits the combination of enzyme information (or information for identifying the reaction unit) for identifying the enzyme fixed to the reaction unit and the calorific value measurement result to the home server 50.
  • the home server 50 predicts a substrate contained in the user's body based on the measurement result of the calorific value.
  • the amount of heat generated in the reaction unit is measured from the measurement results obtained by the temperature sensors 426 1 to 426 3 with reference to the temperature measured by the absolute temperature sensor 422. Therefore, the absolute temperature sensor 422 is preferably provided in the vicinity of the temperature sensors 426 1 to 426 3 . As a result, the absolute temperature sensor 422 and the temperature sensors 426 1 to 426 3 can be provided in the same environment, so that the measurement control unit 430 can accurately measure the amount of heat generation.
  • a waveform W11 shows an example of an output voltage when the substrate concentration in the urine sample is high
  • a waveform W12 shows an example of an output voltage when the substrate concentration is lower than the sample corresponding to the waveform W11.
  • the measurement control unit 430 may measure the amount of heat generated in each reaction unit based on the peak value (voltage P11 in the waveform W11, voltage P12 in the waveform W12) in the output voltage of the temperature sensor, or the waveform of the output voltage You may measure the emitted-heat amount in each reaction part based on an integral value.
  • the amount of heat generated by the catalytic reaction will be described.
  • the substrate “glucose” and the enzyme “glucose oxidase” will be described as examples.
  • the volume of urine that catalyses in the reaction section (that is, the volume of the sample holder) V0 is 16 ⁇ 10 ⁇ 5 [cm 3 ] ⁇ 1.0 ⁇ 10 ⁇ 7 [l].
  • a home server 50 according to the second embodiment will be described.
  • the configuration of the home server 50 is the same as the example shown in FIG.
  • the user information storage unit 52 according to the second embodiment stores a substrate (glucose, uric acid, oxalic acid, etc.) instead of the antigen shown in FIG.
  • processing is omitted for parts that perform similar processing.
  • the authentication unit 53 performs user authentication processing based on the fingerprint image for authentication received from the measurement device 410 and notifies the measurement device 410 of the authentication result.
  • the receiving unit 54 receives the calorific value measurement result from the measurement device 410 via the communication unit 51.
  • the receiving unit 54 receives a combination of enzyme information for identifying the enzyme and a calorific value measurement result from the measurement device 410.
  • the prediction unit 55 predicts a substrate contained in the user's body based on the measurement result of the calorific value received by the reception unit 54. For example, the prediction unit 55 specifies the type of substrate based on the enzyme information transmitted from the measurement device 410. For example, the prediction unit 55 predicts the amount and concentration of the substrate from the predetermined relationship between the calorific value and the amount of substrate. In this way, the prediction unit 55 predicts the type and amount of a substrate (in this example, a urine substance) contained in the user's body. Then, the prediction unit 55 stores the amount and concentration of the substrate as the prediction result in the user information storage unit 52 in association with the user ID. The prediction unit 55 may predict whether or not a predetermined substrate is included in the user's body more than a predetermined value, and the health state of the user may be determined based on the amount or concentration of the substrate that is a prediction result. It may be predicted.
  • the display control unit 56 performs display control of the prediction result on the display device in various manners as in the example illustrated in FIG.
  • the display control unit 56 controls the display device to display the name of the substrate, the amount of the substrate, the health state of the user, and the time-series prediction results.
  • FIG. 23 shows a display example in the second embodiment.
  • FIG. 23 shows an example in which prediction results of urine sugar (glucose) are displayed in time series on the display device 60c which is a tablet terminal.
  • the display control unit 56 acquires the amount of urine sugar collected in the past 20 days from the user information storage unit 52, and information on the graph indicating the relationship between the acquired amount of urine sugar and the sensing date and time. Is transmitted to the display device 60c. At this time, the display control unit 56 includes a warning message (for example, “abnormal urine sugar expression”) indicating that urine sugar is an abnormal value on the graph.
  • the display device 60c displays the concentration of the urine sugar value from 20 days ago to today in time series. Thereby, the user can look back on the life so far and can improve future lifestyle habits by grasping the urine sugar value and the warning message displayed in time series.
  • the urine sugar level corresponds to the blood glucose level.
  • a person whose blood glucose level is below a normal reference value for example, 109 [mg / dl]
  • a normal reference value for example, 109 [mg / dl]
  • the urine sugar level rises rapidly. Since this rapid increase in urine sugar value is an index of diabetes, a so-called hidden diabetic patient can be found based on the urine sugar value.
  • the prediction unit 55 displays the warning message based on such an index value.
  • the display device 60c may display a message to the user to urinate 2 hours after eating.
  • the prediction unit 55 may enter the body from urine excreted in a time zone assumed to be 2 hours after the meal (for example, 9 am to 10 am, 2 pm to 3 pm, 8 pm to 9 pm). The concentration of urine sugar contained may be predicted.
  • FIG. 23 illustrates an example in which the prediction result is displayed on the tablet terminal.
  • the display control unit 56 includes a home monitor, a mobile terminal device, a wearable information terminal, The prediction result may be displayed on a display device such as a wearable terminal.
  • the display control unit 56 is not limited to the example of FIG. 23, and displays whether or not a predetermined substrate is included in the user's body more than a predetermined value on the display device, or displays the predetermined substrate in the user's body. The amount may be displayed on a display device.
  • the sensor chip 420 may be provided with a suction unit that sucks the sample moving through the channels 424 1 to 424 3 toward the discharge unit.
  • the measurement control unit 430 can quickly move the sample to the discharge unit side by controlling the suction unit. Also, since the sample remaining in the flow path 424 1 to 424 3 by sucking can be removed, or to quickly dry the flow path 424 1 to 424 3, or can is filled with a cleaning liquid or a buffer solution.
  • the smart toilet system 4 may perform a prediction process for predicting the cleaning state of the sensor chip 420. Specifically, after performing the above-described cleaning process, the measurement control unit 430 generates heat generated in each reaction unit based on the temperature measured by the absolute temperature sensor 422 and the temperature measured by the temperature sensors 426 1 to 426 3. Measure. Thereby, the amount of the substrate remaining in the reaction units 425 1 to 425 3 after the cleaning is predicted by the prediction unit 55 of the home server 50. At this time, the predicting unit 55 predicts that the sensor chip 420 is sufficiently washed when the predicted amount of the substrate is equal to or less than the predetermined threshold, and when the amount of the substrate is larger than the predetermined threshold. The sensor chip 420 is predicted to be insufficiently cleaned. In this case, the display control unit 56 may display-control information related to the prediction result of the cleaning state on the display device 60c and the like.
  • the reaction units 425 1 to 425 3 and the like are deteriorated, so that there is a possibility that an error is generated in the calorific values measured in the reaction units 425 1 to 425 3 . Therefore, the measurement control unit 430 generates a calorific value measured by injecting a sample (hereinafter, sometimes referred to as “standard solution”) having a known substrate concentration or substrate content into the sample injection hole 423. Based on this, the calorific value measured by actually injecting urine or the like into the sample injection hole 423 by the user may be corrected. Specifically, since the standard solution has a known substrate concentration and substrate content, the calorific value when the standard solution is injected is also known.
  • standard solution has a known substrate concentration and substrate content
  • the measurement control unit 430 obtains a correction coefficient based on an error between the calorific value measured by injecting the standard solution and the known calorific value corresponding to the standard solution. And the measurement control part 430 correct
  • the sensor chip 420 may be removable from the measuring device 410.
  • the measurement control unit 430 informs the display device that the sensor chip 420 is to be replaced. It may be displayed.
  • the example which estimates the substrate contained in a user's body was shown by measuring the temperature change based on the reaction heat of a substrate and an enzyme.
  • the sensor chip may be provided with a mechanism for measuring information indicating characteristics of the substrate contained in the user's body by a method other than the method of measuring the temperature change based on the reaction heat.
  • the sensor chip may be provided with a mechanism for measuring information related to vibration of the flow path through which the sample flows as information indicating the characteristics of the substrate.
  • this point will be described. Note that the sensor chip 420 shown in FIG.
  • test items such as “urine protein”, “urine sugar”, “urinary occult blood reaction”, and “urine urobilinogen”.
  • test items such as “urine protein”, “urine sugar”, “urinary occult blood reaction”, and “urine urobilinogen”.
  • a sensor chip that can handle not only this type of test item but also a test item such as “urine specific gravity” will be described.
  • FIG. 24 is a diagram illustrating an example of a sensor chip 520 according to a modification of the second embodiment.
  • FIG. 25 is a schematic cross-sectional view taken along the line BB in FIG. In the following, it is assumed that the measurement device 410 illustrated in FIG. 19 includes the sensor chip 520 illustrated in FIG. 24 instead of the sensor chip 420. As shown in FIG.
  • the sensor chip 520 includes a substrate 521, an absolute temperature sensor 522 as a first temperature sensor, a sample injection hole 523, flow paths 524 1 to 524 5 , a reaction unit 525 1 to 525 4 , temperature sensors 526 1 to 526 4 as second temperature sensors, electrodes 527 1 to 527 4 , common electrode 528, discharge unit 529, excitation unit 531, and vibration frequency detection unit 532 and an electrode 533.
  • the substrate 521 is, for example, a semiconductor silicon single crystal substrate, and a cavity 530 is formed at the center. For this reason, in the sensor chip 520, the sensing units 530 1 to 530 5 for sensing a substrate or the like have a crosslinked structure.
  • FIG. 24 illustrates only the sensing units 530 1 and 530 5 .
  • the absolute temperature sensor 522 has the same configuration as the absolute temperature sensor 422 shown in FIG.
  • the sample injection hole 523 has the same configuration as the sample injection hole 423.
  • the flow paths 524 1 to 524 4 have the same configuration as the flow paths 424 1 to 424 3 .
  • the reaction units 525 1 to 525 4 have the same configuration as the reaction units 425 1 to 425 3 .
  • the temperature sensors 526 1 to 526 4 have the same configuration as the temperature sensors 426 1 to 426 3 .
  • the electrodes 527 1 to 527 4 have the same configuration as the electrodes 427 1 to 427 3 . That is, the sensor chip 520, like the sensor chip 420 shown in FIG. 20, it has a reaction unit 525 1 to 525 4 which enzyme is fixed.
  • the sensor chip 520 can be used for tests such as “urine protein”, “urine sugar”, “urine occult blood reaction”, “urine urobilinogen”. Furthermore, the sensor chip 520, to accommodate the inspection such as "urine specific gravity”, a flow path 524 5, an excitation portion 531, and the vibration frequency detecting unit 532, and the electrode 533 are provided.
  • Passage 524 plastic (e.g., polyimide resin) is formed by such, to move the injected into the sample injection hole 523 such as urine toward the discharge portion 529.
  • the channel 524 5 is not provided with a site where the enzyme is immobilized.
  • the flow path 524 5, the excitation portion 531 and the vibration frequency detecting unit 532 is provided. This point will be described with reference to FIG.
  • the excitation unit 531 is formed of a double layer of a silicon (Si) thin film 531a and a silicon oxide film (SiO2) 531b.
  • the silicon thin film 531 a and the silicon oxide film 531 b are stacked on the silicon oxide film 534 formed on the substrate 521. Note that the thickness of the silicon oxide film 531b is extremely thin, and is thinner than the silicon oxide film 534.
  • the vibration frequency detecting unit 532 is, for example, a piezo resistor formed in the vicinity of the bridge structure supporting portion of the silicon thin film 531a in the sensing portion 530 5 is a cross-linked structure.
  • the piezoresistor is easily formed by thermally diffusing boron (B), which is a p-type impurity, into the silicon thin film 531a that is an n-type SOI layer.
  • the silicon oxide film 531b has a very small thermal expansion coefficient. Therefore, heating by flowing a silicon thin film 531a to an alternating current of the sensing unit 530 5 crosslinked structure (Joule heating), the excitation portion 531, causing the bimorph vibration by the bimetal effect by the difference in thermal expansion coefficient, the upper cavity 530 Next, the sensing unit 530 5 is excited. Then, the resistance value of the vibration frequency detecting unit 532 is a piezoresistive changes based on the distortion due to the vibration of the sensing unit 530 5.
  • the change in resistance value of the vibration frequency detecting unit 532 detects the vibration frequency of the sensing unit 530 5.
  • the resonance frequency that matches its repetition cycle the natural frequency of the sensing unit 530 5
  • a sample flowing through the channel 524 5 e.g., urine
  • the measurement control unit 430 controls the alternating current flowing from the electrode 533 to the silicon thin film 531a, thereby measuring the resonance frequency and the shift amount (that is, the phase), and measuring a change in mass such as urine from the measurement result. To do.
  • the measuring device 410 having the sensor chip 520 is in addition to test items such as “urine protein”, “urine sugar”, “urine occult blood reaction”, “urine urobilinogen” for predicting a substrate contained in the user's body, It can also be used in scenes of inspection items such as “urine specific gravity”.
  • thermocouple 526 5 is a second temperature sensor used for temperature measurement of a thermal reaction between a substrate having a crosslinked structure and an enzyme formed in the same manner as other sensing units having a crosslinked structure (FIG. 25). Can be used as a heater for Joule heating.
  • thermocouple 526 5 for example, a silicon thin film 531a of the crosslinked structure, the metal thin film through the thin silicon oxide film 531b is used as a thermoelectric material. Further, by forming the piezoelectric thin film in a cross-linked structure, it can be used as the excitation unit 531.
  • the number of flow paths formed in the sensor chip 520 is not limited to the example shown in FIG.
  • the sensor chip 520 may be formed with three or less channels or five or more channels provided with reaction parts.
  • a discharge portion 529 that is a cavity formed in the substrate 521 is formed.
  • the sample such as urine flowing through the flow paths 524 1 to 524 5 is discharged to the outside of the sensor chip 520 through the discharge unit 529. Even the sensor chip 520 having such a structure can be repeatedly used because it can be washed.
  • the measurement control unit 430 depending on the environmental temperature measured by the absolute temperature sensor 522, the heating value in the reaction unit 525 1 to 525 4, or reaction part 525 1 to 525 4
  • the output voltages of the temperature sensors 526 1 to 526 4 provided in the above may be corrected. That is, the prediction unit 55 of the in-home server 50 includes in the user's body based on values after the measurement results by the temperature sensors 526 1 to 526 4 are corrected according to the environmental temperature measured by the absolute temperature sensor 522. Predict substrate This point will be described with reference to FIG.
  • FIG. 26 is a diagram illustrating an example of the relationship between the environmental temperature and the output voltage. The horizontal axis of FIG. 26 shows the passage of time, and the vertical axis of FIG.
  • a waveform W21 shows an example of the output voltage when the environmental temperature is high
  • a waveform W22 shows an example of the output voltage when the environmental temperature is lower than the waveform W21.
  • the waveforms W21 and W22 are assumed to have the same conditions (for example, a sample) other than the environmental temperature. As shown in FIG. 26, the lower the environmental temperature, the later the peak time of the output voltage and the lower the peak value.
  • the measurement control unit 430 measures the amount of heat generated in each reaction unit based on the peak value of the output voltage from the temperature sensors 526 1 to 526 4 or the integrated value of the waveform of the output voltage.
  • the measurement control unit 430 corrects the peak value of the output voltage or the integrated value of the waveform of the output voltage according to the relationship illustrated in FIG. 26 and the environmental temperature measured by the absolute temperature sensor 522. May be. That is, the measurement control unit 430 may correct the amount of heat generated in the reaction units 525 1 to 525 4 according to the environmental temperature. Thereby, the prediction unit 55 of the home server 50 can predict the amount and concentration of the substrate contained in the user's body with high accuracy.
  • the discharge unit 529 of the sensor chip 520 shown in FIG. also good. In this case, when cleaning the sensor chip 520, the measurement control unit 430 can quickly move the sample to the discharge unit 529 side by controlling the suction unit.
  • FIG. 27 is a diagram for explaining a handy-type sensor according to the second embodiment.
  • the handy-type calorimetric sensor 500 shown in FIG. 27 is provided with a sample injection hole 501, and the above-described sensor chip 420 (or sensor chip 520) and measurement control unit 430 are mounted inside.
  • the calorimetric sensor 500 may be equipped with a communication unit 411 that can communicate with the home server 50 and the PHR processing device 20.
  • the calorimetric sensor 500 may be provided with a drain outlet corresponding to the drainage section.
  • the measurement control unit 430 mounted on the calorimetric sensor 500 may perform the process of predicting the type, amount, and concentration of the substrate in the same manner as the prediction unit 55, and may include other than the home server 50, the PHR processing device 20, and the like. The prediction result predicted by the server device may be received.
  • the calorimetric sensor 500 can detect multiple items of substrates and the like, similar to the measurement device 410 described above.
  • the calorimetric sensor 500 can be used for urinalysis, blood tests, and the like.
  • Such a calorimetric sensor 500 can be used not only for group medical examinations such as medical examinations and examinations at medical institutions, but also as a portable inspection machine at home.
  • the smart toilet system 4 has been described as an example.
  • the second embodiment described above can also be applied to a smart brush system or a smart sync system.
  • a measuring device 410 is employed instead of the measuring device 103 shown in FIG. That is, cleaning water that has cleaned a cleaning instrument (such as a toothbrush) that cleans the user is injected into the sample injection hole 423 of the sensor chip 420.
  • a measuring device 410 is employed instead of the measuring device 203 shown in FIG. That is, a substance discharged from the user (eg, water after gargle) and cleaning water (eg, water used when washing the face) discharged from the user are injected into the sample injection hole 423 of the sensor chip 420.
  • the reaction unit 425 1 to 425 3 enzymatic as a reactant that reacts with the body of the biological material.
  • a specific antibody or antigen may be immobilized on the reaction units 425 1 to 425 3 instead of an enzyme.
  • the home server 50 may predict an enzyme, an antigen, or an antibody contained in the body based on the measurement result of the calorific value by the measurement device 410.
  • the in-vivo substance injected into the sample injection hole 423 is not limited to the urine described above, but may be saliva, blood, sweat, washing water that cleans the human body, and the like.
  • FIG. 28 is a diagram illustrating an example of a urine sugar test using a redox current.
  • the amount of glucose is detected by measuring the oxidation-reduction current of hydrogen peroxide generated when glucose is oxidized by glucose oxidase, which is an oxidase. To do.
  • the interfering substances such as uric acid and ascorbic acid contained in urine and gluconic acid generated during oxidation also affect the redox current, it cannot be said that the detection accuracy is high.
  • the sensor structure is complicated and the manufacturing cost is increased.
  • the sensor chip 420 according to the second embodiment measures a temperature change using a thermal reaction due to a catalytic reaction of an enzyme or a coenzyme, but the measurement of the temperature change is not affected by an interfering substance. For this reason, in the sensor chip 420 according to the second embodiment, the structure of the sensor does not become complicated, and the manufacturing cost does not increase.
  • the injected in-vivo substance is discharged to the discharge part, so that it can be washed and used repeatedly.
  • the internal substance is catalyzed in each reaction part to which a different enzyme is immobilized, so that multiple items of biological substances can be detected in one process. .
  • this daily human dock can be realized by using the sensor chip 420 that can be washed, can be repeatedly used, and can detect many items. .
  • the toothbrush washing machine the toilet (toilet bowl), the sink (toilet) etc. were mentioned as an example as an example of a toilet bowl
  • a toilet bowl is not restricted to these examples.
  • the fixture may be a cup from which the user discharges urine or the like.
  • emitted from a fixture with the sensor provided in the fixture was shown.
  • the magnetic field sensor 110 provided in the cleaning machine 101 uses a mixture of waste material, antibodies, and magnetic beads from the cleaning machine 101 as information indicating the characteristics of the biological material of the user.
  • An example of measuring the magnetic field generated from the is shown.
  • prescribed substrate as information which shows the characteristic of a user's biological substance with the sensor chip 420 provided in the toilet bowl 401 is provided. An example of measuring change was given.
  • each of the above-described embodiments may measure information indicating characteristics of a biological material from various types of sensors from a user's internal material taken out of the furniture or collected from the furniture.
  • urine discharged by a user or doctor in a cup which is a fixture, in a hospital, a mass examination, or at home, for example, the first flow path 104 of the measuring device 103 or the sample injection hole 423 of the sensor chip 420. May be injected.
  • FIG. 29 is a diagram illustrating a hardware configuration of the home server 50 according to the embodiment.
  • Home server 50 includes CPU 1100, ROM 1200, RAM 1300, display unit 1400, and input unit 1500.
  • a CPU 1100, a ROM 1200, a RAM 1300, a display unit 1400, and an input unit 1500 are connected via a bus line 1010.
  • a program that realizes various processes by the home server 50 is stored in the ROM 1200 and loaded into the RAM 1300 via the bus line 1010.
  • the CPU 1100 executes a program loaded in the RAM 1300.
  • the CPU 1100 reads out a program from the ROM 1200 in accordance with an instruction input from the input unit 1500 by the operator, expands it in a program storage area in the RAM 1300, and executes various processes.
  • the CPU 1100 temporarily stores various data generated during the various processes in a data storage area formed in the RAM 1300.
  • the program executed in the home server 50 has a module configuration including an authentication unit 53, a reception unit 54, a prediction unit 55, a display control unit 56, and a transmission unit 57, and these are loaded on the main storage device. Are generated on the main memory.
  • the configuration in which the PHR processing device 20 is built on the cloud has been described, but the embodiment is not limited to this.
  • the PHR processing device 20 can also build all or part of its functions on, for example, a network within a data trust company. Further, the PHR processing device 20 does not necessarily have to be constructed at one base.
  • the PHR processing device 20 may be realized by cooperation of functions distributed and arranged at a plurality of bases.
  • the PHR processing device 20 may include a prediction unit 55 and may be a management device that manages various types of information regarding each user in the home by performing the above-described prediction processing.
  • the measurement devices 103, 203, 303, and 410 may include the prediction unit 55 and perform the above-described prediction processing.
  • the embodiment is not limited to the above-described embodiment.
  • the embodiments described above can be combined as appropriate within a range that does not contradict the processing contents.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Primary Health Care (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

A living body management system according to an embodiment comprises an intake unit (104, 423), a measuring unit (130, 430), a predict unit (55), and display units (56, 60). The intake unit (104, 423) takes in a user's bodily substances which are acquired from fixtures which are installed in lavatories or washrooms and which the user uses. The measuring unit (130, 430) measures, with sensors disposed upon the fixtures, from the bodily substances which are taken in by the intake unit (104, 423), information which indicates characteristics of biological matter. On the basis of the information which is measured by the measuring unit (130, 430), the predict unit (55) predicts the biological matter within the user's body, and determines the state of the user's health from the predicted biological matter. On the basis of the determined state of health, the display units (56, 60) display advice for the user.

Description

生体管理システム及び生体管理方法Biological management system and biological management method
 本発明の実施形態は、生体管理システム及び生体管理方法に関する。 Embodiments described herein relate generally to a biological management system and a biological management method.
 従来、先制医療や個別化予防の実現に向けて、世の中では様々な取り組みが進められている。ここで、先制医療とは、疾病の発症前に、高い精度で発症の予測若しくは発症前の診断を行い、発症前の適切な時期に治療的介入を実施して、発症を防止若しくは遅らせることをいう。また、個別化予防とは、各個人に適した疾病の予防をいう。 In the past, various efforts have been made in the world to realize preemptive medicine and prevention of individualization. Here, preemptive medicine is to prevent or delay the onset by predicting onset or making a diagnosis before onset with high accuracy before the onset of the disease, and implementing therapeutic intervention at an appropriate time before onset. Say. Moreover, individualization prevention means prevention of the disease suitable for each individual.
 健康状態の評価や疾病の発症に至る前の未病状態の判別を厳密かつ客観的に行うためには、体内の細菌や生体由来物質等に関する生体物質を精度良く検出することが望ましい。しかしながら、現状では、個人のライフログを収集し、本人にフィードバックする取り組み等が知られているに過ぎず、生体物質を精度良く検出することは困難な状況である。 In order to accurately and objectively evaluate the health condition and discriminate the non-disease state before the onset of the disease, it is desirable to accurately detect biological substances related to bacteria in the body, biological substances and the like. However, at present, there are only known efforts to collect personal life logs and feed them back to the person, and it is difficult to accurately detect biological substances.
特開2001-327472号公報JP 2001-327472 A 特開2006-320735号公報JP 2006-320735 A 特開2005-091156号公報JP 2005-091156 A 特開2007-240289号公報Japanese Patent Laid-Open No. 2007-240289 特開2006-226850号公報JP 2006-226850 A
 本発明は、上記に鑑みてなされたものであって、生体物質を精度良く検出することができる生体管理システム及び生体管理方法を提供することを課題とする。 The present invention has been made in view of the above, and an object of the present invention is to provide a biological management system and a biological management method that can detect biological substances with high accuracy.
 実施形態に係る生体管理システムは、受付部と、測定部と、予測部と、判定部と、表示部とを備える。前記受付部は、トイレ又は洗面所に設置される什器であってユーザが使用する什器から取り出される当該ユーザの体内物質を受け付ける。前記測定部は、前記什器に設けられたセンサにより、前記受付部によって受け付けられた体内物質から、生体物質の特性を示す情報を測定する。前記予測部は、前記測定部によって測定された情報に基づいて、前記ユーザの体内に含まれる生体物質を予測する。前記判定部は、前記予測部によって予測された生体物質から前記ユーザの健康状態を判定する。前記表示部は、前記判定部で判定された健康状態に基づいて、前記ユーザに対するアドバイスを表示する。 The biological management system according to the embodiment includes a reception unit, a measurement unit, a prediction unit, a determination unit, and a display unit. The said reception part is the fixture installed in a toilet or a washroom, Comprising: The said user's body substance taken out from the fixture used by a user is received. The measurement unit measures information indicating characteristics of the biological material from the body material received by the reception unit by a sensor provided in the fixture. The prediction unit predicts a biological material contained in the user's body based on information measured by the measurement unit. The determination unit determines the health state of the user from the biological material predicted by the prediction unit. The display unit displays advice to the user based on the health state determined by the determination unit.
 また、実施形態に係る生体管理システムは、受付部と、測定部と、予測部とを備える。前記受付部は、ユーザが使用する什器から取り出される当該ユーザの体内物質を含む排水物質を受け付ける。前記測定部は、前記受付部によって受け付けられた排水物質に、抗体又は抗原である反応物質と、磁気ビーズとが混合された混合物から発生する磁界を磁界センサによって測定する。前記予測部は、前記測定部によって測定された磁界に基づいて、前記ユーザの体内に含まれる生体物質を予測する。 Moreover, the biological management system according to the embodiment includes a reception unit, a measurement unit, and a prediction unit. The said reception part receives the waste_water | drain substance containing the said user's body substance taken out from the fixture used by a user. The measurement unit measures a magnetic field generated from a mixture of a waste material received by the reception unit and a reactive substance, which is an antibody or an antigen, and magnetic beads, using a magnetic field sensor. The prediction unit predicts a biological material contained in the user's body based on the magnetic field measured by the measurement unit.
 また、実施形態に係る生体管理システムは、受付部と、温度計測部と、予測部とを備える。前記受付部は、ユーザが使用する什器から取り出される当該ユーザの体内物質を受け付ける。前記温度計測部は、前記受付部によって受け付けられた体内物質と所定の反応物質との熱反応に基づく温度変化を計測する。前記予測部は、前記温度計測部によって計測された温度変化に基づいて、前記ユーザの体内に含まれる生体物質を予測する。 In addition, the biological management system according to the embodiment includes a reception unit, a temperature measurement unit, and a prediction unit. The said reception part receives the said internal body material of the said user taken out from the fixture which a user uses. The temperature measuring unit measures a temperature change based on a thermal reaction between the in-vivo substance received by the receiving unit and a predetermined reactant. The prediction unit predicts a biological material contained in the user's body based on the temperature change measured by the temperature measurement unit.
 生体物質を精度良く検出することができるという効果を奏する。 There is an effect that a biological substance can be detected with high accuracy.
図1は、実施形態の一例を説明するための図。FIG. 1 is a diagram for explaining an example of an embodiment. 図2は、実施形態に係る生体管理システムの一例を示す図。FIG. 2 is a diagram illustrating an example of a biological management system according to the embodiment. 図3は、第1の実施形態に係るスマートブラシシステムの一例を示す図。FIG. 3 is a diagram illustrating an example of a smart brush system according to the first embodiment. 図4は、第1の実施形態に係る磁界センサを示す上面図。FIG. 4 is a top view showing the magnetic field sensor according to the first embodiment. 図5は、図4のA-A線に沿った矢視の概略断面図。FIG. 5 is a schematic cross-sectional view taken along the line AA in FIG. 図6は、第1の実施形態に係る他の磁界センサを示す上面図。FIG. 6 is a top view showing another magnetic field sensor according to the first embodiment. 図7は、第1の実施形態に係る磁界センサの他の例を示す図。FIG. 7 is a diagram illustrating another example of the magnetic field sensor according to the first embodiment. 図8は、第1の実施形態に係る処理回路の一例を示す図。FIG. 8 is a diagram illustrating an example of a processing circuit according to the first embodiment. 図9は、第1の実施形態に係る宅内サーバの一例を示す図。FIG. 9 is a diagram illustrating an example of a home server according to the first embodiment. 図10は、第1の実施形態に係るユーザ情報記憶部の一例を示す図。FIG. 10 is a diagram illustrating an example of a user information storage unit according to the first embodiment. 図11は、第1の実施形態における表示例を示す図。FIG. 11 is a diagram illustrating a display example in the first embodiment. 図12は、第1の実施形態における表示例を示す図。FIG. 12 is a diagram showing a display example in the first embodiment. 図13は、第1の実施形態に係るスマートブラシシステムによる処理手順を示すシーケンス図。FIG. 13 is a sequence diagram illustrating a processing procedure performed by the smart brush system according to the first embodiment. 図14は、第1の実施形態に係る洗浄処理を説明するための図。FIG. 14 is a diagram for explaining a cleaning process according to the first embodiment. 図15は、第1の実施形態における表示例を示す図。FIG. 15 is a diagram showing a display example in the first embodiment. 図16は、第1の実施形態に係るスマートシンクシステムの一例を示す図。FIG. 16 is a diagram illustrating an example of a smart sync system according to the first embodiment. 図17は、第1の実施形態に係るスマートトイレシステムの一例を示す図。FIG. 17 is a diagram illustrating an example of a smart toilet system according to the first embodiment. 図18は、第2の実施形態に係るスマートトイレシステムの一例を示す図。FIG. 18 is a diagram illustrating an example of a smart toilet system according to the second embodiment. 図19は、第2の実施形態に係る測定装置の一例を示す図。FIG. 19 is a diagram illustrating an example of a measuring apparatus according to the second embodiment. 図20は、第2の実施形態に係るセンサチップの一例を示す図。FIG. 20 is a diagram illustrating an example of a sensor chip according to the second embodiment. 図21は、第2の実施形態における酵素や補酵素の一例を示す図。FIG. 21 is a diagram illustrating an example of an enzyme and a coenzyme according to the second embodiment. 図22は、第2の実施形態における測定制御部による処理の一例について説明するための図。FIG. 22 is a diagram for explaining an example of processing by the measurement control unit in the second embodiment. 図23は、第2の実施形態における表示例を示す図。FIG. 23 is a diagram showing a display example in the second embodiment. 図24は、第2の実施形態の変形例に係るセンサチップの一例を示す図。FIG. 24 is a diagram illustrating an example of a sensor chip according to a modification of the second embodiment. 図25は、図24のB-B線に沿った矢視の概略断面図。25 is a schematic cross-sectional view taken along the line BB in FIG. 24. 図26は、環境温度と出力電圧との関係の一例を示す図。FIG. 26 is a diagram illustrating an example of a relationship between environmental temperature and output voltage. 図27は、第2の実施形態に係るハンディタイプのセンサを説明するための図。FIG. 27 is a view for explaining a handy type sensor according to the second embodiment. 図28は、酸化還元電流による尿糖検査の例を示す図。FIG. 28 is a diagram illustrating an example of a urine sugar test using an oxidation-reduction current. 図29は、実施形態に係る宅内サーバのハードウェア構成を示す図。FIG. 29 is a diagram illustrating a hardware configuration of the home server according to the embodiment. 図30は、実施形態によって実現される社会を説明するための図。FIG. 30 is a diagram for explaining the society realized by the embodiment.
 以下、図面を参照しながら、実施形態に係る生体管理システム及び生体管理方法を説明する。なお、以下の実施形態においては、生体管理システムが、複数の手法(例えば、磁気的手法、熱的手法等)により生体物質を検出する例を説明するが、必ずしも、複数の手法を実現することが必須の構成ではない。生体管理システムや測定装置は、複数の手法のうちの一部の手法を実現する構成でもよい。 Hereinafter, a biological management system and a biological management method according to the embodiment will be described with reference to the drawings. In the following embodiment, an example will be described in which the biological management system detects a biological substance by a plurality of methods (for example, a magnetic method, a thermal method, etc.), but the plurality of methods are not necessarily realized. Is not a required configuration. The living body management system and the measurement device may be configured to realize a part of the plurality of methods.
(実施形態の一例)
 今日、誰もが、家族と地域の中で健康快活に、仕事や趣味に生きるのが理想だが、将来の病気への不安、痴呆、うつ、孤独感、離れた家族への心配等が、少子高齢化の進む現代社会において人々を脅かし、安寧な生活を蝕んでいる。このような状況において、誰もが、家族と社会の中で健康快活に、仕事や趣味に生きることを理想としている。その実現手段の1つが、『日常人間ドック』である。この『日常人間ドック』では、非意識(Unconscious Sensing)技術により収集される生体情報を含む革新的なPHR(Personal Health Record)ビッグデータを基盤に、理想のライフスタイルを創造する。なお、センシングデータには、例えば、心拍数、ストレス、血圧、ホルモン、血中濃度、薬剤の服用量等がある。また、センシングデータである生体物質には、例えば、生体に含まれる物質や、生体由来物質や、生体の一部の物質や、生体の構成要素である物質等の生体情報がある。なお、生体物質の例としては、細菌、菌類、ウイルス、タンパク質、アミノ酸、ビタミン、酵素、DNA(deoxyribonucleic acid)、RNA(ribonucleic acid)、有機物質、糖分、塩分、胃酸、農薬、微生物、環境物質等が挙げられる。
(Example of embodiment)
Today, it is ideal for everyone to live a healthy life in the family and the community, and to live in work and hobbies. In today's aging society, people are threatened and eroded. In such a situation, it is ideal for everyone to live healthy and lively in work and hobbies in the family and society. One of the means for realizing this is the “daily human dock”. This “Daily Ningen Dock” creates an ideal lifestyle based on innovative PHR (Personal Health Record) big data including biometric information collected by Unconscious Sensing technology. The sensing data includes, for example, heart rate, stress, blood pressure, hormone, blood concentration, drug dose, and the like. In addition, the biological material that is sensing data includes biological information such as a material contained in the living body, a biological material, a part of the living body, and a substance that is a constituent element of the living body. Examples of biological substances include bacteria, fungi, viruses, proteins, amino acids, vitamins, enzymes, DNA (deoxyribonucleic acid), RNA (ribonucleic acid), organic substances, sugars, salts, stomach acids, pesticides, microorganisms, and environmental substances. Etc.
 以下に説明する実施形態では、ユーザが生活している中で、ユーザが日常使用する什器を介して、生体物質を収集することで、生活の中でさりげなく健康状態をユーザにフィードバックする日常人間ドックを実現することにより、結果として将来の病気への不安を解消する。なお、ここでいう什器とは、例えば、洗面所に設置される洗面台(シンク)、トイレに設置される便器などである。また、什器とは、例えば、洗面所に設置される歯ブラシ洗浄機なども該当する。 In the embodiment described below, the daily human dock that casually feeds back the health condition to the user in daily life by collecting biological materials through the furniture that the user uses everyday while the user is living. As a result, the anxiety about the future illness is solved. In addition, a toilet here is a toilet bowl installed in a washroom (sink), a toilet installed in a toilet, etc., for example. Moreover, a toothbrush washing machine etc. which are installed in a washroom correspond, for example.
 図1は、実施形態の一例を説明するための図である。図1では、日常人間ドックが活用されている将来の宅内の様子を示す。ここでは、宅内に、祖父、父、母、長女、長男等のユーザが暮らしており、別宅に祖母が暮らしているものとする。図1に示す実施形態では、ユーザ宅内の洗面所31やトイレ32及び33において、ユーザの体内物質から、ユーザの体内に含まれる細菌や生体由来物質等の生体物質を予測する。ここでいうユーザの体内物質とは、ユーザから得られる物質に該当し、例えば、「唾液」、「汗」、「尿や便等の排出物」、「唾液や汗や尿や便等が含まれる洗浄水」、「体内から取得された血液」等が該当する。以下の実施形態では、例えば、ユーザが洗面所31において使用した歯ブラシ(または、歯間を清掃するための歯間ブラシや、舌を清掃するための舌ブラシ)を洗浄した洗浄水から、体内に含まれる生体物質を予測する。また、例えば、ユーザがトイレ32又は33を利用した際に、肛門等を洗浄した洗浄水から、体内に含まれる生体物質を予測する。 FIG. 1 is a diagram for explaining an example of an embodiment. FIG. 1 shows a state of the future home where the daily human dock is utilized. Here, it is assumed that users such as a grandfather, father, mother, eldest daughter, and eldest son live in the house and a grandmother lives in another house. In the embodiment shown in FIG. 1, in the bathroom 31 and toilets 32 and 33 in the user's house, biological substances such as bacteria and biological substances contained in the user's body are predicted from the user's internal substances. The substance in the user here refers to a substance obtained from the user, and includes, for example, “saliva”, “sweat”, “exhaust such as urine and stool”, “saliva, sweat, urine, stool, etc.” "Washed water", "blood obtained from the body", and the like. In the following embodiments, for example, from the washing water that has washed the toothbrush (or the interdental brush for cleaning the teeth or the tongue brush for cleaning the tongue) used by the user in the washroom 31 into the body. Predict the biological material involved. In addition, for example, when the user uses the toilet 32 or 33, the biological material contained in the body is predicted from the washing water in which the anus or the like is washed.
 そして、実施形態では、収集した生体物質に基づく健康情報をユーザにフィードバックする。例えば、洗面所31を利用している母に対しては、洗面所31の鏡に健康情報(「虫歯のおそれがある」といった情報等)を表示する。また、例えば、携帯端末装置を所有する父に対しては、その携帯端末装置に健康情報(「健康である」といった情報等)を表示する。また、例えば、装着型情報端末を所有する長女に対しては、その装着型情報端末に健康情報(「インフルエンザのおそれがある」といった情報等)を表示する。また、例えば、祖母が暮らす別宅にも実施形態に係る日常人間ドックが適用されている場合には、別宅から送信される祖母の健康情報も所定の表示装置に表示する。図1の例の場合、居間40に置かれているモニタ(ディスプレイ)に、祖母を含む家族全員の健康情報や、健康情報から予測されるユーザへのアドバイスを表示する。このような生体物質の予測処理や健康情報の表示処理は、宅内に構築される生体管理システムによって実現される。例えば、生体物質の予測処理は、洗面所に設置される歯ブラシ洗浄機に組み込まれるセンサによって検知される情報に基づいて行われたり、トイレに設置される便器に組み込まれるセンサによって検知される情報に基づいて行われたり、ハンディタイプ(持ち運び可能な小型タイプ)の測定測定に組み込まれるセンサによって検知される情報に基づいて行われたりする。 In the embodiment, health information based on the collected biological material is fed back to the user. For example, for mothers using the bathroom 31, health information (information such as “there is a possibility of tooth decay”) is displayed on the mirror of the bathroom 31. Further, for example, health information (information such as “health”) is displayed on the mobile terminal device for the father who owns the mobile terminal device. Further, for example, for the eldest daughter who owns the wearable information terminal, health information (information such as “there is a risk of influenza”) is displayed on the wearable information terminal. In addition, for example, when the daily human dock according to the embodiment is applied to a separate house where the grandmother lives, the health information of the grandmother transmitted from the separate house is also displayed on a predetermined display device. In the case of the example in FIG. 1, the health information of the entire family including the grandmother and advice to the user predicted from the health information are displayed on the monitor (display) placed in the living room 40. Such biological substance prediction processing and health information display processing are realized by a biological management system built in the house. For example, the biological material prediction process is performed based on information detected by a sensor incorporated in a toothbrush washing machine installed in a washroom, or information detected by a sensor incorporated in a toilet installed in a toilet. Based on information detected by a sensor incorporated in a measurement measurement of a handy type (small portable type).
 ここで、図1に示したモニタに表示される「健康ニュース」について説明する。例えば、祖父が朝にトイレ32に入り、尿の検査が行われたとする。この結果、生体管理システムが、毎日の検査の履歴から祖父の尿糖値が徐々に上昇していることを検知したものとする。すなわち、生体管理システムが、前日の酒の飲み過ぎや食べ過ぎによる一過性ではないことを検知したものとする。この場合、生体管理システムは、健康情報である尿糖値に基づいて、「お医者さんと相談して」といったアドバイスをモニタに表示する。このとき、生体管理システムは、尿糖値が所定の値(例えば、80[mg/dl])以上になった場合に、アドバスを表示することもできる。なお、空腹時の尿糖の検査では、血糖値が正常範囲以内(110[mg/dl]程度以内)である場合は、尿には糖が出にくいという性質があるが、糖尿病患者では、腎閾値(血糖値が180[mg/dl]程度)を超えると尿に排泄され、尿糖値が例えば、2000[mg/dl]というように急激に増えるといわれている。すなわち、ユーザの体内から尿糖が検出され始めた時が疾病(例えば、糖尿病)の発症リスクの観点から重要である。 Here, “health news” displayed on the monitor shown in FIG. 1 will be described. For example, it is assumed that the grandfather enters the toilet 32 in the morning and the urine test is performed. As a result, it is assumed that the living body management system detects that the grandfather's urine sugar value gradually increases from the history of daily examinations. That is, it is assumed that the living body management system detects that it is not transient due to drinking or eating too much alcohol on the previous day. In this case, the living body management system displays advice such as “consult with a doctor” on the monitor based on the urine sugar value which is health information. At this time, the living body management system can also display an advance when the urine sugar value becomes a predetermined value (for example, 80 [mg / dl]) or more. In the test for fasting urine sugar, when the blood glucose level is within the normal range (within about 110 [mg / dl]), there is a property that sugar is not easily produced in the urine. It is said that when it exceeds a threshold value (blood glucose level of about 180 [mg / dl]), it is excreted in urine, and the urinary sugar value increases rapidly, for example, 2000 [mg / dl]. That is, the time when urine sugar starts to be detected from the user's body is important from the viewpoint of the risk of developing a disease (for example, diabetes).
 また、図1の例において、離れて暮らしている祖母が、トイレに行って、大便や小便の検査の結果、生体物質の中の病原体(細菌やウイルスなど)が見つからないが、祖父同様に尿糖値や乳酸値などが所定の値よりも高くなっているような場合、生体管理システムは、「病院へ行ってね」というアドバイスを表示する。このとき、生体管理システムは、ノロウイルスやO-157などの病原体であるウイルスが検出されたときには、「直ぐ病院に行って下さい!」などの命令的な強いアドバイスを表示してもよい。 In the example of FIG. 1, a grandmother who lives far away goes to the toilet, and as a result of examination of stool and urine, pathogens (bacteria, viruses, etc.) in biological materials are not found. When the sugar value, the lactic acid value, or the like is higher than a predetermined value, the biological management system displays an advice “Go to the hospital”. At this time, when a virus that is a pathogen such as Norovirus or O-157 is detected, the biological management system may display strong instructional advice such as “Please go to the hospital immediately!”.
 また、図1の例において、母が、歯磨きをして、その歯ブラシの洗浄水から特定の菌(例えば、ミュータンス菌やラクトバチラス菌などの虫歯菌)が所定の値(例えば、1x10個/ml)を超えるようになった場合に、生体管理システムは、「必ず病院へ行ってね!」といったアドバイスをモニタに表示する。 Further, in the example of FIG. 1, the mother brushes his teeth brush and a specific fungus (for example, a caries fungus such as mutans or Lactobacillus) has a predetermined value (for example, 1 × 10 6 / ml), the biological management system displays advice such as “Please go to the hospital!” on the monitor.
 また、図1の例において、長女から吐き出された排水物(歯磨き後に口を濯いだ水、うがい時に吐き出した水、痰など)から微量のインフルエンザウイルスが検出された場合や、トイレでの尿検査の結果から微量のインフルエンザウイルスが検出された場合など、生体管理システムは、検出限界に近い微少量であっても、伝染の可能性など危険が高いので、例えば「必ず病院へ行ってね!」といった強い表現のアドバイスをモニタに表示する。なお、図1に示す長女は、右手の保持するハンディタイプの測定測定に痰などを注入することで、検査を行ったものとする。 In addition, in the example of FIG. 1, when a small amount of influenza virus is detected from the waste discharged from the eldest daughter (water rinsed after mouth brushing, water discharged during gargle, sputum, etc.), or urine in the toilet Even if a minute amount of influenza virus is detected from the result of the test, the biological management system has a high risk of transmission even if it is a very small amount close to the detection limit. For example, “Be sure to go to the hospital! ”Is displayed on the monitor. Note that the eldest daughter shown in FIG. 1 is inspected by injecting scissors or the like into a handy type measurement measurement held by the right hand.
 また、図1の例において、長男が、これまで病院から風邪の症状で薬を処方してもらい、くすりを飲み続けて学校を休んでいたが、自宅のトイレ33での病原菌の検出量が閾値以下になった場合、生体管理システムは、「明日から学校いいよ!」といったアドバイスをモニタに表示する。 In the example of FIG. 1, the eldest son has been prescribed a medicine from the hospital with symptoms of a cold, and has continued to take medicine and is absent from school. However, the detection amount of pathogenic bacteria in the toilet 33 at home is a threshold value. In the following cases, the living body management system displays an advice such as “Good school from tomorrow!” On the monitor.
 このように、実施形態に係る生体管理システムは、単にユーザの現時点での健康状態を表示するだけではなく、現時点での健康状態から次の行動に対するアドバイスを表示することができる。例えば、学校において登校停止となる疾病(いわゆる感染症)の代表として、腸管出血性大腸菌感染症O-157が知られているが、生体管理システムは、ユーザから検出される菌に基づいて、「明日から学校いいよ!」等のアドバイスを表示することで、感染拡大を防止するツールとしての役割も担うことができる。 As described above, the biological management system according to the embodiment can display not only the current state of health of the user but also advice for the next action based on the current state of health. For example, enterohemorrhagic Escherichia coli infectious disease O-157 is known as a representative disease that is suspended from school (so-called infectious disease). However, the biological management system is based on the bacteria detected by the user. By displaying advice such as “Good school from tomorrow!”, It can also serve as a tool to prevent the spread of infection.
 また、生体管理システムは、各家庭内で検出結果やアドバイスをユーザが見られるようにすることだけでなく、各ユーザの意思も反映できるような表示を実現してもよい。すなわち、病原体や生体由来物質などの生体物質の検査結果、特定菌や特定のウイルスの検出の有無、生体由来物質の量や日々の量の増加傾向などからの判断により、各個人へのメッセージの形で、個人の勝手な判断ではなく、検査結果に基づく適切は判断ができるようなアドバイスをモニタに表示する。このようにすることにより、ユーザにやさしい表現のメッセージ表示となり、検査結果に対する恐怖感を抱かせないことができる。また、生体管理システムでは、ユーザが更に詳しい結果を要求する場合には、要求された情報を表示ができるようにしてもよい。例えば、音声認識によるコンピュータとの対話形式で、必要な情報をモニタに表示するようにしてもよい。 Also, the biological management system may realize a display that can reflect the intention of each user as well as allowing the user to see the detection result and advice in each home. In other words, the message sent to each individual can be determined based on the results of tests on biological substances such as pathogens and biological substances, the presence or absence of detection of specific bacteria and viruses, the amount of biological substances and the tendency to increase daily quantities, etc. In this form, advice is displayed on the monitor so that appropriate judgment based on the test result can be made instead of individual judgment. By doing in this way, it becomes a message display of a user-friendly expression, and it is possible to prevent fear of the test result. Further, in the biological management system, when the user requests a more detailed result, the requested information may be displayed. For example, necessary information may be displayed on a monitor in an interactive manner with a computer by voice recognition.
 このように、実施形態では、歯磨きや排尿や排便といった行為が行われる日常生活の中で、各ユーザの体内に含まれる生体物質を予測し、予測結果に基づく健康情報をフィードバックすることにより、日常生活の中であたかも人間ドックが日々行われるような日常人間ドックを実現する。 Thus, in the embodiment, in daily life in which actions such as tooth brushing, urination and defecation are performed, the biological material contained in each user's body is predicted, and health information based on the prediction result is fed back to the daily life. Realize daily human docks as if they were carried out every day in life.
 上述したような生体物質の予測処理は、宅内に構築される生体管理システムによって実現される。この点について図2を用いて説明する。図2は、実施形態に係る生体管理システムの一例を示す図である。実施形態に係る生体管理システムとしては、歯ブラシ等を洗浄する洗浄機101と、宅内に設置される宅内サーバ50と、表示装置60とを含むスマートブラシシステム1や、洗面台のシンク201と宅内サーバ50と表示装置60とを含むスマートシンクシステム2や、便器301と宅内サーバ50と表示装置60とを含むスマートトイレシステム3が挙げられる。スマートブラシシステム1、スマートシンクシステム2及びスマートトイレシステム3は、磁気的手法や熱的手法により、ユーザの体内に含まれる生体物質を予測することができる。 The biological substance prediction process as described above is realized by a biological management system built in the house. This point will be described with reference to FIG. FIG. 2 is a diagram illustrating an example of a biological management system according to the embodiment. As the living body management system according to the embodiment, a smart brush system 1 including a washing machine 101 for washing a toothbrush and the like, a home server 50 installed in a home, and a display device 60, a sink 201 of a wash basin, and a home server Smart sink system 2 including 50 and display device 60, and smart toilet system 3 including toilet bowl 301, home server 50, and display device 60. The smart brush system 1, the smart sink system 2, and the smart toilet system 3 can predict a biological material contained in the user's body by a magnetic technique or a thermal technique.
 磁気的手法について説明すると、例えば、スマートブラシシステム1は、歯ブラシを洗浄した洗浄水に含まれる体内物質中の生体物質の抗体に結合した磁気ビーズ等に起因する磁界を測定することで、ユーザの体内に含まれる生体物質として抗原(例えば、細菌)を予測する。また、例えば、スマートシンクシステム2は、うがい後にユーザが吐き出した水等に含まれる体内物質に起因する磁界を測定することで、ユーザの体内に含まれる抗原を予測する。また、例えば、スマートトイレシステム3は、排便後に肛門等を洗浄した洗浄水に含まれる体内物質に起因する磁界を測定することで、ユーザの体内に含まれる抗原を予測する。この場合、宅内サーバ50は、予測された各ユーザの生体物質に関する情報を各種の表示装置60に送信する。これにより、表示装置60は、宅内サーバ50から受信した生体物質に関する情報を表示することで、宅内のユーザに健康情報を知らせることができる。表示装置60としては、例えば、宅内のモニタ、洗面所の鏡、携帯端末装置、装着型情報端末、ウェアラブル端末などが挙げられる。 The magnetic method will be described. For example, the smart brush system 1 measures the magnetic field caused by the magnetic beads or the like bound to the antibody of the biological substance in the body substance contained in the washing water in which the toothbrush is washed. Antigens (for example, bacteria) are predicted as biological substances contained in the body. In addition, for example, the smart sink system 2 predicts an antigen contained in the user's body by measuring a magnetic field caused by a substance in the body contained in water or the like exhaled by the user after gargle. In addition, for example, the smart toilet system 3 predicts an antigen contained in the user's body by measuring a magnetic field caused by a substance in the body contained in washing water that has washed the anus after defecation. In this case, the in-home server 50 transmits information related to the predicted biological material of each user to various display devices 60. Thereby, the display device 60 can notify the health information to the user in the home by displaying the information regarding the biological material received from the home server 50. Examples of the display device 60 include a home monitor, a bathroom mirror, a portable terminal device, a wearable information terminal, and a wearable terminal.
 熱的手法について説明すると、例えば、スマートブラシシステム1は、歯ブラシの洗浄水に含まれる体内物質と、所定の酵素との触媒反応時における発熱量を測定することで、ユーザの体内に含まれる生体物質を予測する。同様に、スマートシンクシステム2は、うがい後の水と酵素との触媒反応時における発熱量を測定する。また、スマートトイレシステム3は、肛門等の洗浄水と酵素との触媒反応時における発熱量を測定する。この後の宅内サーバ50による処理は、上述した磁気的手法で説明した処理と同様である。 Explaining the thermal method, for example, the smart brush system 1 measures the calorific value at the time of a catalytic reaction between a substance in the toothbrush washing water and a predetermined enzyme, thereby providing a living body contained in the user's body. Predict substances. Similarly, the smart sink system 2 measures the amount of heat generated during the catalytic reaction between water and the enzyme after gargle. Further, the smart toilet system 3 measures the amount of heat generated during the catalytic reaction between the washing water such as the anus and the enzyme. The subsequent processing by the home server 50 is the same as the processing described in the magnetic method described above.
 また、ユーザ宅外のネットワーク上に形成されるクラウド(以下、「ヘルスケアクラウド」と表記する場合がある)にはサーバ装置であるPHR処理装置20が構築されてもよい。PHR処理装置20は、宅内サーバ50から各個人の生体情報を収集、蓄積する。このとき、PHR処理装置20は、各個人の生体情報と行動情報とを関連付けてライフログ情報として収集、蓄積してもよい。そして、PHR処理装置20は、時系列で収集した膨大な生体情報とライフログ情報とを複数ユーザについて統合化したPHRビッグデータを、ヘルスケアクラウド上で一元管理する。また、PHR処理装置20は、かかるPHRビッグデータを解析することで、将来の疾病発症リスク、食事量、運動量、又は運動負荷に対する体の応答反応等を高度且つ詳細に分析してもよい。ひいては、疾病発症リスクや発作の予兆、自分の体質、ライフスタイルに最適な食事内容、運動、ライフスタイル、薬やサプリメントの選択等、理想像を目指した日々の生活の設計も可能になる。また、PHR処理装置20は、これらの情報を、ユーザにフィードバックするだけでなく医療機関にフィードバックすることもできる。医師は、PHR処理装置20からフィードバックされた解析の結果をもとに、例えば、ハイリスクな疾病発症予備軍を認識し、必要に応じ積極的にこれらの者にアクセスする。なお、ユーザから送信されたセンシングデータは、ユーザの身体の異常検知にも役立てられる。例えば、PHR処理装置20は、ハイリスクな疾病発症予備軍のユーザについて日々送信されるセンシングデータを常時監視し、その中で異常を検知すると、直ちに医療機関等にフィードバックする。PHR処理装置20が、PHRビッグデータの解析の結果を医療機関や各種企業等に提供することで、様々なサービスへの利用や、新産業創出に貢献することができる。 In addition, a PHR processing device 20 that is a server device may be constructed in a cloud formed on a network outside the user's home (hereinafter sometimes referred to as “healthcare cloud”). The PHR processing device 20 collects and stores biometric information of each individual from the home server 50. At this time, the PHR processing device 20 may collect and accumulate life log information in association with each individual's biological information and behavior information. Then, the PHR processing device 20 centrally manages PHR big data obtained by integrating a large amount of biological information and life log information collected in time series for a plurality of users on the healthcare cloud. Further, the PHR processing device 20 may analyze the PHR big data to analyze the risk of developing the disease in the future, the amount of meal, the amount of exercise, or the response response of the body to the exercise load in an advanced and detailed manner. Eventually, it will be possible to design daily life aiming at an ideal image, such as the risk of disease onset, signs of seizures, personal constitution, diet content optimal for lifestyle, exercise, lifestyle, selection of medicines and supplements, etc. In addition, the PHR processing device 20 can feed back such information to a medical institution as well as to the user. Based on the analysis results fed back from the PHR processing device 20, the doctor recognizes, for example, a high-risk disease onset army and actively accesses these persons as necessary. Note that the sensing data transmitted from the user is also useful for detecting abnormalities in the user's body. For example, the PHR processing device 20 constantly monitors sensing data transmitted every day for users of high-risk disease-causing reserves, and when an abnormality is detected therein, immediately feeds back to a medical institution or the like. The PHR processing apparatus 20 can contribute to the use of various services and the creation of new industries by providing the results of PHR big data analysis to medical institutions and various companies.
 なお、図2では、宅内サーバ50が生体物質に関する情報を表示装置60に送信する例を示したが、PHR処理装置20が生体物質に関する情報を表示装置60に送信してもよい。この場合、宅内サーバ50は、PHR処理装置20に生体物質に関する情報を中継する中継装置としての役割を担う。 2 shows an example in which the in-home server 50 transmits information related to the biological material to the display device 60, but the PHR processing device 20 may transmit information related to the biological material to the display device 60. In this case, the in-home server 50 plays a role as a relay device that relays information on the biological substance to the PHR processing device 20.
 以下、第1の実施形態において、磁気的手法による処理について説明し、第2の実施形態において、熱的手法による処理について説明する。 Hereinafter, in the first embodiment, processing by a magnetic method will be described, and in the second embodiment, processing by a thermal method will be described.
(第1の実施形態)
〔スマートブラシシステム〕
 まず、図2に示したスマートブラシシステム1を例に挙げて説明する。ここでは、歯ブラシ等を洗浄した洗浄水にユーザの体内物質が含まれ、その洗浄水から体内物質に含まれる口腔内細菌(抗原の一例)を磁気的手法により検出する例を示す。図3は、第1の実施形態に係るスマートブラシシステム1の一例を示す図である。図3に示すように、スマートブラシシステム1には、洗浄機101と、濃縮装置102と、測定装置103とが含まれる。なお、図3では、洗浄機101に、濃縮装置102及び測定装置103が外付けされる例を示したが、濃縮装置102及び測定装置103は、洗浄機101内部に組み込まれてもよい。
(First embodiment)
[Smart brush system]
First, the smart brush system 1 shown in FIG. 2 will be described as an example. Here, an example will be shown in which the body water of the user is contained in the wash water for washing the toothbrush and the like, and oral bacteria (an example of an antigen) contained in the body substance are detected from the wash water by a magnetic technique. FIG. 3 is a diagram illustrating an example of the smart brush system 1 according to the first embodiment. As shown in FIG. 3, the smart brush system 1 includes a washing machine 101, a concentrating device 102, and a measuring device 103. In FIG. 3, an example in which the concentration device 102 and the measurement device 103 are externally attached to the washing machine 101 is shown, but the concentration device 102 and the measurement device 103 may be incorporated in the washing machine 101.
 洗浄機101は、ユーザを洗浄するための洗浄器具である歯ブラシ(または、歯間ブラシや舌ブラシ等)を洗浄するための洗浄装置である。例えば、洗浄機101は、洗浄水を入れるための容器と、容器内の洗浄水を濃縮装置102に排水する排水口とを有する。また、洗浄機101は、超音波洗浄の機能を有する。例えば、洗浄機101は、容器内に入れられた洗浄水に歯ブラシが浸された状態で、所定の洗浄開始ボタンが押下された場合に、超音波を発生させることで歯ブラシを洗浄する。ここで、歯ブラシにはユーザから得られる体内物質が付着し得るので、洗浄後の洗浄水には、歯ブラシに付着していた体内物質が含まれ得る。すなわち、洗浄機101は、体内物質が含まれ得る洗浄水を濃縮装置102に排水することとなる。 The washing machine 101 is a washing device for washing a toothbrush (or an interdental brush, a tongue brush, or the like) that is a washing tool for washing a user. For example, the cleaning machine 101 has a container for containing cleaning water and a drain outlet for draining the cleaning water in the container to the concentrating device 102. The cleaning machine 101 has a function of ultrasonic cleaning. For example, the cleaning machine 101 cleans the toothbrush by generating an ultrasonic wave when a predetermined cleaning start button is pressed in a state where the toothbrush is immersed in the cleaning water contained in the container. Here, since the internal substance obtained from a user may adhere to a toothbrush, the internal water substance adhering to a toothbrush may be contained in the wash water after washing | cleaning. That is, the washing machine 101 drains the washing water that may contain the in-vivo substance to the concentration device 102.
 また、洗浄機101には、認証部101aが設けられる。認証部101aは、例えば、ユーザの指紋等を読み取るセンサである。認証部101aを用いた認証処理については後述する。 Also, the cleaning machine 101 is provided with an authentication unit 101a. The authentication unit 101a is, for example, a sensor that reads a user's fingerprint and the like. The authentication process using the authentication unit 101a will be described later.
 濃縮装置102は、洗浄機101から排水された排水物質である洗浄水から水分を飛ばす濃縮処理を行う。そして、濃縮装置102は、濃縮後の洗浄水を測定装置103に排出する。なお、図3では、濃縮装置102を示したが、スマートブラシシステム1には、濃縮装置102が含まれなくてもよい。この場合、洗浄機101から排水される洗浄水は、濃縮されることなく測定装置103に流入される。 The concentrating device 102 performs a concentration process for removing moisture from the cleaning water, which is a drainage material drained from the cleaning machine 101. Then, the concentrating device 102 discharges the concentrated cleaning water to the measuring device 103. In FIG. 3, the concentrating device 102 is shown, but the smart brush system 1 may not include the concentrating device 102. In this case, the washing water drained from the washing machine 101 flows into the measuring device 103 without being concentrated.
 測定装置103は、宅内サーバ50との間で無線通信又は有線通信を行う通信部103a(送信部の一例)を有する。また、測定装置103は、濃縮装置102から排出された洗浄水に、磁気ビーズと、生体物質と反応する反応物質として抗体とを混合させ、混合後の混合物から発生する磁界を測定する。そして、測定装置103は、通信部103aを介して、磁界の測定結果を宅内サーバ50に送信する。 The measuring apparatus 103 includes a communication unit 103a (an example of a transmission unit) that performs wireless communication or wired communication with the home server 50. In addition, the measuring device 103 mixes magnetic beads and an antibody as a reactive substance that reacts with a biological substance in the washing water discharged from the concentrating device 102, and measures a magnetic field generated from the mixed mixture. And the measuring apparatus 103 transmits the measurement result of a magnetic field to the home server 50 via the communication part 103a.
 ここで、図3の破線矩形内に測定装置103の内部構成を示す。図示するように、測定装置103は、第1の流路104と、第2の流路105~105と、混合部106と、直流磁界発生部107と、交流磁界発生部108と、磁界センサ110と、処理回路120と、測定制御部130とを有する。 Here, the internal configuration of the measuring apparatus 103 is shown in a broken-line rectangle in FIG. As shown in the figure, the measuring apparatus 103 includes a first flow path 104, second flow paths 105 1 to 105 n , a mixing section 106, a DC magnetic field generation section 107, an AC magnetic field generation section 108, and a magnetic field. The sensor 110, the processing circuit 120, and the measurement control unit 130 are included.
 第1の流路104は、濃縮装置102から排水された体内物質を含む洗浄水が流れる。図3の例の場合、洗浄水は、濃縮装置102が位置する左側から、第2の流路105~105が位置する右側に向かって第1の流路104を流れるものとする。この第1の流路104のうち、濃縮装置102との接続部分は、濃縮装置102から排水された洗浄水(すなわち、洗浄機101から排水された洗浄水)を受け付ける受付部に該当する。 In the first flow path 104, the wash water containing the body substance drained from the concentrator 102 flows. In the case of the example in FIG. 3, it is assumed that the wash water flows through the first flow path 104 from the left side where the concentrating device 102 is located toward the right side where the second flow paths 105 1 to 105 n are located. In the first flow path 104, the connection portion with the concentrating device 102 corresponds to a reception unit that receives the cleaning water drained from the concentrating device 102 (that is, the cleaning water drained from the cleaning machine 101).
 第2の流路105~105は、第1の流路104から分岐した流路であって、第1の流路104から流入する洗浄水が流れる。図3の例の場合、洗浄水は、第1の流路104が位置する左側から、混合部106が位置する右側に向かって第2の流路105~105を流れるものとする。 The second flow paths 105 1 to 105 n are flow paths branched from the first flow path 104, and the washing water flowing from the first flow path 104 flows therethrough. In the case of the example in FIG. 3, it is assumed that the wash water flows through the second flow paths 105 1 to 105 n from the left side where the first flow path 104 is located toward the right side where the mixing unit 106 is located.
 混合部106は、第2の流路105の上流に設けられる。そして、混合部106は、特定の抗体が結合された磁気ビーズを蓄積しており、この磁気ビーズを第2の流路105に注入する。これにより、混合部106は、第2の流路105を流れる洗浄水に、抗体が結合された磁気ビーズを混合させる。上記の通り、第2の流路105を流れる洗浄水には、ユーザから得られる体内物質が含まれ得る。このため、体内物質に特定の抗原(ここの例では、口腔内細菌)が含まれ、かつ、その特定の抗原と抗原抗体反応を起こす抗体が磁気ビーズに結合されている場合には、特定の抗原は、混合部106によって注入された抗体と抗原抗体反応により結合することにより磁気ビーズと結合する。一方、体内物質に含まれる抗原と抗原抗体反応を起こす抗体が磁気ビーズに結合されていない場合には、磁気ビーズに結合されている抗体がないので、体内物質内の抗原と結合できず、抗原抗体反応を起こさない。 Mixing unit 106 is provided upstream of the second flow path 105 1. Then, the mixing unit 106 has accumulated magnetic beads specific antibody is bound, to inject the magnetic beads in the second flow path 105 1. Accordingly, the mixing unit 106, the washing water flowing in the second flow path 105 1, mixing the magnetic beads to which the antibody is bound. As described above, the washing water flowing through the second flow path 105 1 may include internal substances obtained from the user. Therefore, when a specific antigen (in this example, oral bacteria) is contained in the body substance and an antibody that causes an antigen-antibody reaction with the specific antigen is bound to the magnetic beads, The antigen is bound to the magnetic bead by binding to the antibody injected by the mixing unit 106 through an antigen-antibody reaction. On the other hand, when an antibody that causes an antigen-antibody reaction with an antigen contained in a substance in the body is not bound to the magnetic bead, there is no antibody bound to the magnetic bead. Does not cause antibody reaction.
 なお、第2の流路105を例に挙げて説明したが、混合部106は、第2の流路105~105にも設けられる。そして、第2の流路毎に設けられる混合部106は、それぞれ異なる抗体が結合された磁気ビーズを蓄積する。すなわち、混合部106は、第2の流路毎に異なる抗体を、第2の流路に流れる洗浄水と混合させる。これにより、第2の流路105~105では、混合部106によって注入された抗体と抗原抗体反応を起こす特定の抗原(ここの例では、口腔内細菌)のみが、その抗体を介して磁気ビーズと結合する。一例を挙げて説明すると、第2の流路105には、抗原B1と抗原抗体反応を起こす抗体A1が注入され、第2の流路105には、抗原B2と抗原抗体反応を起こす抗体A2が注入され、第2の流路105には、抗原B3と抗原抗体反応を起こす抗体A3が注入されるものとする。そして、第2の流路105~105を流れる洗浄水には抗原B1、B2及びB3が含まれるものとする。この場合、第2の流路105では抗原B1のみが抗体A1を介して磁気ビーズと結合し、第2の流路105では抗原B2のみが抗体A2を介して磁気ビーズと結合し、第2の流路105では抗原B3のみが抗体A3を介して磁気ビーズと結合する。このように、測定装置103では、第2の流路毎に、異なる抗原が抗体を介して磁気ビーズと結合する。なお、以下では、口腔内細菌等の抗原が結合している磁気ビーズを「結合ビーズ」と表記し、抗原が結合していない磁気ビーズを「未結合ビーズ」と表記する場合がある。 Although the second flow path 105 1 is described as an example, the mixing unit 106, also provided in the second flow path 105 2 ~ 105 n. And the mixing part 106 provided for every 2nd flow path accumulate | stores the magnetic beads to which each different antibody was couple | bonded. That is, the mixing unit 106 mixes different antibodies for each second flow path with the washing water flowing in the second flow path. Thereby, in the second flow paths 105 1 to 105 n , only a specific antigen (in this example, oral bacteria) that causes an antigen-antibody reaction with the antibody injected by the mixing unit 106 passes through the antibody. Bind with magnetic beads. By way of example, the second flow path 105 1, antibody A1 to cause antigen B1 and antigen-antibody reaction is injected into the 2 second flow path 105, an antibody causing antigen B2 and antigen-antibody reaction A2 is injected into the second flow path 105 3, it is assumed that the antibody A3 to cause antigen B3 antigen-antibody reaction is injected. The washing water flowing through the second flow paths 105 1 to 105 3 includes antigens B1, B2, and B3. In this case, only the second flow path 105 1, antigen B1 binds to the magnetic beads via an antibody A1, only the second flow path 105 2, antigens B2 are bound to magnetic beads via an antibody A2, the only 2 of the flow path 105 3, the antigen B3 binds to the magnetic beads via an antibody A3. Thus, in the measuring apparatus 103, a different antigen binds to the magnetic bead via the antibody for each second channel. In the following, magnetic beads to which antigens such as oral bacteria are bound may be referred to as “bound beads”, and magnetic beads to which antigens are not bound may be denoted as “unbound beads”.
 直流磁界発生部107は、混合部106よりも第2の流路105の下流に設けられ、直流磁界を発生する。具体的には、直流磁界発生部107は、直流磁界発生部107から発生する磁界内に第2の流路105が位置するように、第2の流路105の近傍に設けられる。例えば、直流磁界発生部107は、着磁コイルによって形成され、この着磁コイルに電圧が印加されることで直流磁界を発生する。また、例えば、直流磁界発生部107は、直流磁界を発生する永久磁石や電磁石等であってもよい。このような直流磁界発生部107は、直流磁界を発生させることで、第2の流路105を流れる磁気ビーズを着磁する。ここでは第2の流路105を例に挙げて説明したが、直流磁界発生部107は、第2の流路105~105にも設けられる。なお、混合部106によって着磁済みの磁気ビーズが注入される場合には、測定装置103は、直流磁界発生部107を有しなくてもよい。 Direct current magnetic field generator 107, than mixing unit 106 disposed downstream of the second flow path 105 1, generates a DC magnetic field. Specifically, the DC magnetic field generator 107, such that the second flow path 105 1 is positioned in the magnetic field generated from the direct current magnetic field generator 107, is provided in the vicinity of the second channel 105 1. For example, the DC magnetic field generator 107 is formed of a magnetized coil, and generates a DC magnetic field by applying a voltage to the magnetized coil. Further, for example, the DC magnetic field generator 107 may be a permanent magnet or an electromagnet that generates a DC magnetic field. Such direct current magnetic field generator 107 by generating a DC magnetic field, magnetized magnetic beads flowing through the second flow path 105 1. This has been described as an example 1 second flow path 105, the DC magnetic field generator 107, also provided to the second flow path 105 2 ~ 105 n. When magnetic beads that have been magnetized by the mixing unit 106 are injected, the measuring apparatus 103 does not have to include the DC magnetic field generation unit 107.
 交流磁界発生部108は、直流磁界発生部107よりも第2の流路105の下流に設けられ、交流磁界を発生する。具体的には、交流磁界発生部108は、交流磁界発生部108から発生する磁界内に第2の流路105が位置するように、第2の流路105の近傍に設けられる。例えば、交流磁界発生部108は、コイルによって形成され、このコイルに電圧が印加されることで交流磁界を発生する。ここでは第2の流路105を例に挙げて説明したが、交流磁界発生部108は、第2の流路105~105にも設けられる。 AC magnetic field generation unit 108, rather than direct current magnetic field generator 107 is provided downstream of the second flow path 105 1, generates an AC magnetic field. Specifically, the AC magnetic field generation unit 108, as the second flow path 105 1 is located in the magnetic field generated from the alternating magnetic field generating unit 108, is provided in the vicinity of the second channel 105 1. For example, the AC magnetic field generation unit 108 is formed of a coil, and generates an AC magnetic field by applying a voltage to the coil. This has been described as an example 1 second flow path 105, the AC magnetic field generation unit 108 is also provided in the second flow path 105 2 ~ 105 n.
 ここで、洗浄水(実際には磁気ビーズ)から発生する磁界は、交流磁界発生部108から発生する交流磁界に応じて変動する。この点について説明する。図3に、抗原109が抗体109を介して結合している磁気ビーズ109が洗浄水に含まれる例を示す。また、ここでは図示しないが、混合部106によって注入される抗体と抗原抗体反応を起こす抗原が洗浄水に含まれない場合には、抗原が結合していない磁気ビーズが洗浄水に含まれることになる。また、抗体と抗原抗体反応を起こす抗原が洗浄水に含まれる場合であっても、抗原の量が抗体の量よりも少ない場合には、抗原が結合している磁気ビーズと、抗原が結合していない磁気ビーズとが洗浄水に含まれることになる。このような磁気ビーズは、交流磁界発生部108によって交流磁界が印加された場合に、ブラウン緩和現象により回転する。このブラウン緩和現象によるブラウン回転運動の速さ(周波数)は、磁気ビーズの質量に依存する。具体的には、結合ビーズは、未結合ビーズと比較して抗原の分だけ質量が重くなり、かつブラウン回転運動の回転半径が大きくなる。このため、結合ビーズのブラウン回転運動は、未結合ビーズのブラウン回転運動よりも遅くなる。すなわち、未結合ビーズよりも相対的に質量が重い結合ビーズは、交流磁界発生部108から発生する交流磁界の周波数が低周波であれば、交流磁界に共鳴し、より大きな磁界を発生する。これに対して、結合ビーズよりも相対的に質量が軽い未結合ビーズは、交流磁界発生部108から発生する交流磁界の周波数が高周波であれば、交流磁界に共鳴し、より大きな磁界を発生する。すなわち、ブラウン回転運動に対応する周波数の交流磁界を交流磁界発生部108から発生させることで、結合ビーズから発生する磁界を大きくしたり、未結合ビーズから発生する磁界を大きくすることが可能となる。 Here, the magnetic field generated from the cleaning water (actually magnetic beads) varies in accordance with the AC magnetic field generated from the AC magnetic field generator 108. This point will be described. Figure 3 shows an example where magnetic beads 109 3 is included in the wash water antigen 109 1 is attached via the antibody 109 2. Although not shown here, when the antigen that causes an antigen-antibody reaction with the antibody injected by the mixing unit 106 is not contained in the washing water, magnetic beads to which no antigen is bound are contained in the washing water. Become. Even if the antigen that causes an antigen-antibody reaction with the antibody is contained in the washing water, if the amount of the antigen is less than the amount of the antibody, the antigen is bound to the magnetic beads to which the antigen is bound. Unwashed magnetic beads will be contained in the washing water. Such magnetic beads rotate due to the Brownian relaxation phenomenon when an alternating magnetic field is applied by the alternating magnetic field generator 108. The speed (frequency) of Brownian rotational movement due to this Brownian relaxation phenomenon depends on the mass of the magnetic beads. Specifically, the bound bead is heavier in mass by the antigen than the unbound bead, and the turning radius of the Brownian rotational motion is increased. For this reason, the Brownian rotational motion of the bonded beads is slower than the Brownian rotational motion of the unbound beads. That is, if the frequency of the AC magnetic field generated from the AC magnetic field generator 108 is low, the bonded beads having a relatively higher mass than the unbound beads resonate with the AC magnetic field and generate a larger magnetic field. On the other hand, an unbound bead having a lighter weight than the bound bead resonates with the alternating magnetic field and generates a larger magnetic field if the frequency of the alternating magnetic field generated from the alternating magnetic field generator 108 is high. . That is, by generating an alternating magnetic field having a frequency corresponding to the Brownian rotational motion from the alternating magnetic field generator 108, it is possible to increase the magnetic field generated from the coupled beads or to increase the magnetic field generated from the unbound beads. .
 磁界センサ110及び処理回路120は、交流磁界発生部108によって交流磁界が印加された結合ビーズや未結合ビーズから発生する磁界を測定する。磁界センサ110及び処理回路120については後述する。 The magnetic field sensor 110 and the processing circuit 120 measure the magnetic field generated from the bound beads and unbound beads to which an alternating magnetic field is applied by the alternating magnetic field generator 108. The magnetic field sensor 110 and the processing circuit 120 will be described later.
 測定制御部130は、例えば、ASIC(Application Specific Integrated Circuit)やFPGA(Field Programmable Gate Array)等の集積回路により実現される。また、例えば、測定制御部130は、CPU(Central Processing Unit)やMPU(Micro Processing Unit)等によって、各種プログラムがRAM(Random Access Memory)を作業領域として実行されることにより実現される。 The measurement control unit 130 is realized by an integrated circuit such as ASIC (Application Specific Integrated Circuit) or FPGA (Field Programmable Gate Array). Further, for example, the measurement control unit 130 is realized by executing various programs using a RAM (Random Access Memory) as a work area by a CPU (Central Processing Unit), an MPU (Micro Processing Unit), or the like.
 このような測定制御部130は、測定装置103による処理を制御する測定部に該当する。具体的には、測定制御部130は、認証部101aによって読み取られた指紋の画像を宅内サーバ50に送信する。この場合、宅内サーバ50は、測定制御部130から受信した画像に基づいてユーザ認証を行い、認証結果を測定制御部130に通知する。このとき、宅内サーバ50は、認証成功である場合には、認証結果とともに、ユーザを識別するためのユーザIDを測定制御部130に通知する。 Such a measurement control unit 130 corresponds to a measurement unit that controls processing by the measurement apparatus 103. Specifically, the measurement control unit 130 transmits the fingerprint image read by the authentication unit 101 a to the home server 50. In this case, the home server 50 performs user authentication based on the image received from the measurement control unit 130 and notifies the measurement control unit 130 of the authentication result. At this time, if the authentication is successful, the home server 50 notifies the measurement control unit 130 of the user ID for identifying the user together with the authentication result.
 そして、測定制御部130は、宅内サーバ50から通知される認証結果が失敗を示す場合には、混合部106に抗体及び磁気ビーズを注入させず、直流磁界発生部107に直流磁界を発生させず、交流磁界発生部108に交流磁界を発生させず、処理回路120に磁界の測定処理を行わせない。これにより、測定制御部130は、ユーザ認証が成功した場合のみ、センシング処理を行うことができる。 Then, when the authentication result notified from the in-home server 50 indicates failure, the measurement control unit 130 does not inject the antibody and the magnetic beads into the mixing unit 106 and does not generate the DC magnetic field at the DC magnetic field generation unit 107. The AC magnetic field generator 108 does not generate an AC magnetic field, and the processing circuit 120 does not perform the magnetic field measurement process. Thereby, the measurement control unit 130 can perform the sensing process only when the user authentication is successful.
 一方、測定制御部130は、認証結果が成功を示す場合には、混合部106に抗体及び磁気ビーズを注入させ、直流磁界発生部107に直流磁界を発生させ、交流磁界発生部108に交流磁界を発生させ、処理回路120に磁界の測定処理を行わせる。上記のとおり、結合ビーズ及び未結合ビーズから発生する磁界の大きさは、交流磁界の周波数に依存する。このため、測定制御部130は、交流磁界発生部108から発生させる交流磁界の周波数を制御することで、結合ビーズから発生する磁界を大きくしたり、未結合ビーズから発生する磁界を大きくすることができる。例えば、測定制御部130は、結合ビーズから発生する磁界を大きくさせた状態で磁界を測定したり、未結合ビーズから発生する磁界を大きくさせた状態で磁界を測定する。そして、測定制御部130は、第2の流路毎に、このような各種状態で磁界を測定し、第2の流路毎の測定結果を宅内サーバ50に送信する。例えば、測定制御部130は、測定状態を識別する状態情報と、第2の流路に注入される抗体を識別する抗体情報(または、第2の流路を識別する情報)と、磁界の測定結果との組合せを宅内サーバ50に送信する。後述する宅内サーバ50は、磁界の測定結果に基づいて、洗浄水に含まれる結合ビーズの量や、結合ビーズと未結合ビーズの相対量を求める。これにより、宅内サーバ50は、ユーザ体内に含まれる抗原(ここの例では、口腔内細菌)の量や濃度を予測する。 On the other hand, when the authentication result indicates success, the measurement control unit 130 causes the mixing unit 106 to inject antibodies and magnetic beads, causes the DC magnetic field generation unit 107 to generate a DC magnetic field, and causes the AC magnetic field generation unit 108 to generate an AC magnetic field. To cause the processing circuit 120 to perform magnetic field measurement processing. As described above, the magnitude of the magnetic field generated from the bound and unbound beads depends on the frequency of the alternating magnetic field. Therefore, the measurement control unit 130 can control the frequency of the AC magnetic field generated from the AC magnetic field generation unit 108 to increase the magnetic field generated from the bound beads or increase the magnetic field generated from the unbound beads. it can. For example, the measurement control unit 130 measures the magnetic field in a state where the magnetic field generated from the bonded beads is increased, or measures the magnetic field in a state where the magnetic field generated from the unbound beads is increased. And the measurement control part 130 measures a magnetic field in such various states for every 2nd flow path, and transmits the measurement result for every 2nd flow path to the home server 50. FIG. For example, the measurement control unit 130 measures state information identifying the measurement state, antibody information identifying the antibody injected into the second flow path (or information identifying the second flow path), and magnetic field measurement. The combination with the result is transmitted to the home server 50. The home server 50 described later obtains the amount of bound beads contained in the wash water and the relative amount of bound and unbound beads based on the magnetic field measurement result. Thereby, the in-home server 50 predicts the amount and concentration of the antigen (in this example, oral bacteria) contained in the user's body.
 なお、抗原及び抗体によるが、抗原抗体反応には所定の時間(例えば、30分~60分程度)がかかる。このため、図3に示した第2の流路105~105には、開閉可能な弁が設けられてもよい。例えば、混合部106が設けられる位置と直流磁界発生部107が設けられる位置との間や、直流磁界発生部107が設けられる位置と交流磁界発生部108が設けられる位置との間に弁が設けられてもよい。そして、測定制御部130は、抗原抗体反応にかかる時間が経過するまで弁が閉状態となるよう制御し、抗原抗体反応にかかる時間が経過した後に弁を開状態となるよう制御してもよい。 Depending on the antigen and antibody, the antigen-antibody reaction takes a predetermined time (for example, about 30 to 60 minutes). Therefore, valves that can be opened and closed may be provided in the second flow paths 105 1 to 105 n shown in FIG. For example, a valve is provided between the position where the mixing unit 106 is provided and the position where the DC magnetic field generation unit 107 is provided, or between the position where the DC magnetic field generation unit 107 is provided and the position where the AC magnetic field generation unit 108 is provided. May be. Then, the measurement control unit 130 may control the valve to be closed until the time required for the antigen-antibody reaction elapses, and may control the valve to be opened after the time required for the antigen-antibody reaction elapses. .
〔磁界センサ〕
 次に、図3に示した磁界センサ110について説明する。磁界センサ110は、外部磁界が印加された場合に磁界の関数として透磁率が変化する磁性体を有し、その磁性体の近傍に設けられた伝送線路に通電された電流(キャリア)の位相に基づいて、磁性体に印加された磁界を検出するためのセンサである。なお、伝送線路を流れる電流は、磁性体における磁場の影響によって変化する特性があり、この特性が、ユーザの体内に含まれる抗原の特性を示すと言える。図4は、第1の実施形態に係る磁界センサ110を示す上面図である。図5は、図4のA-A線に沿った矢視の概略断面図である。
[Magnetic field sensor]
Next, the magnetic field sensor 110 shown in FIG. 3 will be described. The magnetic field sensor 110 has a magnetic body whose permeability changes as a function of the magnetic field when an external magnetic field is applied, and has a phase of a current (carrier) supplied to a transmission line provided in the vicinity of the magnetic body. Based on this, it is a sensor for detecting a magnetic field applied to a magnetic body. In addition, it can be said that the electric current which flows through a transmission line has the characteristic which changes with the influence of the magnetic field in a magnetic body, and this characteristic shows the characteristic of the antigen contained in a user's body. FIG. 4 is a top view showing the magnetic field sensor 110 according to the first embodiment. FIG. 5 is a schematic sectional view taken along the line AA in FIG.
 図4及び図5に示すように、磁界センサ110は、基板111と、CoNbZr(コバルトニオブジルコニウム)薄膜112と、SrTiO(チタン酸ストロンチウム)薄膜113と、Cu(銅)薄膜114~114とを有する。 4 and 5, the magnetic field sensor 110 includes a substrate 111, a CoNbZr (cobalt niobium zirconium) thin film 112, a SrTiO (strontium titanate) thin film 113, and Cu (copper) thin films 114 1 to 114 3 . Have
 基板111は、例えば、カリガラスやソーダライムガラス等のガラスによって形成される。基板111のうち、CoNbZr薄膜112やSrTiO薄膜113が積層される基板111の面における短手方向の寸法H1は、例えば1.15[mm]であり、長手方向の寸法H2は、例えば12[mm]である。また、基板111の厚さH3は、例えば1[mm]である。ただし、基板111の材質や寸法は、この例に限られない。 The substrate 111 is formed of glass such as potash glass or soda lime glass, for example. Of the substrate 111, the dimension H1 in the short direction on the surface of the substrate 111 on which the CoNbZr thin film 112 and the SrTiO thin film 113 are laminated is 1.15 [mm], for example, and the dimension H2 in the longitudinal direction is 12 [mm], for example. ]. The thickness H3 of the substrate 111 is, for example, 1 [mm]. However, the material and dimensions of the substrate 111 are not limited to this example.
 CoNbZr薄膜112は、アモルファスであり、レジストパターンが形成された基板111上に、高周波スパッタ法等により磁気インピーダンス効果を有する磁性膜として成膜される。CoNbZr薄膜112の厚さは、例えば5[μm]である。CoNbZr薄膜112が成膜された後にレジスト剥離が実施されることで、磁性膜のパターンが得られる。また、CoNbZr薄膜112は、磁界中熱処理等によって、所定軸方向への磁気異方性が付与される。ここの例では、CoNbZr薄膜112には、短手方向の磁気異方性が付与される。 The CoNbZr thin film 112 is amorphous, and is formed as a magnetic film having a magnetic impedance effect on the substrate 111 on which a resist pattern is formed by a high frequency sputtering method or the like. The thickness of the CoNbZr thin film 112 is, for example, 5 [μm]. The resist film is peeled off after the CoNbZr thin film 112 is formed, whereby a magnetic film pattern is obtained. Further, the CoNbZr thin film 112 is given magnetic anisotropy in a predetermined axial direction by heat treatment in a magnetic field or the like. In this example, the CoNbZr thin film 112 is given a short direction magnetic anisotropy.
 SrTiO薄膜113は、絶縁層としての強誘電体膜であり、CoNbZr薄膜112が成膜された基板111上に、高周波スパッタ法等により成膜される。SrTiO薄膜113の厚さは、例えば6[μm]以下である。 The SrTiO thin film 113 is a ferroelectric film as an insulating layer, and is formed on the substrate 111 on which the CoNbZr thin film 112 is formed by high frequency sputtering or the like. The thickness of the SrTiO thin film 113 is, for example, 6 [μm] or less.
 Cu薄膜114~114は、コプレーナ線路作成用のレジストパターンが形成されたSrTiO薄膜113上に、高周波スパッタ法等により成膜される。具体的には、SrTiO薄膜113上には、膜の密着性向上のための下地として、厚さ0.2[μm]程度のCr(クロム)が成膜される。そして、Cu薄膜114~114は、Cr薄膜上に高周波スパッタ法等により成膜される。Cu薄膜114~114の厚さは、例えば4[μm]である。Cu薄膜114~114が成膜された後にレジスト剥離が実施されることで、コプレーナ線路のパターンが得られる。なお、隣接するCu薄膜の間隔H4は、例えば0.05[mm]である。また、コプレーナ線路の短手方向の寸法H5は、例えば0.3[mm]である。 The Cu thin films 114 1 to 114 3 are formed on the SrTiO thin film 113 on which a resist pattern for forming a coplanar line is formed by a high frequency sputtering method or the like. Specifically, Cr (chromium) having a thickness of about 0.2 [μm] is formed on the SrTiO thin film 113 as a base for improving the adhesion of the film. Then, the Cu thin films 114 1 to 114 3 are formed on the Cr thin film by a high frequency sputtering method or the like. The thickness of the Cu thin films 114 1 to 114 3 is, for example, 4 [μm]. By removing the resist after the Cu thin films 114 1 to 114 3 are formed, a coplanar line pattern can be obtained. The interval H4 between adjacent Cu thin films is, for example, 0.05 [mm]. The dimension H5 in the short direction of the coplanar line is, for example, 0.3 [mm].
 上述した磁界センサ110は、図3に示した例において、第2の流路105を流れる混合物から発生する磁界内(実際には、結合ビーズや未結合ビーズから発生する磁界内)に、磁気インピーダンス効果を有する磁性体であるCoNbZr薄膜112が位置するように、第2の流路105の近傍に設けられる。また、磁界センサ110のCu薄膜114は、例えば、信号を伝送する伝送線路(ここの例では、コプレーナ線路)となる。このため、第2の流路105を流れる結合ビーズや未結合ビーズから磁界が発生した場合、短手方向の磁気異方性が付与された磁性膜(CoNbZr薄膜112)の透磁率は変化する。この磁性膜の透磁率の変化に応じて、コプレーナ線路のインピーダンスや表皮効果が変化するので、コプレーナ線路を流れる電流(キャリア)の位相や振幅は変動する。後述する処理回路120は、磁界センサ110のコプレーナ線路に流れる電流の位相差を検出することで、結合ビーズや未結合ビーズから発生する磁界を測定する。 Magnetic field sensor 110 described above, in the example shown in FIG. 3, (in practice, the magnetic field in generated from bound beads and unbound beads) field in generated from a mixture flowing through the second flow channel 105 1, the magnetic as CoNbZr film 112 is a magnetic material having an impedance effect is located, it is provided in the vicinity of the second channel 105 1. Furthermore, Cu thin film 114 2 of the magnetic field sensor 110, for example, (in the case examples, coplanar line) transmission lines for transmitting signals becomes. Therefore, if the magnetic field coupling beads or unbound beads flowing through the second flow path 105 1 occurs, the permeability of the magnetic film magnetic anisotropy is imparted in the lateral direction (CoNbZr film 112) changes . Since the impedance and skin effect of the coplanar line change according to the change in the magnetic permeability of the magnetic film, the phase and amplitude of the current (carrier) flowing through the coplanar line vary. The processing circuit 120 described later measures the magnetic field generated from the coupled beads and unbound beads by detecting the phase difference of the current flowing through the coplanar line of the magnetic field sensor 110.
 図4及び図5では直線形状のコプレーナ線路を示したが、コプレーナ線路は直線形状に限られない。この点について図6を用いて説明する。図6は、第1の実施形態に係る他の磁界センサを示す上面図である。図6に例示した磁界センサ110a、110b、110c、110d、110e、110fのそれぞれは、コプレーナ線路114a、114b、114c、114d、114e、114fが形成される。このように、コプレーナ線路は、直線形状に限られず、ミアンダ形状(ジグザグ形状)であってもよい。また、図6に示した例に限られず、コプレーナ線路は、スパイラル形状であってもよい。 4 and 5 show a linear coplanar line, the coplanar line is not limited to a linear shape. This point will be described with reference to FIG. FIG. 6 is a top view showing another magnetic field sensor according to the first embodiment. In each of the magnetic field sensors 110a, 110b, 110c, 110d, 110e, and 110f illustrated in FIG. 6, coplanar lines 114a, 114b, 114c, 114d, 114e, and 114f are formed. Thus, the coplanar line is not limited to a linear shape, but may be a meander shape (zigzag shape). Further, the example is not limited to the example illustrated in FIG. 6, and the coplanar line may have a spiral shape.
 なお、図6では、磁界センサ110a、110b、110c、110d、110e、110fの上部に、磁性薄膜113a、113b、113c、113d、113e、113fが更に設けられる例を示す。このように、伝送線路を磁性薄膜で挟む構造としてもよく、これにより高感度な磁界センサを実現することができる。 FIG. 6 shows an example in which magnetic thin films 113a, 113b, 113c, 113d, 113e, and 113f are further provided on the magnetic field sensors 110a, 110b, 110c, 110d, 110e, and 110f. Thus, it is good also as a structure which pinches | interposes a transmission line with a magnetic thin film, and can implement | achieve a highly sensitive magnetic field sensor by this.
 第1の実施形態に係る測定装置103では、図4に示した磁界センサ110や、図6に示した磁界センサ110a、110b、110c、110d、110e、110fのいずれが採用されてもよい。ただし、磁性薄膜と重なるコプレーナ線路が長いほど、高感度に磁界を検出することができる一方でSN比が劣化する傾向にある。このため、検出精度とSN比との兼ね合いにより、いずれかの磁界センサが採用されることが望ましい。 In the measurement apparatus 103 according to the first embodiment, any of the magnetic field sensor 110 shown in FIG. 4 and the magnetic field sensors 110a, 110b, 110c, 110d, 110e, and 110f shown in FIG. 6 may be adopted. However, the longer the coplanar line that overlaps the magnetic thin film, the more sensitive the magnetic field can be detected while the S / N ratio tends to deteriorate. For this reason, it is desirable to employ any one of the magnetic field sensors depending on the balance between the detection accuracy and the SN ratio.
 また、上記例では、磁界センサ110にコプレーナ線路が形成される例を示したが、この例に限られない。例えば、磁界センサ110には、マイクロストリップ線路や、トリプレート線路が形成されてもよい。 In the above example, the coplanar line is formed in the magnetic field sensor 110. However, the present invention is not limited to this example. For example, the magnetic field sensor 110 may be formed with a microstrip line or a triplate line.
 また、上記例では、基板111上に、磁性膜(CoNbZr薄膜112)、誘電体膜(SrTiO薄膜113)、伝送線路(Cu薄膜114~114)が積層される例を示した。しかし、この例に限られず、磁性膜は、基板上に成膜されずに、伝送線路上に設けられてもよい。この点について図7を用いて説明する。図7は、第1の実施形態に係る磁界センサの他の例を示す図である。図7に示すように、磁界センサ110gは、グランドプレーン115と、絶縁膜116と、導電体117と、磁性薄膜118とを有する。 In the above example, the magnetic film (CoNbZr thin film 112), the dielectric film (SrTiO thin film 113), and the transmission lines (Cu thin films 114 1 to 114 3 ) are stacked on the substrate 111. However, the present invention is not limited to this example, and the magnetic film may be provided on the transmission line without being formed on the substrate. This point will be described with reference to FIG. FIG. 7 is a diagram illustrating another example of the magnetic field sensor according to the first embodiment. As shown in FIG. 7, the magnetic field sensor 110 g includes a ground plane 115, an insulating film 116, a conductor 117, and a magnetic thin film 118.
 グランドプレーン115上には、絶縁膜116と導電体117とが順に積層される。導電体117は、電流が流れる伝送線路として、マイクロストリップ線路を形成する。そして、磁界センサ110gでは、マイクロストリップ線路上に、磁性薄膜118が載置される。磁性薄膜118としては、例えば、CoNbZr、NiFe(ニッケル合金)等の軟磁性膜が用いられる。なお、磁性薄膜118は、マイクロストリップ線路と直交する方向の磁気異方性が付与されているものとする。 An insulating film 116 and a conductor 117 are sequentially stacked on the ground plane 115. The conductor 117 forms a microstrip line as a transmission line through which a current flows. In the magnetic field sensor 110g, the magnetic thin film 118 is placed on the microstrip line. As the magnetic thin film 118, for example, a soft magnetic film such as CoNbZr or NiFe (nickel alloy) is used. The magnetic thin film 118 is assumed to have magnetic anisotropy in a direction orthogonal to the microstrip line.
 図7の例の場合、外部から磁界センサ110gに磁界が印加されると、磁性薄膜118の透磁率が変化することで、伝送線路(マイクロストリップ線路)のインピーダンスが変化する。このため、伝送線路を流れる電流の位相や振幅は、外部磁界の影響により変動する。第1の実施形態では、図7に例示するような磁界センサ110gが用いられてもよい。 In the example of FIG. 7, when a magnetic field is applied to the magnetic field sensor 110g from the outside, the permeability of the magnetic thin film 118 changes, thereby changing the impedance of the transmission line (microstrip line). For this reason, the phase and amplitude of the current flowing through the transmission line vary due to the influence of the external magnetic field. In the first embodiment, a magnetic field sensor 110g illustrated in FIG. 7 may be used.
 なお、図7では直線形状のマイクロストリップ線路を示したが、マイクロストリップ線路は、ミアンダ形状(ジグザグ形状)やスパイラル形状であってもよい。また、磁界センサ110gには、マイクロストリップ線路ではなく、コプレーナ線路や、トリプレート線路が形成されてもよい。 Although FIG. 7 shows a linear microstrip line, the microstrip line may have a meander shape (zigzag shape) or a spiral shape. The magnetic field sensor 110g may be formed with a coplanar line or a triplate line instead of the microstrip line.
〔処理回路〕
 処理回路120は、磁界センサ110に入力される信号と、磁界センサ110から出力される信号とに基づいて、第2の流路を流れる混合物(結合ビーズや未結合ビーズ)から発生する磁界を測定する。例えば、処理回路120は、DMTD(Dual Mixer Time Difference)法などにより磁界を測定する。この点について図8を用いて説明する。図8は、第1の実施形態に係る処理回路120の一例を示す図である。図8に示すように、処理回路120は、発振器121と、位相シフタ122と、発振器123と、ミキサ124a及び124bと、アンプ125a及び125bと、バンドパスフィルタ(BPF:Band Pass Filter)126a及び126bと、コンパレータ127a及び127bと、カウンタ128とを有する。また、処理回路120には、発振器121とミキサ124aとの間に磁界センサ110が設けられる。
[Processing circuit]
The processing circuit 120 measures the magnetic field generated from the mixture (bound beads or unbound beads) flowing through the second flow path based on the signal input to the magnetic field sensor 110 and the signal output from the magnetic field sensor 110. To do. For example, the processing circuit 120 measures the magnetic field by a DMTD (Dual Mixer Time Difference) method or the like. This point will be described with reference to FIG. FIG. 8 is a diagram illustrating an example of the processing circuit 120 according to the first embodiment. As shown in FIG. 8, the processing circuit 120 includes an oscillator 121, a phase shifter 122, an oscillator 123, mixers 124a and 124b, amplifiers 125a and 125b, and band pass filters (BPFs) 126a and 126b. And comparators 127a and 127b and a counter 128. In the processing circuit 120, a magnetic field sensor 110 is provided between the oscillator 121 and the mixer 124a.
 発振器121は、所定の周波数fの第1の繰り返し信号を発生する。例えば、発振器121は、回路に2~3[GHz]の交流電流を流す。発振器121から発生する第1の繰り返し信号は、磁界センサ110と、位相シフタ122とに分配される。 Oscillator 121 generates a first repetitive signal having a predetermined frequency f 1. For example, the oscillator 121 supplies an AC current of 2 to 3 [GHz] to the circuit. The first repetitive signal generated from the oscillator 121 is distributed to the magnetic field sensor 110 and the phase shifter 122.
 磁界センサ110に分配される第1の繰り返し信号は、磁界センサ110のコプレーナ線路によって伝送される。ここで、磁界センサ110は、上記の通り、結合ビーズや未結合ビーズから発生する外部磁界が印加されることにより、伝送線路のインピーダンスが変化する。このため、磁界センサ110に外部磁界が印加される場合には、第1の繰り返し信号の位相は変調する。 The first repetitive signal distributed to the magnetic field sensor 110 is transmitted by the coplanar line of the magnetic field sensor 110. Here, as described above, the magnetic field sensor 110 changes the impedance of the transmission line by applying an external magnetic field generated from the coupled beads or the unbound beads. For this reason, when an external magnetic field is applied to the magnetic field sensor 110, the phase of the first repetitive signal is modulated.
 また、位相シフタ122に分配される第1の繰り返し信号は、位相シフタ122によって減衰されるとともに位相シフトされる。ここで、位相シフタ122から出力される第1の繰り返し信号は、磁界センサ110を経由しないため、結合ビーズや未結合ビーズから発生する外部磁界の影響を受けない。このため、位相シフタ122から出力される第1の繰り返し信号の位相は変調しない。 Also, the first repetitive signal distributed to the phase shifter 122 is attenuated and phase shifted by the phase shifter 122. Here, since the first repetitive signal output from the phase shifter 122 does not pass through the magnetic field sensor 110, it is not affected by the external magnetic field generated from the bound beads or unbound beads. For this reason, the phase of the first repetitive signal output from the phase shifter 122 is not modulated.
 発振器123は、第1の繰り返し信号の周波数fとは異なる周波数fの第2の繰り返し信号を発生する。発振器123から発生する第2の繰り返し信号は、ミキサ124aと、ミキサ124bとに分配される。 Oscillator 123 generates a second repetitive signal of a different frequency f 2 to the frequency f 1 of the first repetitive signal. The second repetitive signal generated from the oscillator 123 is distributed to the mixer 124a and the mixer 124b.
 ミキサ124aは、発振器123から発生する第2の繰り返し信号と、磁界センサ110からの出力信号とを混合する。また、ミキサ124bは、発振器123から発生する第2の繰り返し信号と、位相シフタ122からの出力信号とを混合する。例えば、ミキサ124a及び124bは、2~3[GHz]の繰り返し信号を5[kHz]程度にダウンコンバートする。 The mixer 124 a mixes the second repetitive signal generated from the oscillator 123 and the output signal from the magnetic field sensor 110. Further, the mixer 124 b mixes the second repetitive signal generated from the oscillator 123 and the output signal from the phase shifter 122. For example, the mixers 124a and 124b down-convert a repetitive signal of 2 to 3 [GHz] to about 5 [kHz].
 ミキサ124aから出力される信号は、アンプ125aによって増幅され、バンドパスフィルタ126aによって所定の周波数の成分のみが通過され、コンパレータ127aによって矩形波に変換される。同様に、ミキサ124bから出力される信号は、アンプ125bによって増幅され、バンドパスフィルタ126bによって所定の周波数の成分のみが通過され、コンパレータ127bによって矩形波に変換される。 The signal output from the mixer 124a is amplified by the amplifier 125a, only the component of the predetermined frequency is passed by the band-pass filter 126a, and is converted into a rectangular wave by the comparator 127a. Similarly, the signal output from the mixer 124b is amplified by the amplifier 125b, only the component of the predetermined frequency is passed through the band-pass filter 126b, and is converted into a rectangular wave by the comparator 127b.
 カウンタ128は、信号波形129aによって示されるようなコンパレータ127aからの出力信号と、信号波形129bによって示されるようなコンパレータ127bからの出力信号との位相差を時間差として計測する。上記の通り、磁界センサ110は、外部磁界が印加された場合に磁界の関数として透磁率が変化する磁性体(例えば、CoNbZr薄膜112)を有する。すなわち、カウンタ128は、計測した位相差に基づいて、磁界センサ110に印加された磁界、すなわち、結合ビーズや未結合ビーズから発生した磁界を計測することができる。 The counter 128 measures the phase difference between the output signal from the comparator 127a as shown by the signal waveform 129a and the output signal from the comparator 127b as shown by the signal waveform 129b as a time difference. As described above, the magnetic field sensor 110 has a magnetic material (for example, the CoNbZr thin film 112) whose permeability changes as a function of the magnetic field when an external magnetic field is applied. That is, the counter 128 can measure the magnetic field applied to the magnetic field sensor 110 based on the measured phase difference, that is, the magnetic field generated from the bound beads and unbound beads.
 このように、図8に示した処理回路120によれば、出力信号の位相差に基づき磁界を検出することによって、磁界センサ110及び各回路素子の熱雑音によるSN比の制約がなくなるため、高感度の磁気センサユニットを構成することができる。また、図8に示した処理回路120によれば、ミキサ124a、124bからの出力信号をアンプ125a、125bによってそれぞれ増幅することで、SN比の向上させることができる。 As described above, according to the processing circuit 120 illustrated in FIG. 8, since the magnetic field is detected based on the phase difference of the output signal, the restriction of the SN ratio due to the thermal noise of the magnetic field sensor 110 and each circuit element is eliminated. A sensitive magnetic sensor unit can be constructed. Further, according to the processing circuit 120 shown in FIG. 8, the S / N ratio can be improved by amplifying the output signals from the mixers 124a and 124b by the amplifiers 125a and 125b, respectively.
〔宅内サーバ〕
 次に、宅内サーバ50について説明する。宅内サーバ50は、ユーザ宅内に設けられ、ユーザに関する各種情報を管理する管理装置である。図9は、第1の実施形態に係る宅内サーバ50の一例を示す図である。図9に示すように、宅内サーバ50は、通信部51と、ユーザ情報記憶部52と、認証部53と、受信部54と、予測部55と、表示制御部56と、送信部57とを有する。
[Home server]
Next, the home server 50 will be described. The home server 50 is a management device that is provided in the user's home and manages various types of information related to the user. FIG. 9 is a diagram illustrating an example of the home server 50 according to the first embodiment. As shown in FIG. 9, the home server 50 includes a communication unit 51, a user information storage unit 52, an authentication unit 53, a reception unit 54, a prediction unit 55, a display control unit 56, and a transmission unit 57. Have.
 通信部51は、測定装置103の通信部103aとの間で無線通信や有線通信を行う。例えば、通信部51は、通信部103aから、認証部101aによって取得された認証用の指紋画像や、測定装置103によって測定された磁界に関する情報を受信する。 The communication unit 51 performs wireless communication or wired communication with the communication unit 103a of the measurement apparatus 103. For example, the communication unit 51 receives, from the communication unit 103a, an authentication fingerprint image acquired by the authentication unit 101a and information on the magnetic field measured by the measurement device 103.
 ユーザ情報記憶部52は、ユーザに関する各種情報を記憶する。例えば、ユーザ情報記憶部52は、宅内に所在する家族や、別宅に暮らす家族に関する情報を記憶する。ここで、図10に、第1の実施形態に係るユーザ情報記憶部52の一例を示す。図10に示すように、ユーザ情報記憶部52には、「ユーザID」、「日時」、「抗原」といった項目が含まれる。 The user information storage unit 52 stores various types of information related to the user. For example, the user information storage unit 52 stores information on a family located in the house or a family living in another house. Here, FIG. 10 shows an example of the user information storage unit 52 according to the first embodiment. As shown in FIG. 10, the user information storage unit 52 includes items such as “user ID”, “date and time”, and “antigen”.
 「ユーザID」は、ユーザを識別するための識別情報を示す。「日時」は、ユーザから口腔内細菌等の生体物質がセンシングされた日時を示す。「抗原」は、ユーザの体内に含まれる抗原の量を示す。なお、図10では、歯周病を起こす嫌気性菌として知られている「ポルフィノモナスジンジバリス」と「プレボテラインテルメディア」を示したが、これに限られない。例えば、ユーザ情報記憶部52は、歯周病を起こす嫌気性菌として、「アクチノバチラスアクチノミセテムコミタンス」、「ポルフィロモナスジンジバリス」、「フソバクテリウムヌクレアトゥム」、「トレポネーマデンティコーラ」等を記憶してもよい。また、ユーザ情報記憶部52は、虫歯原因菌(例えば、「ミュータンス菌」や「ラクトバチラス菌」)等を記憶してもよい。 “User ID” indicates identification information for identifying a user. “Date and time” indicates the date and time when a biological substance such as oral bacteria was sensed by the user. “Antigen” indicates the amount of antigen contained in the user's body. Although FIG. 10 shows “Porphynomonas gingivalis” and “Prevotella Intel Media” known as anaerobic bacteria that cause periodontal disease, the present invention is not limited thereto. For example, as the anaerobic bacteria that cause periodontal disease, the user information storage unit 52 includes “Actinobacillus actinomycetemcomitans”, “Porphyromonas gingivalis”, “Fusobacterium nucleatum”, and “Trepone madenticola”. Etc. may be stored. Further, the user information storage unit 52 may store caries causing bacteria (for example, “mutans bacteria” or “Lactobacillus bacteria”).
 すなわち、図10では、2014年12月1日7時にスマートブラシシステム1を利用した祖父の体内に、「ポルフィノモナスジンジバリス」が「M11」個含まれ、「プレボテラインテルメディア」が「N11」個含まれると予測された例を示す。なお、ここでは、ユーザ情報記憶部52に抗原の量が記憶される例を示したが、抗原の濃度(個/ml)が記憶されてもよい。 That is, in FIG. 10, “M11” “Porphynomonas gingivalis” is included in the body of the grandfather using the smart brush system 1 at 7:00 on December 1, 2014, and “Prevoterra Intel Media” is “N11”. An example predicted to be included is shown. Here, an example in which the amount of the antigen is stored in the user information storage unit 52 is shown, but the concentration of the antigen (number / ml) may be stored.
 認証部53は、測定装置103から受信した認証用の指紋画像に基づいて、ユーザの認証処理を行う。例えば、図10では図示を省略したが、ユーザ情報記憶部52は、予め各ユーザによって登録された指紋画像を記憶する。この場合、認証部53は、認証用の指紋画像と、登録済みの指紋画像とを比較することで認証処理を行う。そして、認証部53は、通信部51を介して、認証結果を測定装置103に通知する。上記の通り、宅内サーバ50は、認証成功である場合には、認証結果とともにユーザIDを測定制御部130に通知する。 The authentication unit 53 performs user authentication processing based on the fingerprint image for authentication received from the measurement apparatus 103. For example, although not shown in FIG. 10, the user information storage unit 52 stores a fingerprint image registered in advance by each user. In this case, the authentication unit 53 performs authentication processing by comparing the fingerprint image for authentication with the registered fingerprint image. Then, the authentication unit 53 notifies the measurement device 103 of the authentication result via the communication unit 51. As described above, if the authentication is successful, the home server 50 notifies the measurement control unit 130 of the user ID together with the authentication result.
 受信部54は、通信部51を介して、測定装置103から磁界の測定結果を受信する。例えば、受信部54は、測定装置103から、測定状態を識別する状態情報と、第2の流路に注入される抗体を識別する抗体情報と、磁界の測定結果との組合せを受信する。 The receiving unit 54 receives the measurement result of the magnetic field from the measuring device 103 via the communication unit 51. For example, the receiving unit 54 receives a combination of state information for identifying a measurement state, antibody information for identifying an antibody injected into the second flow path, and a magnetic field measurement result from the measurement device 103.
 予測部55は、受信部54によって受信された磁界の測定結果に基づいて、混合部106によって混合された抗体毎に、その抗体との間で抗原抗体反応を起こす抗原であってユーザの体内に含まれる抗原を予測する。具体的には、予測部55は、測定装置103から送信される抗体情報に基づいて、抗原の種類を特定する。そして、予測部55は、測定装置103から送信される状態情報と磁界の測定結果に基づいて、結合ビーズの量や、未結合ビーズの量を予測する。例えば、予測部55は、結合ビーズから発生する磁界を大きくした状態で測定装置103により測定された磁界に基づいて、結合ビーズの量を予測することで、結合ビーズに結合されている抗原の量を予測する。また、例えば、予測部55は、未結合ビーズから発生する磁界を大きくした状態で測定装置103により測定された磁界に基づいて、未結合ビーズの量を予測してもよい。そして、予測部55は、結合ビーズと未結合ビーズとの相対量を予測してもよい。なお、測定装置103は、結合ビーズから発生する磁界を大きくした状態のみで磁界を測定してもよい。この場合、予測部55は、結合ビーズの量のみを予測してもよい。また、予測部55は、第2の流路を流れる洗浄水の量が予め決められている場合には、結合ビーズの量から洗浄水に含まれる抗原の濃度を予測してもよい。このようにして、予測部55は、ユーザ体内に含まれる抗原(ここの例では、口腔内細菌)の種類及び量を予測する。そして、予測部55は、予測結果である抗原の量を、ユーザIDに対応付けてユーザ情報記憶部52に格納する。なお、予測部55による予測結果は、ユーザ体内に含まれる抗原の種類及び量の検出結果であると言える。すなわち、予測部55は、抗原の種類及び量を検出するとも言える。 The predicting unit 55 is an antigen that causes an antigen-antibody reaction with each antibody mixed by the mixing unit 106 based on the measurement result of the magnetic field received by the receiving unit 54. Predict antigens involved. Specifically, the prediction unit 55 identifies the type of antigen based on the antibody information transmitted from the measurement device 103. Then, the prediction unit 55 predicts the amount of bound beads and the amount of unbound beads based on the state information transmitted from the measuring apparatus 103 and the measurement result of the magnetic field. For example, the predicting unit 55 predicts the amount of bound beads based on the magnetic field measured by the measuring device 103 in a state where the magnetic field generated from the bound beads is increased, so that the amount of antigen bound to the bound beads. Predict. For example, the prediction unit 55 may predict the amount of unbound beads based on the magnetic field measured by the measurement device 103 in a state where the magnetic field generated from the unbound beads is increased. Then, the prediction unit 55 may predict the relative amount of the bound bead and the unbound bead. Note that the measuring device 103 may measure the magnetic field only in a state where the magnetic field generated from the binding beads is increased. In this case, the prediction unit 55 may predict only the amount of bound beads. The predicting unit 55 may predict the concentration of the antigen contained in the wash water from the amount of the bound beads when the amount of the wash water flowing through the second flow path is determined in advance. In this way, the prediction unit 55 predicts the type and amount of antigen (in this example, oral bacteria) included in the user's body. Then, the prediction unit 55 stores the amount of antigen as a prediction result in the user information storage unit 52 in association with the user ID. In addition, it can be said that the prediction result by the prediction part 55 is a detection result of the kind and quantity of the antigen contained in a user's body. That is, it can be said that the prediction unit 55 detects the type and amount of the antigen.
 なお、上記例に限られず、予測部55は、ユーザの体内に含まれる抗原の量を予測せずに、単にユーザの体内に所定の抗原が含まれるか否かを予測してもよい。また、予測部55は、予測結果である抗原等の生体物質から、ユーザの健康状態を判定する判定部として機能してもよい。例えば、予測部55は、予測結果である抗原の量に基づいて、ユーザの健康状態を判定してもよい。すなわち、予測部55は、ユーザが患っている病気、又は、ユーザが将来患うおそれがある病気を予測してもよい。一例を挙げて説明すると、予測部55は、ユーザの体内に虫歯原因菌が含まれると予測したものとする。このとき、予測部55は、予測した虫歯原因菌の量が所定量よりも多い場合には、ユーザが虫歯を患っていると判定したり、虫歯を患うおそれがあると判定する。 Note that the present invention is not limited to the above example, and the prediction unit 55 may simply predict whether or not a predetermined antigen is contained in the user's body without predicting the amount of antigen contained in the user's body. The prediction unit 55 may function as a determination unit that determines a user's health state from a biological material such as an antigen that is a prediction result. For example, the prediction unit 55 may determine the health state of the user based on the amount of antigen that is the prediction result. That is, the prediction unit 55 may predict a disease that the user is suffering from or a disease that the user is likely to suffer in the future. To explain with an example, it is assumed that the predicting unit 55 predicts that a causative agent for caries is included in the user's body. At this time, the prediction unit 55 determines that the user is suffering from caries or that there is a possibility of suffering from caries when the predicted amount of the causative agent for caries is greater than a predetermined amount.
 表示制御部56は、予測部55による予測結果を表示装置60aに表示させる。例えば、表示制御部56は、予測部55による予測結果を表示装置60aに送信することで、予測結果を表示装置60aに表示させる。ここで、図11に、第1の実施形態における表示例を示す。図11では、予測部55によって虫歯原因菌がユーザ体内に含まれると予測された例を示す。また、図11では、洗面所の鏡が表示機能を有する表示装置60aである例を示す。このような表示装置60aは、例えば、ユーザと対向する対向面が鏡のように特殊加工された透明部材(例えば、ガラス等)が表示ディプレイの表示面に取り付けられることで実現される。また、図11では、表示装置60aが無線通信機能を有するものとする。 The display control unit 56 displays the prediction result by the prediction unit 55 on the display device 60a. For example, the display control unit 56 causes the display device 60a to display the prediction result by transmitting the prediction result from the prediction unit 55 to the display device 60a. Here, FIG. 11 shows a display example in the first embodiment. FIG. 11 shows an example in which the causative causative bacteria are predicted to be included in the user's body by the prediction unit 55. FIG. 11 shows an example in which the bathroom mirror is a display device 60a having a display function. Such a display device 60a is realized, for example, by attaching a transparent member (for example, glass) whose surface facing the user is specially processed like a mirror to the display surface of the display display. In FIG. 11, the display device 60a is assumed to have a wireless communication function.
 図11に示すように、表示制御部56は、ユーザ体内に虫歯原因菌が含まれると予測部55に予測された場合に、虫歯原因菌が発見された旨を表示装置60aに表示制御する。具体的には、表示制御部56は、虫歯原因菌が発見された旨のメッセージを表示装置60aに送信する。これにより、表示装置60aは、虫歯原因菌が発見された旨のメッセージ(例えば、「虫歯菌が発見されました」)を表示する。 As shown in FIG. 11, when the prediction unit 55 predicts that a causative causative bacterium is included in the user's body, the display control unit 56 performs display control on the display device 60 a to the effect that the causative causative fungus has been found. Specifically, the display control unit 56 sends a message to the display device 60a that a causative agent for caries has been found. Accordingly, the display device 60a displays a message (for example, “Caries fungus has been found”) indicating that a causative agent for caries has been found.
 また、例えば、表示制御部56は、予測部55によって虫歯原因菌の量が予測された場合に、虫歯原因菌の量に関する情報を表示装置60aに表示制御してもよい。この場合、表示装置60aは、虫歯原因菌の量に関するメッセージ(例えば、「虫歯菌が20個発見されました」)を表示する。また、例えば、表示制御部56は、予測部55によってユーザの健康状態が予測された場合には、健康状態に関するメッセージを表示装置60aに表示制御してもよい。図11の例では、表示装置60aは、虫歯原の危険性に関するメッセージ(例えば、「虫歯のおそれがあります」、「虫歯の可能性は低いです」)を表示制御する。 Also, for example, when the amount of carious causative bacteria is predicted by the predicting unit 55, the display control unit 56 may display and control information on the amount of carious causative bacteria on the display device 60a. In this case, the display device 60a displays a message related to the amount of caries-causing bacteria (for example, “20 caries were found”). Further, for example, when the prediction unit 55 predicts the user's health state, the display control unit 56 may display and control a message related to the health state on the display device 60a. In the example of FIG. 11, the display device 60 a controls display of messages related to the danger of caries (for example, “there is a possibility of caries”, “the possibility of caries is low”).
 また、表示制御部56は、予測部55による予測結果を時系列に表示装置60aに表示させてもよい。例えば、表示制御部56は、ユーザ情報記憶部52から所定期間(例えば、1週間や1か月)に収集された抗原の量を取得し、抗原の量とセンシング日時との関係を示すグラフに関する情報を表示装置60aに送信する。このとき、表示制御部56は、グラフ上に虫歯の危険性に関するメッセージを含めてもよい。この場合、表示装置60aは、例えば、抗原の量とセンシング日時との関係を示すグラフとともに、虫歯の危険性に関するメッセージ(例えば、「ローリスク」、「ハイリスク」)を表示制御する。図11の例では、表示装置60aは、30日前から20日前までは虫歯原因菌の量がローリスクの範囲であったものの、10日前から今日までに虫歯原因菌の量がハイリスクの範囲であることを表示する。これにより、ユーザは、時系列に表示される病気の危険度を把握することで、これまでの生活を振り返り、今後の生活習慣を改善することができる。 Further, the display control unit 56 may display the prediction results by the prediction unit 55 on the display device 60a in time series. For example, the display control unit 56 obtains the amount of antigen collected in a predetermined period (for example, one week or one month) from the user information storage unit 52, and relates to a graph showing the relationship between the amount of antigen and the sensing date and time. Information is transmitted to the display device 60a. At this time, the display control unit 56 may include a message regarding the danger of tooth decay on the graph. In this case, for example, the display device 60a controls display of a message (for example, “low risk” and “high risk”) regarding the danger of dental caries together with a graph indicating the relationship between the amount of antigen and the sensing date and time. In the example of FIG. 11, the amount of the causative causative bacteria in the display device 60a is in a low risk range from 30 days to 20 days ago, but the amount of the caries causative bacteria is in a high risk range from 10 days ago to today. Display. Thereby, the user can look back on the life so far and can improve future lifestyle habits by grasping the risk of disease displayed in time series.
 また、図11では図示することを省略したが、表示制御部56は、図1を用いて説明したように、予測部55によって予測された抗原の量に応じたアドバイス(例えば、「1日3回歯磨きしましょう」)を表示装置に表示させてもよい。この点について一例を挙げて説明する。例えば、宅内サーバ50には、抗原量の閾値と、ユーザの健康状態と、アドバイスとを対応付けた健康状態テーブルを保持するものとする。この場合、予測部55は、例えば、予測結果である抗原等の量が閾値を超えた場合に、健康状態テーブルにおいて閾値に対応する健康状態がユーザの状態であると判定する。そして、表示制御部56は、健康状態テーブルにおいてユーザの健康状態に対応するアドバイスを表示装置に表示させてもよい。なお、健康状態テーブルには、同一の抗原に対して複数の閾値が記憶されてもよい。例えば、健康状態テーブルには、抗原Aの閾値「T[個/dl]」と、健康状態「虫歯なし」と、アドバイス「よく歯磨きできています」とを対応付けた情報と、抗原Aの閾値「T[個/dl]」と、健康状態「虫歯になる恐れあり」と、アドバイス「1日3回歯磨きしましょう」とを対応付けた情報と、抗原Aの閾値「T[個/dl]」と、健康状態「虫歯の可能性が高い」と、アドバイス「必ず歯医者へ行ってね!」とを対応付けた情報とを記憶する。ここでは、「T<T<T」であるものとする。この場合、予測部55は、予測結果である抗原Aの量が閾値T未満である場合には、ユーザの健康状態が「虫歯なし」であると判定する。そして、表示制御部56は、アドバイス「よく歯磨きできています」(又は、健康状態「虫歯なし」)を表示装置に表示させる。また、予測部55は、予測結果である抗原Aの量が閾値T以上かつ閾値T未満である場合には、ユーザの健康状態が「虫歯になる恐れあり」と判定する。そして、表示制御部56は、アドバイス「1日3回歯磨きしましょう」を表示装置に表示させる。また、予測部55は、予測結果である抗原Aの量が閾値T以上である場合には、ユーザの健康状態が「虫歯の可能性が高い」と判定する。そして、表示制御部56は、アドバイス「必ず歯医者へ行ってね!」を表示装置に表示させる。なお、ここでは、虫歯を例に挙げて説明したが、健康状態テーブルには、予測され得る生体物質毎に、健康状態(糖尿病など)やアドバイスが対応付けられた情報が記憶される。また、表示制御部56は、これまで表示してきたアドバイスに応じて、現時点で表示させるアドバイスを変動させてもよい。例えば、表示制御部56は、予測部55によって感染症の病原菌がユーザの体内にあると予測されたことから、これまでに「学校に行かないで」といったアドバイスを表示し続けていたものとする。その後に、表示制御部56は、予測部55によって感染症の病原菌がユーザの体内にあると予測されなくなった最初の日には、「学校に行っていいよ」といったアドバイスを表示してもよい。そして、この例において、表示制御部56は、「学校に行っていいよ」と表示した翌日からは、予測部55によって感染症の病原菌がユーザの体内にあると予測されていない限り、例えば「今日も健康です」といったアドバイスを表示する。 Although not shown in FIG. 11, the display control unit 56 advises according to the amount of antigen predicted by the prediction unit 55 as described with reference to FIG. Let's brush dentition ") on the display. This point will be described with an example. For example, it is assumed that the home server 50 holds a health state table in which the antigen amount threshold value, the user's health state, and advice are associated with each other. In this case, for example, when the amount of an antigen or the like as a prediction result exceeds a threshold, the prediction unit 55 determines that the health state corresponding to the threshold in the health state table is the user's state. And the display control part 56 may display the advice corresponding to a user's health condition on a display apparatus in a health condition table. In the health condition table, a plurality of threshold values may be stored for the same antigen. For example, in the health status table, information that associates the threshold value “T 1 [units / dl]” of antigen A with the health status “no tooth decay” and advice “well brushed” and antigen A Information that associates the threshold “T 2 [pieces / dl]” with the health condition “May cause tooth decay” and the advice “Let's brush your teeth three times a day” with the threshold “T 3 [pieces] for antigen A / Dl] ”, information relating to the health condition“ high possibility of tooth decay ”and the advice“ Be sure to go to the dentist! ”. Here, it is assumed that “T 1 <T 2 <T 3 ”. In this case, the prediction unit 55, when the amount of the antigen A is a prediction result is less than the thresholds T 1 determines the health condition of the user is "no caries". Then, the display control unit 56 causes the display device to display the advice “I have brushed my teeth well” (or the health condition “No tooth decay”). Also, the prediction unit 55, when the amount of the antigen A is a prediction result is thresholds T 1 or more and less than the threshold T 2 are, determines the health status of the user that "there is a possibility to become a dental caries". Then, the display control unit 56 displays the advice “Let's brush your teeth three times a day” on the display device. Also, the prediction unit 55, when the amount of the antigen A is a prediction result is the threshold value T 3 or more, determines the health status of the user is a "likely caries". Then, the display control unit 56 displays the advice “Please go to the dentist!” On the display device. In addition, although the tooth decay was described here as an example, the health state table stores information in which a health state (such as diabetes) and advice are associated with each predictable biological material. Further, the display control unit 56 may vary the advice displayed at the present time in accordance with the advice displayed so far. For example, it is assumed that the display control unit 56 has continued to display advice such as “Don't go to school” so far, because the prediction unit 55 has predicted that the pathogen of the infectious disease is in the user's body. . Thereafter, the display control unit 56 may display an advice such as “You can go to school” on the first day when the prediction unit 55 no longer predicts that the infectious disease pathogen is in the user's body. In this example, the display control unit 56, for example, “today” unless the prediction unit 55 predicts that the pathogen of the infectious disease is in the user's body from the next day when “you can go to school” is displayed. "I am healthy too".
 また、例えば、宅内サーバ50は、予測部55による予測結果をPHR処理装置20に送信することで、PHR処理装置20を介して医師からのアドバイスを取得してもよい。この場合、表示制御部56は、医師からのアドバイスを表示装置に表示させてもよい。 Further, for example, the home server 50 may acquire advice from a doctor via the PHR processing device 20 by transmitting the prediction result by the prediction unit 55 to the PHR processing device 20. In this case, the display control unit 56 may display advice from the doctor on the display device.
 また、図11では、鏡が表示機能を有する表示装置60aであるものとして説明したが、この例に限られない。この点について図12を用いて説明する。図12は、第1の実施形態における表示例を示す図である。図12に示すスマートブラシシステム1には、投影機70が含まれる。投影機70は、例えば、洗面所の天井や壁に取り付けられ、宅内サーバ50との間における無線通信機能を有する。そして、投影機70は、宅内サーバ50から受信する各種メッセージを洗面台の鏡60bに視認可能に投影する。このように、投影機70によって鏡に各種メッセージを表示させてもよい。 In FIG. 11, the mirror is described as the display device 60a having a display function, but the present invention is not limited to this example. This point will be described with reference to FIG. FIG. 12 is a diagram illustrating a display example in the first embodiment. A smart brush system 1 shown in FIG. 12 includes a projector 70. For example, the projector 70 is attached to the ceiling or wall of a washroom, and has a wireless communication function with the in-home server 50. Then, the projector 70 projects various messages received from the home server 50 on the mirror 60b of the washstand so as to be visible. As described above, various messages may be displayed on the mirror by the projector 70.
 また、図11及び図12では、洗面台の鏡に各種メッセージが表示される例を示したが、図2に示した例のように、表示制御部56は、宅内のモニタ、携帯端末装置、装着型情報端末、ウェアラブル端末などの表示装置に各種メッセージを表示させてもよい。 11 and 12 show examples in which various messages are displayed on the mirror of the washstand. As in the example shown in FIG. 2, the display control unit 56 includes a home monitor, a mobile terminal device, Various messages may be displayed on a display device such as a wearable information terminal or a wearable terminal.
 また、上記例では、宅内サーバ50が表示装置60aに各種メッセージを送信する例を示したが、宅内サーバ50は、各種メッセージを測定装置103に送信してもよい。この場合、測定装置103は、自装置(測定装置103)に予め対応付けられている表示装置に、宅内サーバ50から受信した各種メッセージを表示させる。例えば、洗面所に配置される洗浄機101の測定装置103には、洗面台の鏡に設けられた表示装置60aが対応付けられているものとする。この場合、測定装置103は、表示装置60aに各種メッセージを表示させる。これにより、宅内サーバ50は、ユーザ近傍にある表示装置に、そのユーザに対する各種メッセージを表示させることができる。 In the above example, the home server 50 transmits various messages to the display device 60a. However, the home server 50 may transmit various messages to the measurement device 103. In this case, the measuring device 103 displays various messages received from the home server 50 on a display device associated with the own device (measuring device 103) in advance. For example, it is assumed that the display device 60a provided in the mirror of the washstand is associated with the measuring device 103 of the washing machine 101 disposed in the washroom. In this case, the measuring apparatus 103 displays various messages on the display device 60a. Thereby, the home server 50 can display various messages for the user on the display device in the vicinity of the user.
 送信部57は、予測部55による予測結果をPHR処理装置20に送信する。例えば、送信部57は、予測部55による予測処理が行われるたびに、ユーザIDと予測結果とをPHR処理装置20に送信する。また、例えば、送信部57は、ユーザ情報記憶部52に記憶されている各種情報を定期的に取得し、取得した各種情報をPHR処理装置20に送信する。このようにして、PHR処理装置20は、各宅内に設置された宅内サーバから各個人の生体情報を収集、蓄積し、複数ユーザについて統合化したPHRビッグデータを、ヘルスケアクラウド上で一元管理する。 The transmission unit 57 transmits the prediction result by the prediction unit 55 to the PHR processing device 20. For example, the transmission unit 57 transmits the user ID and the prediction result to the PHR processing device 20 every time the prediction process by the prediction unit 55 is performed. For example, the transmission unit 57 periodically acquires various information stored in the user information storage unit 52 and transmits the acquired various information to the PHR processing device 20. In this way, the PHR processing device 20 collects and accumulates each individual's biometric information from the home server installed in each home, and centrally manages the PHR big data integrated for a plurality of users on the healthcare cloud. .
〔処理手順〕
 次に、第1の実施形態に係るスマートブラシシステム1による処理手順について説明する。図13は、第1の実施形態に係るスマートブラシシステム1による処理手順を示すシーケンス図である。
[Processing procedure]
Next, a processing procedure by the smart brush system 1 according to the first embodiment will be described. FIG. 13 is a sequence diagram illustrating a processing procedure performed by the smart brush system 1 according to the first embodiment.
 図13に示すように、洗浄機101は、ユーザ操作に従って、超音波洗浄を行う(ステップS101)。超音波洗浄に用いられた洗浄水は、測定装置103に排水される(ステップS102)。測定装置103に流入した洗浄水は、第1の流路104から分岐した第2の流路105~105を流れる。なお、ここでは省略したが、洗浄水は、濃縮装置102によって濃縮された後に測定装置103に排水されてもよい。 As shown in FIG. 13, the cleaning machine 101 performs ultrasonic cleaning in accordance with a user operation (step S101). The cleaning water used for the ultrasonic cleaning is drained to the measuring device 103 (step S102). The washing water that has flowed into the measuring device 103 flows through the second flow paths 105 1 to 105 n branched from the first flow path 104. Although omitted here, the washing water may be drained to the measuring device 103 after being concentrated by the concentrating device 102.
 続いて、測定装置103は、第2の流路毎に、特定の抗体が結合された磁気ビーズを洗浄水に注入する(ステップS103)。そして、測定装置103は、交流磁界を洗浄水に印加した上で(ステップS104)、洗浄水から発生する磁界を測定する(ステップS105)。そして、測定装置103は、磁界の測定結果を宅内サーバ50に送信する(ステップS106)。 Subsequently, the measuring apparatus 103 injects magnetic beads, to which a specific antibody is bound, into the washing water for each second flow path (step S103). And the measuring apparatus 103 measures the magnetic field which generate | occur | produces from washing water, after applying an alternating current magnetic field to washing water (step S104). Then, the measuring apparatus 103 transmits the magnetic field measurement result to the home server 50 (step S106).
 宅内サーバ50は、測定装置103から受信した磁界の測定結果に基づいて、体内に含まれる抗原を予測する(ステップS107)。図13の例では、歯ブラシ等の洗浄機101を例に挙げているので、宅内サーバ50は、体内に含まれる口腔内細菌を予測する。そして、宅内サーバ50は、予測結果に基づく情報(例えば、抗原の量、ユーザの健康情報)をユーザにフィードバックする(ステップS108)。 The home server 50 predicts an antigen contained in the body based on the magnetic field measurement result received from the measurement device 103 (step S107). In the example of FIG. 13, since the cleaning machine 101 such as a toothbrush is taken as an example, the in-home server 50 predicts oral bacteria contained in the body. Then, the home server 50 feeds back information (for example, the amount of antigen, user health information) based on the prediction result to the user (step S108).
〔変形例(洗浄処理)〕
 上述した洗浄機101は、複数のユーザによって利用される場合がある。この場合、所定のユーザが洗浄機101を利用することで、第1の流路104及び第2の流路105~105に所定のユーザの体内物質や結合ビーズが残存する可能性がある。そこで、スマートブラシシステム1は、第1の流路104及び第2の流路105~105を洗浄する洗浄機能を有してもよい。
[Modification (cleaning treatment)]
The cleaning machine 101 described above may be used by a plurality of users. In this case, when the predetermined user uses the washing machine 101, there is a possibility that the internal substance and the binding beads of the predetermined user remain in the first flow path 104 and the second flow paths 105 1 to 105 n. . Therefore, the smart brush system 1 may have a cleaning function for cleaning the first channel 104 and the second channels 105 1 to 105 n .
 図14は、第1の実施形態に係る洗浄処理を説明するための図である。図14に示した洗浄機101は、洗浄ボタン101bが設けられる。ユーザは、洗浄機101の容器に歯ブラシ等を入れずに水のみを入れた状態で洗浄ボタン101bを押下する。この場合、洗浄ボタン101bは、洗浄処理を行うよう測定制御部130に通知する。 FIG. 14 is a diagram for explaining the cleaning process according to the first embodiment. The cleaning machine 101 shown in FIG. 14 is provided with a cleaning button 101b. The user presses the washing button 101b in a state where only water is put in the container of the washing machine 101 without putting a toothbrush or the like. In this case, the cleaning button 101b notifies the measurement control unit 130 to perform the cleaning process.
 測定制御部130は、洗浄処理を行う旨の通知を受信した場合には、混合部106に抗体及び磁気ビーズを注入させず、直流磁界発生部107に直流磁界を発生させず、交流磁界発生部108に交流磁界を発生させず、処理回路120に磁界の測定処理を行わせない。これにより、洗浄機101の容器に入れられた水が流れることにより、第1の流路104及び第2の流路105~105が洗浄される。この結果、第1の実施形態に係るスマートブラシシステム1では、複数のユーザによって洗浄機101が利用される場合であっても、ユーザの体内に含まれる抗原を高精度に予測することができる。 When the measurement control unit 130 receives a notification that the cleaning process is to be performed, the antibody and the magnetic beads are not injected into the mixing unit 106, the DC magnetic field generation unit 107 is not generated with a DC magnetic field, and the AC magnetic field generation unit An AC magnetic field is not generated in 108, and a magnetic field measurement process is not performed in the processing circuit 120. As a result, the first flow path 104 and the second flow paths 105 1 to 105 n are cleaned by the flow of water contained in the container of the cleaning machine 101. As a result, in the smart brush system 1 according to the first embodiment, even when the washing machine 101 is used by a plurality of users, antigens contained in the user's body can be predicted with high accuracy.
 また、図14に示す例において、スマートブラシシステム1は、洗浄機101の洗浄状態を予測する予測処理を行ってもよい。具体的には、測定制御部130は、上述した洗浄処理において水が第1の流路104及び第2の流路105~105に流れている状態で、交流磁界発生部108に交流磁界を発生させ、処理回路120に磁界の測定処理を行わせる。これにより、宅内サーバ50の予測部55により洗浄後の第2の流路105~105に残存する抗原の量が予測される。このとき、予測部55は、予測した抗原の量が所定の閾値以下である場合には、洗浄が十分であると予測し、抗原の量が所定の閾値よりも多い場合には、洗浄が不十分であると予測する。この場合、表示制御部56は、洗浄状態の予測結果に関する情報を表示装置60aに表示制御してもよい。 In the example illustrated in FIG. 14, the smart brush system 1 may perform a prediction process for predicting the cleaning state of the cleaning machine 101. Specifically, the measurement control unit 130 sends an AC magnetic field to the AC magnetic field generation unit 108 in a state where water flows through the first flow path 104 and the second flow paths 105 1 to 105 n in the above-described cleaning process. To cause the processing circuit 120 to perform magnetic field measurement processing. As a result, the amount of antigen remaining in the second flow paths 105 1 to 105 n after washing is predicted by the prediction unit 55 of the home server 50. At this time, the predicting unit 55 predicts that the washing is sufficient when the predicted amount of the antigen is equal to or less than the predetermined threshold, and the washing is not performed when the amount of the antigen is larger than the predetermined threshold. Predict that it is sufficient. In this case, the display control unit 56 may display-control information related to the prediction result of the cleaning state on the display device 60a.
 例えば、予測部55によって洗浄が不十分であると予測されたものとする。この場合、表示制御部56は、図14の左側に示すように、洗浄が不十分であることを示すメッセージ(例えば、「もう1度洗浄してください!」)を表示装置60aに表示させる。この状態で再度洗浄が行われ、予測部55によって洗浄が十分であると予測されたものとする。この場合、表示制御部56は、図14の右側に示すように、洗浄が十分であると判定されたメッセージ(例えば、「きれに洗浄できました」)を表示させる。このように、測定装置103の洗浄状態を予測することにより、十分に洗浄された洗浄機101をユーザに利用させることができるので、ユーザの体内に含まれる抗原を更に高精度に予測することができる。 For example, it is assumed that the prediction unit 55 predicts that the cleaning is insufficient. In this case, as shown on the left side of FIG. 14, the display control unit 56 causes the display device 60a to display a message indicating that the cleaning is insufficient (for example, “Please clean again!”). It is assumed that the cleaning is performed again in this state and the prediction unit 55 predicts that the cleaning is sufficient. In this case, as shown on the right side of FIG. 14, the display control unit 56 displays a message that is determined to be sufficient for cleaning (for example, “I was able to clean cleanly”). As described above, by predicting the cleaning state of the measuring apparatus 103, the user can use the sufficiently cleaned washer 101, so that the antigen contained in the user's body can be predicted with higher accuracy. it can.
〔変形例(予測タイミング)〕
 上述した抗原抗体反応には、30分~60分程度がかかる場合がある。そこで、上記の通り、測定装置103の第2の流路105~105に開閉可能な弁が設けられてもよい点を説明した。ここで、同一の抗原であっても、全ての抗原における抗原抗体反応が一律に30分~60分程度がかかるわけではなく、一部の抗原は即座に抗原抗体反応を起こす可能性もある。そこで、上述したスマートブラシシステム1では、ユーザが洗浄機101を利用した直後に「体内に抗原が含まれるか否か」を予測し、抗原抗体反応に要する十分な時間(例えば、30分~60分)が経過した後に「体内に含まれる抗原の量」を予測してもよい。
[Modification (Predicted timing)]
The antigen-antibody reaction described above may take about 30 to 60 minutes. Therefore, as described above, it has been described that a valve that can be opened and closed may be provided in the second flow paths 105 1 to 105 n of the measuring apparatus 103. Here, even for the same antigen, the antigen-antibody reaction in all antigens does not take about 30 to 60 minutes uniformly, and some antigens may cause an antigen-antibody reaction immediately. Therefore, in the smart brush system 1 described above, immediately after the user uses the washing machine 101, “whether or not an antigen is contained in the body” is predicted, and a sufficient time required for the antigen-antibody reaction (for example, 30 minutes to 60 minutes). “Amount of antigen contained in the body” may be predicted after a minute).
 図15は、第1の実施形態における表示例を示す図である。図15に示した例では、ユーザによって、7時に洗浄機101が利用されたものとする。この場合、測定装置103は、洗浄機101から流入した洗浄水に抗体及び磁気ビーズが混合されてから任意の時間が経過した後に(例えば、混合直後や、1分経過後や、5分経過後)、上述した磁界の測定処理を行う。そして、宅内サーバ50は、この測定結果に基づいて、ユーザ体内に抗原が含まれるか否かを予測し、予測結果(例えば、「虫歯原因菌が発見されました。危険な菌の量か・・・」)を表示装置60aに表示させる。さらに、測定装置103は、前述の任意の時間よりも長い時間(例えば、30分)が経過した後に、上述した磁界の測定処理を再度行う。そして、宅内サーバ50は、この測定結果に基づいて、ユーザ体内に含まれる抗原の量を予測し、予測結果に基づく情報(例えば、「・・・危険な量ではありません。」)を表示装置60aに表示させる。このように、スマートブラシシステム1では、抗原抗体反応に時間を要する場合であっても、病気の原因菌の有無をユーザに即座にフィードバックすることができる。 FIG. 15 is a diagram showing a display example in the first embodiment. In the example shown in FIG. 15, it is assumed that the cleaning machine 101 is used by the user at 7:00. In this case, the measuring apparatus 103 may be used after an arbitrary time has elapsed since the antibody and magnetic beads were mixed with the washing water flowing from the washing machine 101 (for example, immediately after mixing, after 1 minute has elapsed, or after 5 minutes have elapsed). ), The magnetic field measurement process described above is performed. Then, the home server 50 predicts whether or not an antigen is contained in the user body based on the measurement result, and the prediction result (for example, “the causative causative fungus has been found. .. ") is displayed on the display device 60a. Furthermore, the measurement apparatus 103 performs the above-described magnetic field measurement process again after a time (for example, 30 minutes) longer than the above-described arbitrary time has elapsed. Then, the home server 50 predicts the amount of antigen contained in the user's body based on the measurement result, and displays information (for example, “... not a dangerous amount”) based on the prediction result on the display device 60a. To display. As described above, in the smart brush system 1, even if it takes time for the antigen-antibody reaction, the presence or absence of the causative agent of the disease can be immediately fed back to the user.
〔変形例(予測処理)〕
 また、上述した測定装置103は、第2の流路105~105のうち、所定の第2の流路を比較用として抗体及び磁気ビーズを注入しないように制御してもよい。この場合、宅内サーバ50は、抗体及び磁気ビーズが注入されない第2の流路において測定される比較用の磁界と、抗体及び磁気ビーズが注入される第2の流路において測定される磁界とを比較することで、高精度かつ素早く予測結果を得ることができる。具体的には、予測部55は、比較用の磁界と、予測対象の第2の流路に対応する磁界との差異が所定値以上になった時点で、体内に抗原が含まれていると予測する。このように、予測部55は、比較用の磁界を用いることで、極力早く抗原の有無を予測することができる。また、予測部55は、抗原抗体反応に要する時間が経過した後にも、双方の磁界の差異に基づくことで、抗原の量を高精度に予測することができる。
[Modification (Prediction process)]
In addition, the measuring apparatus 103 described above may be controlled so as not to inject the antibody and the magnetic beads using the predetermined second channel among the second channels 105 1 to 105 n for comparison. In this case, the in-home server 50 generates a comparison magnetic field measured in the second flow path where the antibody and the magnetic beads are not injected, and a magnetic field measured in the second flow path where the antibody and the magnetic beads are injected. By comparing, a prediction result can be obtained with high accuracy and speed. Specifically, when the difference between the magnetic field for comparison and the magnetic field corresponding to the second flow path to be predicted becomes equal to or greater than a predetermined value, the prediction unit 55 determines that the body contains an antigen. Predict. Thus, the prediction unit 55 can predict the presence or absence of an antigen as soon as possible by using the magnetic field for comparison. The predicting unit 55 can predict the amount of the antigen with high accuracy even after the time required for the antigen-antibody reaction has elapsed, based on the difference between the two magnetic fields.
〔変形例(他のシステム)〕
 また、上述した第1の実施形態では、洗浄機101を含むスマートブラシシステム1を例に挙げて説明した。しかし、上述した第1の実施形態は、スマートシンクシステム2やスマートトイレシステム3にも適用することができる。
[Modification (Other systems)]
Moreover, in 1st Embodiment mentioned above, the smart brush system 1 containing the washing machine 101 was mentioned as an example, and was demonstrated. However, the first embodiment described above can also be applied to the smart sink system 2 and the smart toilet system 3.
 図16は、第1の実施形態に係るスマートシンクシステム2の一例を示す図である。図16に示すように、スマートシンクシステム2には、シンク201と、濃縮装置202と、測定装置203とが含まれる。シンク201は、ユーザの排出物が排出され、その排出物を排水する什器である。例えば、シンク201は、ユーザがうがい時に吐き出した水や、ユーザが歯磨き時に吐き出した水や、ユーザが手や顔の洗浄に用いた水を濃縮装置202に排水する。また、高圧水流や空圧によって口腔内(歯や歯間や歯ぐき)を洗浄する口腔洗浄器も知られている。この場合、シンク201は、口腔洗浄器の使用時に出る水や、口腔洗浄器を洗浄する洗浄水を排水する。このようなシンク201により排水される水は、体内物質が含まれることがある。濃縮装置202は、図3に示した濃縮装置102と同様の処理を行う。測定装置203は、図3に示した測定装置103と同様の処理を行う。また、シンク201に設けられる認証部201aは、図3に示した認証部101aと同様の処理を行う。ここでは、濃縮装置202、測定装置203、認証部201aによる処理の説明を省略する。 FIG. 16 is a diagram illustrating an example of the smart sync system 2 according to the first embodiment. As shown in FIG. 16, the smart sync system 2 includes a sink 201, a concentration device 202, and a measurement device 203. The sink 201 is a fixture that discharges the user's discharge and drains the discharge. For example, the sink 201 drains, to the concentrator 202, water discharged when the user gargles, water discharged when the user brushes his teeth, or water used by the user to wash his hands and face. In addition, an oral cleaning device is also known that cleans the oral cavity (teeth, interdental teeth and gums) with high-pressure water flow or pneumatic pressure. In this case, the sink 201 drains water that is discharged when the oral cleaning device is used and cleaning water that cleans the oral cleaning device. The water drained by such a sink 201 may contain body substances. The concentrator 202 performs the same processing as the concentrator 102 shown in FIG. The measuring device 203 performs the same processing as that of the measuring device 103 shown in FIG. Further, the authentication unit 201a provided in the sink 201 performs the same processing as the authentication unit 101a illustrated in FIG. Here, description of processing by the concentrating device 202, the measuring device 203, and the authentication unit 201a is omitted.
 このようなスマートシンクシステム2によれば、「うがい」、「歯磨き」、「手洗い」、「洗顔」といった行為を行う日常生活において、口腔内細菌や、手や顔に付着している細菌を検出することができる。 According to such a smart sync system 2, in daily life in which “gargle”, “toothpaste”, “hand washing”, “face washing” are performed, bacteria in the oral cavity and bacteria attached to the hands and face are detected. can do.
 なお、口腔内細菌は、起床直後のユーザの口腔内に多く含まれていることが知られている。このため、スマートシンクシステム2では、図16に示すように、「歯磨きの前にうがいをしてください」といったメッセージを洗面台の鏡に表示してもよい。これにより、起床直後のうがい水をシンク201に吐き出すことをユーザに促すことができるので、口腔内細菌を効率的に検出することができる。 In addition, it is known that many bacteria in the oral cavity are contained in the oral cavity of the user immediately after getting up. Therefore, in the smart sink system 2, as shown in FIG. 16, a message such as “please gargle before brushing teeth” may be displayed on the mirror of the washstand. Accordingly, the user can be prompted to discharge the gargle immediately after getting up to the sink 201, so that bacteria in the oral cavity can be detected efficiently.
 図17は、第1の実施形態に係るスマートトイレシステム3の一例を示す図である。図17に示すように、スマートトイレシステム3には、便器301と、濃縮装置302と、測定装置303とが含まれる。便器301は、ユーザから排出される物質を排水する。便器301には、肛門等を洗浄するためのノズルが設けられ、ノズルの先端には受け皿301bが設けられる。スマートトイレシステム3では、ユーザの肛門等を洗浄した洗浄水を受け皿301bにより受け、受けた洗浄水を真空吸引法等により採取して濃縮装置302に排水する。濃縮装置302は、図3に示した濃縮装置102と同様の処理を行う。測定装置303は、図3に示した測定装置103と同様の処理を行う。また、便器301に設けられる認証部301aは、図3に示した認証部101aと同様の処理を行う。ここでは、濃縮装置302、測定装置303、認証部301aによる処理の説明を省略する。 FIG. 17 is a diagram illustrating an example of the smart toilet system 3 according to the first embodiment. As shown in FIG. 17, the smart toilet system 3 includes a toilet 301, a concentrating device 302, and a measuring device 303. The toilet bowl 301 drains the substance discharged from the user. The toilet 301 is provided with a nozzle for washing the anus and the like, and a tray 301b is provided at the tip of the nozzle. In the smart toilet system 3, the wash water obtained by washing the user's anus and the like is received by the tray 301 b, and the received wash water is collected by a vacuum suction method or the like and drained to the concentrator 302. The concentrator 302 performs the same processing as the concentrator 102 shown in FIG. The measuring device 303 performs the same processing as the measuring device 103 shown in FIG. Further, the authentication unit 301a provided in the toilet bowl 301 performs the same processing as the authentication unit 101a illustrated in FIG. Here, description of processing by the concentrating device 302, the measuring device 303, and the authentication unit 301a is omitted.
 このようなスマートトイレシステム3によれば、ユーザの日常生活において、腸内細菌を検出することができる。腸内細菌の中に感染症に繋がる細菌も知られているが、スマートトイレシステム3では、検出された腸内細菌を宅内の表示装置に表示することで、感染症の拡大防止を図ることができる。なお、スマートトイレシステム3によって検出される腸内細菌の例としては、現代社会で発生率が高いノロウイルスやカンピロバクター、現代社会で発生率が低いサルモネラ菌、腸炎ビブリオ菌、黄色ブドウ球菌、ボツリヌス菌などが挙げられる。 Such a smart toilet system 3 can detect enteric bacteria in the daily life of the user. Bacteria that lead to infectious diseases are also known among intestinal bacteria, but in smart toilet system 3, it is possible to prevent the spread of infectious diseases by displaying the detected intestinal bacteria on a home display device. it can. Examples of enteric bacteria detected by the smart toilet system 3 include norovirus and Campylobacter, which have a high incidence in modern society, Salmonella, Vibrio parahaemolyticus, Staphylococcus aureus, and Clostridium botulinum that have a low incidence in modern society. Can be mentioned.
〔変形例(予測対象)〕
 また、第1の実施形態では、体内の生体物質と反応する反応物質として抗体を洗浄水等に注入する例を示した。しかし、上述した測定装置103、203及び303は、抗体ではなく、反応物質として抗原を注入してもよい。そして、宅内サーバ50は、測定装置103、203及び303による磁界の測定結果に基づいて、体内に含まれる抗体(例えば、タンパク質等の免疫物質)を予測してもよい。この場合、宅内サーバ50は、体内に含まれる抗体が正常値であればユーザが健康であると予測し、予測結果を各種表示装置に表示させてもよい。
[Modification (Target for prediction)]
In the first embodiment, an example is shown in which an antibody is injected into washing water or the like as a reactive substance that reacts with a biological substance in the body. However, the measuring devices 103, 203, and 303 described above may inject an antigen as a reactive substance instead of an antibody. Then, the home server 50 may predict an antibody (for example, an immune substance such as a protein) contained in the body based on the measurement result of the magnetic field by the measurement devices 103, 203, and 303. In this case, the home server 50 may predict that the user is healthy if the antibody contained in the body is a normal value, and may display the prediction results on various display devices.
〔効果〕
 第1の実施形態によれば、混合物から発生する磁界を上述した磁界センサ110によって精度良く測定することができるので、ユーザの体内に含まれる生体物質を精度良く検出することができる。さらに、第1の実施形態によれば、第2の流路毎に異なる抗体や抗原を注入するので、1回の処理で複数項目の抗原や抗体等を検出することができる。上述してきた日常人間ドックでは、歯ブラシの洗浄機等にセンサが設けられるので、多項目を検出可能な測定装置103を用いることで、この日常人間ドックを実現することが可能になる。
〔effect〕
According to the first embodiment, since the magnetic field generated from the mixture can be accurately measured by the magnetic field sensor 110 described above, the biological material contained in the user's body can be accurately detected. Furthermore, according to the first embodiment, since different antibodies and antigens are injected for each second flow path, a plurality of items of antigens and antibodies can be detected in a single process. In the daily human dock described above, since a sensor is provided in a toothbrush washing machine or the like, this daily human dock can be realized by using the measuring device 103 capable of detecting many items.
(第2の実施形態)
〔スマートトイレシステム〕
 第2の実施形態では、生体管理システムによる熱的手法の処理について説明する。まず、生体管理システムのうち、スマートトイレシステムを例に挙げて熱的手法の処理について説明する。図18は、第2の実施形態に係るスマートトイレシステム4の一例を示す図である。図18に示すように、スマートトイレシステム4には、便器401と宅内サーバ50と表示装置60とが含まれる。
(Second Embodiment)
[Smart toilet system]
In the second embodiment, processing of a thermal technique by the living body management system will be described. First, the process of the thermal method will be described using a smart toilet system as an example of the biological management system. FIG. 18 is a diagram illustrating an example of the smart toilet system 4 according to the second embodiment. As shown in FIG. 18, the smart toilet system 4 includes a toilet 401, a home server 50, and a display device 60.
 便器401には、認証部401aと、測定装置410とが設けられる。認証部401aは、図3に示した認証部101aと同様に、ユーザの指紋等を読み取るセンサに該当する。 The toilet bowl 401 is provided with an authentication unit 401a and a measuring device 410. The authentication unit 401a corresponds to a sensor that reads a user's fingerprint and the like, like the authentication unit 101a illustrated in FIG.
 測定装置410は、便器401の便座の裏側又は便座の中に設置される。また、測定装置410には、内部が空洞の筒状に形成されたアーム410aが取り付けられる。アーム410aの一端は、測定装置410に取り付けられる。また、アーム410aの他端には、受け皿が設けられるとともに、液体との接触を検知するための液体検知センサが受け皿上に設けられる。また、アーム410aは、図18に示すように、測定装置410に取り付けられる一端を支点として搖動可能である。なお、アーム410aは、ユーザによって便器401が利用されていない場合には、便座の裏側又は便座の中に収納される。 The measuring device 410 is installed behind the toilet seat of the toilet 401 or in the toilet seat. Further, the measuring device 410 is attached with an arm 410a formed in a hollow cylindrical shape. One end of the arm 410 a is attached to the measuring device 410. In addition, a receiving tray is provided at the other end of the arm 410a, and a liquid detection sensor for detecting contact with the liquid is provided on the receiving tray. Further, as shown in FIG. 18, the arm 410 a can swing with one end attached to the measuring device 410 as a fulcrum. In addition, when the toilet bowl 401 is not utilized by the user, the arm 410a is accommodated in the back side of the toilet seat or in the toilet seat.
 このような測定装置410は、ユーザによって便器401が利用される場合(例えば、便座の蓋が開かれた場合や、認証部401aを介した認証が成功した場合)、アーム410aを搖動させることで、ユーザから排出される尿とアーム410aとを接触させる。例えば、測定装置410は、アーム410aの液体検知センサが液体との接触を検知するまでアーム410aを搖動させ、液体との接触が検知された場合に、アーム410aを停止させる。これにより、アーム410aの受け皿にはユーザから排出された尿が入る。そして、受け皿が受けた尿は、アーム410a内を介して測定装置410に流入する。測定装置410は、このような尿と所定の酵素とを触媒反応させ、触媒反応における発熱量を測定し、測定結果を宅内サーバ50に送信する。宅内サーバ50は、発熱量の測定結果に基づいて、尿に含まれる基質(例えば、グルコース:尿糖)等である生体物質を予測する。そして、宅内サーバ50は、PHR処理装置20や各種の表示装置60に予測結果を送信する。これにより、PHR処理装置20は、各個人の生体情報を蓄積する。また、表示装置60は、宅内サーバ50から受信した予測結果等を表示する。 Such a measuring device 410 can be used by swinging the arm 410a when the user uses the toilet bowl 401 (for example, when the toilet seat lid is opened or when authentication through the authentication unit 401a is successful). The urine discharged from the user is brought into contact with the arm 410a. For example, the measuring device 410 swings the arm 410a until the liquid detection sensor of the arm 410a detects contact with the liquid, and stops the arm 410a when contact with the liquid is detected. Thereby, the urine discharged | emitted from the user enters into the saucer of the arm 410a. Then, the urine received by the tray flows into the measuring device 410 through the arm 410a. The measuring device 410 causes such urine and a predetermined enzyme to undergo a catalytic reaction, measures the amount of heat generated in the catalytic reaction, and transmits the measurement result to the home server 50. The home server 50 predicts a biological material such as a substrate (for example, glucose: urine sugar) contained in urine based on the measurement result of the calorific value. Then, the home server 50 transmits the prediction result to the PHR processing device 20 and various display devices 60. Thereby, the PHR processing apparatus 20 accumulate | stores each individual's biometric information. Further, the display device 60 displays the prediction result received from the home server 50.
〔測定装置〕
 次に、図18に示した測定装置410について説明する。図19は、第2の実施形態に係る測定装置410の一例を示す図である。図19に示すように、測定装置410は、通信部411と、センサチップ420と、測定制御部430とを有する。
〔measuring device〕
Next, the measuring apparatus 410 shown in FIG. 18 will be described. FIG. 19 is a diagram illustrating an example of the measurement apparatus 410 according to the second embodiment. As illustrated in FIG. 19, the measurement device 410 includes a communication unit 411, a sensor chip 420, and a measurement control unit 430.
 通信部411は、宅内サーバ50との間で無線通信又は有線通信を行う。例えば、通信部411は、認証部401aによって取得された認証用の指紋画像や、後述する測定制御部430によって測定された発熱量の測定結果を宅内サーバ50に送信する送信部に該当する。 The communication unit 411 performs wireless communication or wired communication with the home server 50. For example, the communication unit 411 corresponds to a transmission unit that transmits the fingerprint image for authentication acquired by the authentication unit 401 a and the measurement result of the calorific value measured by the measurement control unit 430 described later to the in-home server 50.
 センサチップ420は、アーム410aを介して流入されるユーザの尿と、所定の酵素との触媒反応による温度変化を計測する。例えば、センサチップ420は、測定装置410に固定されてもよいし、測定装置410に対して取り外し可能であってもよい。センサチップ420については後述する。 The sensor chip 420 measures a temperature change due to a catalytic reaction between a user's urine flowing through the arm 410a and a predetermined enzyme. For example, the sensor chip 420 may be fixed to the measurement device 410 or may be removable from the measurement device 410. The sensor chip 420 will be described later.
 測定制御部430は、例えば、ASICやFPGA等の集積回路により実現される。また、例えば、測定制御部430は、CPUやMPU等によって、各種プログラムがRAMを作業領域として実行されることにより実現される。 The measurement control unit 430 is realized by an integrated circuit such as ASIC or FPGA, for example. Further, for example, the measurement control unit 430 is realized by executing various programs using the RAM as a work area by a CPU, an MPU, or the like.
 このような測定制御部430は、測定装置410による処理を制御する測定部に該当する。具体的には、測定制御部430は、宅内サーバ50から通知される認証結果が成功を示す場合には、便座に収納されているアーム410aを搖動させることで、ユーザから排出される尿とアーム410aとを接触させる。この場合、測定制御部430は、センサチップ420によって検出された温度変化に基づいて、尿と酵素との触媒反応による発熱量を算出し、算出した発熱量を通信部411を介して宅内サーバ50に送信する。 Such a measurement control unit 430 corresponds to a measurement unit that controls processing by the measurement apparatus 410. Specifically, when the authentication result notified from the in-home server 50 indicates success, the measurement control unit 430 swings the arm 410a stored in the toilet seat, and the urine discharged from the user and the arm 410a is brought into contact. In this case, the measurement control unit 430 calculates the amount of heat generated by the catalytic reaction between urine and the enzyme based on the temperature change detected by the sensor chip 420, and the calculated amount of generated heat is transmitted to the home server 50 via the communication unit 411. Send to.
 一方、測定制御部430は、認証結果が失敗を示す場合には、アーム410aを搖動させずに便座に収納させたままとすることで、ユーザから排出される尿とアーム410aとを接触させない。この場合、測定制御部430は、発熱量の算出処理や、発熱量を宅内サーバ50に送信する処理を行わない。 On the other hand, when the authentication result indicates failure, the measurement control unit 430 does not allow the arm 410a to contact the urine discharged from the user by keeping the arm 410a in the toilet seat without swinging. In this case, the measurement control unit 430 does not perform a heat generation amount calculation process or a process for transmitting the heat generation amount to the home server 50.
 また、測定制御部430は、センサチップ420を洗浄する処理を行う。例えば、図18に示した便器401には、水を放出する放水部403が設けられる。そして、測定制御部430は、ユーザによって便器401が使用されてから所定時間が経過した場合や、アーム410aの液体検知センサが液体との接触を検知してから所定時間が経過した場合に、放水部403からアーム410aの受け皿に水が放出されるよう放水部403を制御する。これにより、放水部403から放出された水は、アーム410aを介してセンサチップ420に流入する。この結果、センサチップ420は、放水部403からの水によって洗浄される。 In addition, the measurement control unit 430 performs processing for cleaning the sensor chip 420. For example, the toilet 401 illustrated in FIG. 18 includes a water discharge unit 403 that discharges water. Then, the measurement control unit 430 discharges water when a predetermined time has elapsed since the toilet 401 was used by the user, or when a predetermined time has elapsed since the liquid detection sensor of the arm 410a detected contact with the liquid. The water discharge part 403 is controlled so that water is discharged from the part 403 to the tray of the arm 410a. Thereby, the water discharged | emitted from the water discharge part 403 flows in into the sensor chip 420 via the arm 410a. As a result, the sensor chip 420 is washed with water from the water discharge unit 403.
〔センサチップ〕
 次に、図19に示したセンサチップ420について説明する。センサチップ420は、生体物質と酵素等との熱反応による温度変化を利用して、常温かつ低消費電力であっても、生体物質の種類や量を特定可能にするカロリメトリックセンサである。図20は、第2の実施形態に係るセンサチップ420の一例を示す図である。図20に示すように、センサチップ420は、基板421と、第1の温度センサとしての絶対温度センサ422と、試料注入孔423と、流路424~424と、反応部425~425と、第2の温度センサとしての温度センサ426~426と、電極427~427と、共通電極428とを有する。
[Sensor chip]
Next, the sensor chip 420 shown in FIG. 19 will be described. The sensor chip 420 is a calorimetric sensor that uses a temperature change caused by a thermal reaction between a biological material and an enzyme to identify the type and amount of the biological material even at normal temperature and low power consumption. FIG. 20 is a diagram illustrating an example of a sensor chip 420 according to the second embodiment. As shown in FIG. 20, the sensor chip 420 includes a substrate 421, an absolute temperature sensor 422 as a first temperature sensor, a sample injection hole 423, flow paths 424 1 to 424 3 and reaction units 425 1 to 425. 3 , temperature sensors 426 1 to 426 3 as second temperature sensors, electrodes 427 1 to 427 3, and a common electrode 428.
 基板421は、例えば、半導体のシリコン単結晶基板である。絶対温度センサ422は、例えばpn接合ダイオードであり、基板421上に設けられる。絶対温度センサ422は、基板421の絶対温度を計測する。 The substrate 421 is, for example, a semiconductor silicon single crystal substrate. The absolute temperature sensor 422 is a pn junction diode, for example, and is provided on the substrate 421. The absolute temperature sensor 422 measures the absolute temperature of the substrate 421.
 試料注入孔423は、アーム410aを介して尿等の試料が注入される。流路424~424は、試料注入孔423から分岐した分岐流路であって、試料注入孔423から排出部まで延伸する。流路424~424は、例えばマイクロキャピラリやマイクロチャネルに該当し、試料注入孔423に注入された尿等を毛細管現象により排出部に向かって移動させる。なお、この例に限られず、流路424~424は、電気泳動法もしくは誘電泳動法により、試料注入孔423に注入された尿等を排出部に向かって移動させてもよい。排出部は、便器401の排水路と連結されており、試料注入孔423に注入された尿や水等を排水路に排出する。この試料注入孔423は、便器401から排出された尿を受け付ける受付部に該当する。 A sample such as urine is injected into the sample injection hole 423 through the arm 410a. Channels 424 1 to 424 3 are branched channels branched from the sample injection hole 423 and extend from the sample injection hole 423 to the discharge portion. The flow paths 424 1 to 424 3 correspond to, for example, a microcapillary or a microchannel, and move urine or the like injected into the sample injection hole 423 toward the discharge portion by capillary action. Note that the flow paths 424 1 to 424 3 are not limited to this example, and urine or the like injected into the sample injection hole 423 may be moved toward the discharge portion by electrophoresis or dielectrophoresis. The discharge unit is connected to the drainage channel of the toilet 401 and discharges urine, water, and the like injected into the sample injection hole 423 to the drainage channel. The sample injection hole 423 corresponds to a reception unit that receives urine discharged from the toilet 401.
 このように、第2の実施形態に係るセンサチップ420では、試料注入孔423に注入された試料が流路424~424から排出部へ排出されるので、容易に洗浄することができる。具体的には、上述した測定制御部430は、放水部403を制御することでセンサチップ420を洗浄する。このとき、センサチップ420に注入済みの尿は、放水部403からの洗浄水によって排出部へ洗い流される。この結果、センサチップ420は、容易に洗浄可能であり、繰り返し何度も利用することが可能となる。 As described above, in the sensor chip 420 according to the second embodiment, since the sample injected into the sample injection hole 423 is discharged from the flow paths 424 1 to 424 3 to the discharge portion, it can be easily cleaned. Specifically, the measurement control unit 430 described above cleans the sensor chip 420 by controlling the water discharge unit 403. At this time, urine already injected into the sensor chip 420 is washed away to the discharge portion by the wash water from the water discharge portion 403. As a result, the sensor chip 420 can be easily washed and can be used repeatedly.
 反応部425~425は、流路424~424のうち、試料注入孔423と、排出部との間の位置にそれぞれ設けられる。反応部425~425には、流路424~424を移動する尿が入る試料ホルダが形成される。また、反応部425~425には、特定の基質に対して触媒活性機能部位がある酵素が固定される。例えば、反応部425~425には、酵素溶液と光架橋性ポリビニルアルコール樹脂との混合物が添付されることで、特定の酵素が固定される。なお、反応部425~425には、酵素とともに、触媒反応を活性化させる補酵素が固定されてもよい。図21に、第2の実施形態における酵素や補酵素の一例を示す。図21では、各種基質と、基質に対応する酵素や補酵素等の具体例を示す。例えば、図21に示すように、基質「グルコース」と酵素「グルコースオキシダーゼ」とは触媒反応することが知られている。なお、反応部425~425としては、例えば、反応部425~425と反応部425~425の前後における流路424~424の一部とに対向する基板421に空洞が形成される架橋構造を採用することができる。また、センサチップ420の洗浄を要しない場合には、反応部425~425としては、例えば、特許文献5に開示されているカンチレバ構造を採用することができる。また、反応部425~425には、試料ホルダを所定温度(例えば、38[℃])に保つ加熱部(例えば、薄膜ヒータ)が設けられてもよい。加熱部が設けられることにより、試料ホルダを触媒反応に適した温度(例えば、38[℃])に保つことができ、かつ、試料ホルダを同一環境に保つことができるので、発熱量を精度良く測定することができる。 The reaction units 425 1 to 425 3 are respectively provided in the flow paths 424 1 to 424 3 between the sample injection hole 423 and the discharge unit. In the reaction units 425 1 to 425 3 , a sample holder into which urine moving through the channels 424 1 to 424 3 enters is formed. In addition, an enzyme having a catalytically active functional site with respect to a specific substrate is immobilized in the reaction units 425 1 to 425 3 . For example, a specific enzyme is fixed to the reaction units 425 1 to 425 3 by attaching a mixture of an enzyme solution and a photocrosslinkable polyvinyl alcohol resin. In addition, a coenzyme that activates the catalytic reaction may be fixed to the reaction units 425 1 to 425 3 together with the enzyme. FIG. 21 shows an example of an enzyme and a coenzyme in the second embodiment. FIG. 21 shows specific examples of various substrates and enzymes and coenzymes corresponding to the substrates. For example, as shown in FIG. 21, it is known that the substrate “glucose” and the enzyme “glucose oxidase” undergo a catalytic reaction. As the reaction units 425 1 to 425 3 , for example, a cavity is formed in the substrate 421 facing the reaction units 425 1 to 425 3 and a part of the flow paths 424 1 to 424 3 before and after the reaction units 425 1 to 425 3. A cross-linked structure in which can be formed can be employed. When the sensor chip 420 does not need to be cleaned, for example, a cantilever structure disclosed in Patent Document 5 can be adopted as the reaction units 425 1 to 425 3 . The reaction units 425 1 to 425 3 may be provided with a heating unit (for example, a thin film heater) that keeps the sample holder at a predetermined temperature (for example, 38 [° C.]). By providing the heating unit, the sample holder can be kept at a temperature suitable for the catalytic reaction (for example, 38 [° C.]), and the sample holder can be kept in the same environment. Can be measured.
 ここで、反応部425~425には、それぞれ異なる酵素が固定される。すなわち、流路424~424を移動する尿に含まれる各種基質のうち、特定の基質のみが反応部425~425に固定された酵素と触媒反応する。一例を挙げて説明すると、反応部425には、基質SU1と触媒反応する酵素E1が固定され、反応部425には、基質SU2と触媒反応する酵素E2が固定され、反応部425には、基質SU3と触媒反応する酵素E3が固定されているものとする。そして、流路424~424を移動する尿には基質SU1、SU2及びSU3が含まれるものとする。この場合、反応部425では基質SU1のみが酵素E1と触媒反応し、反応部425では基質SU2のみが酵素E2と触媒反応し、反応部425では基質SU3のみが酵素E3と触媒反応する。このように、センサチップ420では、反応部毎(すなわち、流路毎)に、特定の基質を選択的に酵素と触媒反応させることができる。 Here, different enzymes are immobilized on the reaction units 425 1 to 425 3 , respectively. That is, of the various substrates contained in the urine moving through the channels 424 1 to 424 3 , only a specific substrate undergoes a catalytic reaction with the enzyme immobilized on the reaction units 425 1 to 425 3 . By way of example, to the reaction unit 425 1, a substrate SU1 enzyme E1 which catalyzes the reaction is fixed, the reaction unit 425 2, a substrate SU2 and enzyme E2 to catalyze the reaction is fixed, the reaction unit 425 3 Assumes that the enzyme E3 that catalyzes the substrate SU3 is immobilized. The urine moving through the channels 424 1 to 424 3 includes the substrates SU1, SU2, and SU3. In this case, only the reaction part 425 1, a substrate SU1 enzymes E1 and catalyze the reaction, only the reaction part 425 2, a substrate SU2 enzyme E2 and catalyze the reaction, only the reaction part 425 3, substrate SU3 to enzyme E3 and catalysis . Thus, in the sensor chip 420, a specific substrate can be selectively reacted with an enzyme for each reaction part (that is, for each flow path).
 温度センサ426~426は、絶対温度センサ422と同様に、基板421上に設けられる。具体的には、温度センサ426~426は、反応部425~425にそれぞれ設けられる。例えば、温度センサ426~426は、薄膜熱電対などである。すなわち、温度センサ426~426は、反応部425~425における温度変化に応じた電圧を発生させる。電極427~427は、測定制御部430による制御に従って、温度センサ426~426のそれぞれからの熱反応に基づく熱起電力を取り出すためのものである。なお、絶対温度センサ422及び温度センサ426~426(または、絶対温度センサ422と、温度センサ426~426と、電極427~427)は、反応部425~425へ移動した体内物質と酵素との熱反応に基づく温度変化を計測する温度計測部であると言える。 The temperature sensors 426 1 to 426 3 are provided on the substrate 421 similarly to the absolute temperature sensor 422. Specifically, the temperature sensors 426 1 to 426 3 are provided in the reaction units 425 1 to 425 3 , respectively. For example, the temperature sensors 426 1 to 426 3 are thin film thermocouples. That is, the temperature sensors 426 1 to 426 3 generate voltages according to temperature changes in the reaction units 425 1 to 425 3 . The electrodes 427 1 to 427 3 are for taking out the thermoelectromotive force based on the thermal reaction from each of the temperature sensors 426 1 to 426 3 under the control of the measurement control unit 430. The absolute temperature sensor 422 and the temperature sensors 426 1 to 426 3 (or the absolute temperature sensor 422, the temperature sensors 426 1 to 426 3 and the electrodes 427 1 to 427 3 ) are moved to the reaction units 425 1 to 425 3 . It can be said that this is a temperature measurement unit that measures a temperature change based on the thermal reaction between the body substance and the enzyme.
 なお、センサチップ420に形成される流路の数は、図20に示した例に限られない。例えば、センサチップ420には、1又は2個の流路が形成されてもよいし、4個以上の流路が形成されてもよい。センサチップ420に多数の流路が形成されるほど、多種の基質を検出することが可能になる。 Note that the number of flow paths formed in the sensor chip 420 is not limited to the example shown in FIG. For example, one or two flow paths may be formed in the sensor chip 420, or four or more flow paths may be formed. The more channels are formed in the sensor chip 420, the more various substrates can be detected.
 図19に示した測定制御部430は、絶対温度センサ422によって計測される温度を基準として、電極427~427によって取り出された温度センサ426~426の出力電圧から得られる温度差(すなわち、触媒反応による上昇温度)を測定する。そして、測定制御部430は、測定結果である温度変化に基づいて、各反応部における発熱量を測定する。そして、測定制御部430は、反応部毎の測定結果を宅内サーバ50に送信する。例えば、測定制御部430は、反応部に固定される酵素を識別する酵素情報(または、反応部を識別する情報)と、発熱量の測定結果との組合せを宅内サーバ50に送信する。宅内サーバ50は、発熱量の測定結果に基づいて、ユーザの体内に含まれる基質を予測する。このように、反応部における発熱量は、絶対温度センサ422による計測温度を基準として、温度センサ426~426による計測結果から測定される。このため、絶対温度センサ422は、温度センサ426~426の近傍に設けられることが好ましい。これにより、絶対温度センサ422と温度センサ426~426とを同様の環境下に設けることができるので、測定制御部430は、発熱量を精度良く測定することができる。 The measurement control unit 430 shown in FIG. 19 uses the temperature measured by the absolute temperature sensor 422 as a reference and the temperature difference (from the output voltage of the temperature sensors 426 1 to 426 3 taken out by the electrodes 427 1 to 427 3 ( That is, the temperature rise due to the catalytic reaction) is measured. And the measurement control part 430 measures the emitted-heat amount in each reaction part based on the temperature change which is a measurement result. Then, the measurement control unit 430 transmits the measurement result for each reaction unit to the home server 50. For example, the measurement control unit 430 transmits the combination of enzyme information (or information for identifying the reaction unit) for identifying the enzyme fixed to the reaction unit and the calorific value measurement result to the home server 50. The home server 50 predicts a substrate contained in the user's body based on the measurement result of the calorific value. As described above, the amount of heat generated in the reaction unit is measured from the measurement results obtained by the temperature sensors 426 1 to 426 3 with reference to the temperature measured by the absolute temperature sensor 422. Therefore, the absolute temperature sensor 422 is preferably provided in the vicinity of the temperature sensors 426 1 to 426 3 . As a result, the absolute temperature sensor 422 and the temperature sensors 426 1 to 426 3 can be provided in the same environment, so that the measurement control unit 430 can accurately measure the amount of heat generation.
 ここで、図22を用いて、測定制御部430による処理の一例について説明する。図22の横軸は時間経過を示し、図22の縦軸は温度センサ426~426からの出力電圧を示す。また、波形W11は、試料である尿内の基質濃度が高い場合における出力電圧の例を示し、波形W12は、波形W11に対応する試料よりも基質濃度が低い場合における出力電圧の例を示す。図22に示すように、基質濃度が高いほど温度センサからの出力電圧は高い値となり、基質濃度が低いほど温度センサからの出力電圧は低い値となる。測定制御部430は、温度センサの出力電圧におけるピーク値(波形W11では電圧P11、波形W12では電圧P12)に基づいて、各反応部における発熱量を測定してもよいし、出力電圧の波形の積分値に基づいて、各反応部における発熱量を測定してもよい。 Here, an example of processing by the measurement control unit 430 will be described with reference to FIG. The horizontal axis of FIG. 22 shows the passage of time, and the vertical axis of FIG. 22 shows the output voltage from the temperature sensors 426 1 to 426 3 . A waveform W11 shows an example of an output voltage when the substrate concentration in the urine sample is high, and a waveform W12 shows an example of an output voltage when the substrate concentration is lower than the sample corresponding to the waveform W11. As shown in FIG. 22, the higher the substrate concentration, the higher the output voltage from the temperature sensor, and the lower the substrate concentration, the lower the output voltage from the temperature sensor. The measurement control unit 430 may measure the amount of heat generated in each reaction unit based on the peak value (voltage P11 in the waveform W11, voltage P12 in the waveform W12) in the output voltage of the temperature sensor, or the waveform of the output voltage You may measure the emitted-heat amount in each reaction part based on an integral value.
 また、触媒反応による発熱量の一例について説明する。ここでは、基質「グルコース」と酵素「グルコースオキシダーゼ」を例に挙げて説明する。また、反応部において触媒反応する尿の体積(すなわち、試料ホルダの体積)V0は、16×10-5[cm]≒1.0×10-7[l]であるものとする。また、グルコース濃度Nsは、100[mg/dl]=1[g/l]=1/180[mol]であるものとする。この場合、触媒反応する尿体積V0中のグルコース量Nmは、V0・Ns=5.5×10-10[mol]となる。そして、グルコースのモル質量は180[g/mol]であり、発熱量H=80[kJ/mol]であるので、触媒反応による発熱量Pは、H・Nm=44×10-6[J]となる。すなわち、測定制御部430は、0.44[℃]の温度上昇を検出した場合には、発熱量として44×10-6[J]を求める。 An example of the amount of heat generated by the catalytic reaction will be described. Here, the substrate “glucose” and the enzyme “glucose oxidase” will be described as examples. Further, the volume of urine that catalyses in the reaction section (that is, the volume of the sample holder) V0 is 16 × 10 −5 [cm 3 ] ≈1.0 × 10 −7 [l]. The glucose concentration Ns is 100 [mg / dl] = 1 [g / l] = 1/180 [mol]. In this case, the amount of glucose Nm in the urine volume V0 undergoing catalytic reaction is V0 · Ns = 5.5 × 10 −10 [mol]. Since the molar mass of glucose is 180 [g / mol] and the calorific value H = 80 [kJ / mol], the calorific value P due to the catalytic reaction is H · Nm = 44 × 10 −6 [J]. It becomes. That is, when the measurement control unit 430 detects a temperature increase of 0.44 [° C.], the measurement control unit 430 obtains 44 × 10 −6 [J] as the heat generation amount.
〔宅内サーバ〕
 次に、第2の実施形態に係る宅内サーバ50について説明するが、宅内サーバ50の構成は図9に示した例と同様である。ただし、第2の実施形態に係るユーザ情報記憶部52は、図10に示した抗原の代わりに基質(グルコース、尿酸、シュウ酸など)を記憶する。以下では、同様の処理を行う部位については処理を省略する。
[Home server]
Next, a home server 50 according to the second embodiment will be described. The configuration of the home server 50 is the same as the example shown in FIG. However, the user information storage unit 52 according to the second embodiment stores a substrate (glucose, uric acid, oxalic acid, etc.) instead of the antigen shown in FIG. In the following, processing is omitted for parts that perform similar processing.
 第2の実施形態に係る認証部53は、測定装置410から受信した認証用の指紋画像に基づいてユーザの認証処理を行い、認証結果を測定装置410に通知する。また、受信部54は、通信部51を介して、測定装置410から発熱量の測定結果を受信する。例えば、受信部54は、測定装置410から、酵素を識別する酵素情報と、発熱量の測定結果との組合せを受信する。 The authentication unit 53 according to the second embodiment performs user authentication processing based on the fingerprint image for authentication received from the measurement device 410 and notifies the measurement device 410 of the authentication result. In addition, the receiving unit 54 receives the calorific value measurement result from the measurement device 410 via the communication unit 51. For example, the receiving unit 54 receives a combination of enzyme information for identifying the enzyme and a calorific value measurement result from the measurement device 410.
 予測部55は、受信部54によって受信された発熱量の測定結果に基づいて、ユーザの体内に含まれる基質を予測する。例えば、予測部55は、測定装置410から送信される酵素情報に基づいて、基質の種類を特定する。また、例えば、予測部55は、予め定められている発熱量と基質の量との関係から、基質の量や濃度を予測する。このようにして、予測部55は、ユーザ体内に含まれる基質(ここの例では、尿内物質)の種類及び量を予測する。そして、予測部55は、予測結果である基質の量や濃度を、ユーザIDに対応付けてユーザ情報記憶部52に格納する。なお、予測部55は、ユーザの体内に所定の基質が所定値よりも多く含まれるか否かを予測してもよいし、予測結果である基質の量や濃度に基づいてユーザの健康状態を予測してもよい。 The prediction unit 55 predicts a substrate contained in the user's body based on the measurement result of the calorific value received by the reception unit 54. For example, the prediction unit 55 specifies the type of substrate based on the enzyme information transmitted from the measurement device 410. For example, the prediction unit 55 predicts the amount and concentration of the substrate from the predetermined relationship between the calorific value and the amount of substrate. In this way, the prediction unit 55 predicts the type and amount of a substrate (in this example, a urine substance) contained in the user's body. Then, the prediction unit 55 stores the amount and concentration of the substrate as the prediction result in the user information storage unit 52 in association with the user ID. The prediction unit 55 may predict whether or not a predetermined substrate is included in the user's body more than a predetermined value, and the health state of the user may be determined based on the amount or concentration of the substrate that is a prediction result. It may be predicted.
 表示制御部56は、図11に示した例と同様に、各種態様で予測結果を表示装置に表示制御する。例えば、表示制御部56は、基質の名称や、基質の量や、ユーザの健康状態や、時系列の予測結果を表示装置に表示制御する。図23に、第2の実施形態における表示例を示す。図23では、タブレット端末である表示装置60cに、尿糖(グルコース)の予測結果を時系列に表示する例を示す。 The display control unit 56 performs display control of the prediction result on the display device in various manners as in the example illustrated in FIG. For example, the display control unit 56 controls the display device to display the name of the substrate, the amount of the substrate, the health state of the user, and the time-series prediction results. FIG. 23 shows a display example in the second embodiment. FIG. 23 shows an example in which prediction results of urine sugar (glucose) are displayed in time series on the display device 60c which is a tablet terminal.
 図23の例では、表示制御部56は、ユーザ情報記憶部52から過去20日間に収集された尿糖の量を取得し、取得した尿糖の量とセンシング日時との関係を示すグラフに関する情報を表示装置60cに送信する。このとき、表示制御部56は、グラフ上に尿糖が異常値であることを示す警告メッセージ(例えば、「尿糖異常発現」)を含める。この場合、表示装置60cは、図23に示すように、20日前から今日までの尿糖値の濃度を時系列に表示する。これにより、ユーザは、時系列に表示される尿糖値や警告メッセージを把握することで、これまでの生活を振り返り、今後の生活習慣を改善することができる。 In the example of FIG. 23, the display control unit 56 acquires the amount of urine sugar collected in the past 20 days from the user information storage unit 52, and information on the graph indicating the relationship between the acquired amount of urine sugar and the sensing date and time. Is transmitted to the display device 60c. At this time, the display control unit 56 includes a warning message (for example, “abnormal urine sugar expression”) indicating that urine sugar is an abnormal value on the graph. In this case, as shown in FIG. 23, the display device 60c displays the concentration of the urine sugar value from 20 days ago to today in time series. Thereby, the user can look back on the life so far and can improve future lifestyle habits by grasping the urine sugar value and the warning message displayed in time series.
 なお、一般に、尿糖値は、血糖値と対応することが知られている。例えば、血糖値が正常の基準値(例えば、109[mg/dl])以下である人は、尿糖が10[mg/dl]程度であるが、血糖値が正常の基準値を超えると、尿糖値が急激に上昇すると言われている。この急激な尿糖値の上昇が糖尿病の指標となるので、尿糖値に基づいて、いわゆる隠れ糖尿病患者を発見することができる。予測部55は、このような指標値に基づいて、上記の警告メッセージを表示させる。 In general, it is known that the urine sugar level corresponds to the blood glucose level. For example, a person whose blood glucose level is below a normal reference value (for example, 109 [mg / dl]) is about 10 [mg / dl] urine sugar, but when the blood glucose level exceeds the normal reference value, It is said that the urine sugar level rises rapidly. Since this rapid increase in urine sugar value is an index of diabetes, a so-called hidden diabetic patient can be found based on the urine sugar value. The prediction unit 55 displays the warning message based on such an index value.
 また、一般に、尿糖検査は、食後2時間後が適していると言われている。このため、表示装置60cは、ユーザに食後2時間後に排尿する旨のメッセージを表示してもよい。または、予測部55は、食後2時間後と想定される時間帯(例えば、午前9時~10時、午後2時~3時、午後8時~9時)に排出された尿から、体内に含まれる尿糖の濃度を予測してもよい。 In general, it is said that the urine sugar test is suitable 2 hours after meals. For this reason, the display device 60c may display a message to the user to urinate 2 hours after eating. Alternatively, the prediction unit 55 may enter the body from urine excreted in a time zone assumed to be 2 hours after the meal (for example, 9 am to 10 am, 2 pm to 3 pm, 8 pm to 9 pm). The concentration of urine sugar contained may be predicted.
 また、図23では、タブレット端末に予測結果が表示される例を示したが、図2に示した例のように、表示制御部56は、宅内のモニタ、携帯端末装置、装着型情報端末、ウェアラブル端末などの表示装置に予測結果を表示させてもよい。また、表示制御部56は、図23の例に限られず、ユーザの体内に所定の基質が所定値よりも多く含まれるか否かを表示装置に表示させたり、ユーザの体内に所定の基質の量を表示装置に表示させたりしてもよい。 FIG. 23 illustrates an example in which the prediction result is displayed on the tablet terminal. However, as in the example illustrated in FIG. 2, the display control unit 56 includes a home monitor, a mobile terminal device, a wearable information terminal, The prediction result may be displayed on a display device such as a wearable terminal. Further, the display control unit 56 is not limited to the example of FIG. 23, and displays whether or not a predetermined substrate is included in the user's body more than a predetermined value on the display device, or displays the predetermined substrate in the user's body. The amount may be displayed on a display device.
〔変形例(洗浄処理)〕
 上述した第2の実施形態では、放水部403によりセンサチップ420を洗浄する例を示した。ここで、センサチップ420には、流路424~424を移動する試料を排出部側に吸引する吸引部が設けられてもよい。この場合、測定制御部430は、センサチップ420を洗浄する場合に、吸引部を制御することで、試料を素早く排出部側に移動させることができる。また、吸引することで流路424~424に残存する試料を除去できるので、流路424~424を素早く乾燥させたり、洗浄液やバッファ液で充填させたりすることができる。
[Modification (cleaning treatment)]
In 2nd Embodiment mentioned above, the example which wash | cleans the sensor chip 420 by the water discharge part 403 was shown. Here, the sensor chip 420 may be provided with a suction unit that sucks the sample moving through the channels 424 1 to 424 3 toward the discharge unit. In this case, when cleaning the sensor chip 420, the measurement control unit 430 can quickly move the sample to the discharge unit side by controlling the suction unit. Also, since the sample remaining in the flow path 424 1 to 424 3 by sucking can be removed, or to quickly dry the flow path 424 1 to 424 3, or can is filled with a cleaning liquid or a buffer solution.
 また、スマートトイレシステム4は、センサチップ420の洗浄状態を予測する予測処理を行ってもよい。具体的には、測定制御部430は、上述した洗浄処理を行った後に、絶対温度センサ422による計測温度と、温度センサ426~426による計測温度とに基づいて、各反応部における発熱量を測定する。これにより、宅内サーバ50の予測部55により洗浄後の反応部425~425に残存する基質の量が予測される。このとき、予測部55は、予測した基質の量が所定の閾値以下である場合には、センサチップ420の洗浄が十分であると予測し、基質の量が所定の閾値よりも多い場合には、センサチップ420の洗浄が不十分であると予測する。この場合、表示制御部56は、洗浄状態の予測結果に関する情報を表示装置60c等に表示制御してもよい。 The smart toilet system 4 may perform a prediction process for predicting the cleaning state of the sensor chip 420. Specifically, after performing the above-described cleaning process, the measurement control unit 430 generates heat generated in each reaction unit based on the temperature measured by the absolute temperature sensor 422 and the temperature measured by the temperature sensors 426 1 to 426 3. Measure. Thereby, the amount of the substrate remaining in the reaction units 425 1 to 425 3 after the cleaning is predicted by the prediction unit 55 of the home server 50. At this time, the predicting unit 55 predicts that the sensor chip 420 is sufficiently washed when the predicted amount of the substrate is equal to or less than the predetermined threshold, and when the amount of the substrate is larger than the predetermined threshold. The sensor chip 420 is predicted to be insufficiently cleaned. In this case, the display control unit 56 may display-control information related to the prediction result of the cleaning state on the display device 60c and the like.
〔変形例(補正処理)〕
 また、上記第2の実施形態において、反応部425~425等が劣化することにより、反応部425~425において測定される発熱量には誤差が生じる可能性がある。そこで、測定制御部430は、基質濃度や基質の含有量が既知である試料(以下、「標準液」と表記する場合がある)を試料注入孔423に注入することで測定される発熱量に基づいて、実際にユーザによって尿等が試料注入孔423に注入されることで測定される発熱量を補正してもよい。具体的には、標準液は、基質濃度や基質の含有量が既知であるので、標準液が注入された場合における発熱量も既知である。したがって、測定制御部430は、標準液を注入することで測定される発熱量と、標準液に対応する既知の発熱量との誤差に基づく補正係数を求める。そして、測定制御部430は、実際にユーザによって尿等が注入されることで測定される発熱量を補正係数によって補正する。これにより、測定制御部430は、基質濃度に対応する発熱量を精度良く測定することができる。
[Modification (Correction)]
In the second embodiment, the reaction units 425 1 to 425 3 and the like are deteriorated, so that there is a possibility that an error is generated in the calorific values measured in the reaction units 425 1 to 425 3 . Therefore, the measurement control unit 430 generates a calorific value measured by injecting a sample (hereinafter, sometimes referred to as “standard solution”) having a known substrate concentration or substrate content into the sample injection hole 423. Based on this, the calorific value measured by actually injecting urine or the like into the sample injection hole 423 by the user may be corrected. Specifically, since the standard solution has a known substrate concentration and substrate content, the calorific value when the standard solution is injected is also known. Therefore, the measurement control unit 430 obtains a correction coefficient based on an error between the calorific value measured by injecting the standard solution and the known calorific value corresponding to the standard solution. And the measurement control part 430 correct | amends the emitted-heat amount measured when urine etc. are actually inject | poured by a user with a correction coefficient. Thereby, the measurement control unit 430 can accurately measure the calorific value corresponding to the substrate concentration.
 なお、上記の通り、センサチップ420は、測定装置410に取り外し可能であってもよい。ここで、測定制御部430は、標準液を注入することで測定される発熱量と既知の発熱量との差異が所定値よりも大きい場合には、センサチップ420を交換する旨を表示装置に表示させてもよい。 As described above, the sensor chip 420 may be removable from the measuring device 410. Here, when the difference between the calorific value measured by injecting the standard solution and the known calorific value is larger than a predetermined value, the measurement control unit 430 informs the display device that the sensor chip 420 is to be replaced. It may be displayed.
〔変形例(センサチップ)〕
 また、上記第2の実施形態では、基質と酵素との反応熱に基づく温度変化を計測することにより、ユーザの体内に含まれる基質を予測する例を示した。しかし、センサチップには、反応熱に基づく温度変化を計測する手法以外の他の手法によって、ユーザの体内に含まれる基質の特性を示す情報を計測する機構が設けられてもよい。例えば、センサチップには、基質の特性を示す情報として、試料が流れる流路の振動に関する情報を計測する機構が設けられてもよい。以下、この点について説明する。なお、図20に示したセンサチップ420によれば、「尿蛋白」、「尿糖」、「尿潜血反応」、「尿ウロビリノーゲン」などの検査項目に対応することができる。第2の実施形態では、この種の検査項目に限らず、「尿比重」などの検査項目に対応可能なセンサチップの例について説明する。
[Modification (sensor chip)]
Moreover, in the said 2nd Embodiment, the example which estimates the substrate contained in a user's body was shown by measuring the temperature change based on the reaction heat of a substrate and an enzyme. However, the sensor chip may be provided with a mechanism for measuring information indicating characteristics of the substrate contained in the user's body by a method other than the method of measuring the temperature change based on the reaction heat. For example, the sensor chip may be provided with a mechanism for measuring information related to vibration of the flow path through which the sample flows as information indicating the characteristics of the substrate. Hereinafter, this point will be described. Note that the sensor chip 420 shown in FIG. 20 can cope with test items such as “urine protein”, “urine sugar”, “urinary occult blood reaction”, and “urine urobilinogen”. In the second embodiment, an example of a sensor chip that can handle not only this type of test item but also a test item such as “urine specific gravity” will be described.
 図24は、第2の実施形態の変形例に係るセンサチップ520の一例を示す図である。図25は、図24のB-B線に沿った矢視の概略断面図である。なお、以下では、図19に示した測定装置410が、センサチップ420の代わりに、図24に示すセンサチップ520を有するものとする。図24に示すように、変形例に係るセンサチップ520は、基板521と、第1の温度センサとしての絶対温度センサ522と、試料注入孔523と、流路524~524と、反応部525~525と、第2の温度センサとしての温度センサ526~526と、電極527~527と、共通電極528と、排出部529と、励振部531と、振動周波数検出部532と、電極533とを有する。 FIG. 24 is a diagram illustrating an example of a sensor chip 520 according to a modification of the second embodiment. FIG. 25 is a schematic cross-sectional view taken along the line BB in FIG. In the following, it is assumed that the measurement device 410 illustrated in FIG. 19 includes the sensor chip 520 illustrated in FIG. 24 instead of the sensor chip 420. As shown in FIG. 24, the sensor chip 520 according to the modification includes a substrate 521, an absolute temperature sensor 522 as a first temperature sensor, a sample injection hole 523, flow paths 524 1 to 524 5 , a reaction unit 525 1 to 525 4 , temperature sensors 526 1 to 526 4 as second temperature sensors, electrodes 527 1 to 527 4 , common electrode 528, discharge unit 529, excitation unit 531, and vibration frequency detection unit 532 and an electrode 533.
 基板521は、例えば、半導体のシリコン単結晶基板であり、中央部に空洞530が形成される。このため、センサチップ520のうち、基質等をセンシングするためのセンシング部530~530は、架橋構造となる。なお、図24では、センシング部530及び530のみを図示する。 The substrate 521 is, for example, a semiconductor silicon single crystal substrate, and a cavity 530 is formed at the center. For this reason, in the sensor chip 520, the sensing units 530 1 to 530 5 for sensing a substrate or the like have a crosslinked structure. FIG. 24 illustrates only the sensing units 530 1 and 530 5 .
 絶対温度センサ522は、図20に示した絶対温度センサ422と同様の構成である。また、試料注入孔523は、試料注入孔423と同様の構成である。流路524~524は、流路424~424と同様の構成である。反応部525~525は、反応部425~425と同様の構成である。温度センサ526~526は、温度センサ426~426と同様の構成である。電極527~527は、電極427~427と同様の構成である。すなわち、センサチップ520は、図20に示したセンサチップ420と同様に、酵素が固定される反応部525~525を有する。これにより、センサチップ520は、「尿蛋白」、「尿糖」、「尿潜血反応」、「尿ウロビリノーゲン」などの検査に用いられることができる。さらに、センサチップ520には、「尿比重」などの検査に対応できるように、流路524と、励振部531と、振動周波数検出部532と、電極533とが設けられる。 The absolute temperature sensor 522 has the same configuration as the absolute temperature sensor 422 shown in FIG. The sample injection hole 523 has the same configuration as the sample injection hole 423. The flow paths 524 1 to 524 4 have the same configuration as the flow paths 424 1 to 424 3 . The reaction units 525 1 to 525 4 have the same configuration as the reaction units 425 1 to 425 3 . The temperature sensors 526 1 to 526 4 have the same configuration as the temperature sensors 426 1 to 426 3 . The electrodes 527 1 to 527 4 have the same configuration as the electrodes 427 1 to 427 3 . That is, the sensor chip 520, like the sensor chip 420 shown in FIG. 20, it has a reaction unit 525 1 to 525 4 which enzyme is fixed. Thereby, the sensor chip 520 can be used for tests such as “urine protein”, “urine sugar”, “urine occult blood reaction”, “urine urobilinogen”. Furthermore, the sensor chip 520, to accommodate the inspection such as "urine specific gravity", a flow path 524 5, an excitation portion 531, and the vibration frequency detecting unit 532, and the electrode 533 are provided.
 流路524は、プラスチック(例えば、ポリイミド樹脂)等により形成され、試料注入孔523に注入された尿等を排出部529に向かって移動させる。流路524は、流路524~524と異なり酵素が固定される部位が設けられない。その代わりに、流路524には、励振部531と振動周波数検出部532とが設けられる。この点について、図25を用いて説明する。図25に示すように、励振部531は、シリコン(Si)薄膜531aと、シリコン酸化膜(SiO2)531bの二重層により形成される。シリコン薄膜531a及びシリコン酸化膜531bは、基板521上の形成されるシリコン酸化膜534に積層される。なお、シリコン酸化膜531bの厚さは、極めて薄く、シリコン酸化膜534と比較しても薄い。また、振動周波数検出部532は、例えば、架橋構造であるセンシング部530におけるシリコン薄膜531aの架橋構造支持部付近に形成されるピエゾ抵抗である。ピエゾ抵抗は、n型のSOI層であるシリコン薄膜531aに対して、p型の不純物であるホウ素(B)を熱拡散することで容易に形成される。 Passage 524 5, plastic (e.g., polyimide resin) is formed by such, to move the injected into the sample injection hole 523 such as urine toward the discharge portion 529. Unlike the channels 524 1 to 524 4 , the channel 524 5 is not provided with a site where the enzyme is immobilized. Alternatively, the flow path 524 5, the excitation portion 531 and the vibration frequency detecting unit 532 is provided. This point will be described with reference to FIG. As shown in FIG. 25, the excitation unit 531 is formed of a double layer of a silicon (Si) thin film 531a and a silicon oxide film (SiO2) 531b. The silicon thin film 531 a and the silicon oxide film 531 b are stacked on the silicon oxide film 534 formed on the substrate 521. Note that the thickness of the silicon oxide film 531b is extremely thin, and is thinner than the silicon oxide film 534. The vibration frequency detecting unit 532 is, for example, a piezo resistor formed in the vicinity of the bridge structure supporting portion of the silicon thin film 531a in the sensing portion 530 5 is a cross-linked structure. The piezoresistor is easily formed by thermally diffusing boron (B), which is a p-type impurity, into the silicon thin film 531a that is an n-type SOI layer.
 上述したシリコン薄膜531aの熱膨張係数は大きいが、シリコン酸化膜531bの熱膨張係数は極めて小さい。このため、架橋構造のセンシング部530のシリコン薄膜531aに交流電流を流して加熱(ジュール加熱)すると、励振部531は、熱膨張係数の違いによるバイメタル効果によりバイモルフ振動を引き起こして、空洞530上のセンシング部530を励振する。そして、ピエゾ抵抗である振動周波数検出部532の抵抗値は、センシング部530の振動によるひずみに基づき変化する。 Although the above-described silicon thin film 531a has a large thermal expansion coefficient, the silicon oxide film 531b has a very small thermal expansion coefficient. Therefore, heating by flowing a silicon thin film 531a to an alternating current of the sensing unit 530 5 crosslinked structure (Joule heating), the excitation portion 531, causing the bimorph vibration by the bimetal effect by the difference in thermal expansion coefficient, the upper cavity 530 Next, the sensing unit 530 5 is excited. Then, the resistance value of the vibration frequency detecting unit 532 is a piezoresistive changes based on the distortion due to the vibration of the sensing unit 530 5.
 上述した測定制御部430は、振動周波数検出部532の抵抗値の変化から、センシング部530の振動周波数を検出する。ここで、励振部531に対する1回の加熱及び冷却を1サイクルとすると、その繰り返しサイクルと、センシング部530の固有振動数と一致する共振周波数は、流路524を流れる試料(例えば、尿)の質量に依存する。具体的には、その質量が大きいほど、共振周波数は、低周波側にシフトする。測定制御部430は、電極533からシリコン薄膜531aに流す交流電流を制御することにより、この共振周波数やシフト量(すわなち、位相)を計測し、計測結果から尿等の質量の変化を計測する。すなわち、センサチップ520を有する測定装置410は、ユーザの体内に含まれる基質を予測する「尿蛋白」、「尿糖」、「尿潜血反応」、「尿ウロビリノーゲン」などの検査項目に加えて、「尿比重」などの検査項目の場面でも用いることができる。 Measurement control unit 430 described above, the change in resistance value of the vibration frequency detecting unit 532 detects the vibration frequency of the sensing unit 530 5. Here, when one of the heating and 1 cycle cooling to the excitation portion 531, the resonance frequency that matches its repetition cycle, the natural frequency of the sensing unit 530 5, a sample flowing through the channel 524 5 (e.g., urine ) Depending on the mass. Specifically, the resonance frequency shifts to the lower frequency side as the mass increases. The measurement control unit 430 controls the alternating current flowing from the electrode 533 to the silicon thin film 531a, thereby measuring the resonance frequency and the shift amount (that is, the phase), and measuring a change in mass such as urine from the measurement result. To do. That is, the measuring device 410 having the sensor chip 520 is in addition to test items such as “urine protein”, “urine sugar”, “urine occult blood reaction”, “urine urobilinogen” for predicting a substrate contained in the user's body, It can also be used in scenes of inspection items such as “urine specific gravity”.
 なお、上記のジュール加熱は、他の架橋構造のセンシング部と同様に形成する架橋構造の基質と酵素との熱反応の温度計測に使用する第2の温度センサである熱電対526(図25に一例を図示)をジュール加熱用ヒータとして利用することもできる。この熱電対526としては、例えば、架橋構造のシリコン薄膜531aと、薄いシリコン酸化膜531bを介した金属薄膜とが熱電材料として使用される。また、圧電性薄膜を架橋構造に形成することにより、励振部531として利用することもできる。 The Joule heating is performed by thermocouple 526 5, which is a second temperature sensor used for temperature measurement of a thermal reaction between a substrate having a crosslinked structure and an enzyme formed in the same manner as other sensing units having a crosslinked structure (FIG. 25). Can be used as a heater for Joule heating. As the thermocouple 526 5, for example, a silicon thin film 531a of the crosslinked structure, the metal thin film through the thin silicon oxide film 531b is used as a thermoelectric material. Further, by forming the piezoelectric thin film in a cross-linked structure, it can be used as the excitation unit 531.
 また、センサチップ520に形成される流路の数は、図24に示した例に限られない。例えば、センサチップ520には、反応部が設けられる流路が3個以下、又は、5個以上形成されてもよい。 Further, the number of flow paths formed in the sensor chip 520 is not limited to the example shown in FIG. For example, the sensor chip 520 may be formed with three or less channels or five or more channels provided with reaction parts.
 また、上述したセンサチップ520は、基板521に形成された空洞である排出部529が形成される。図24の例の場合、流路524~524を流れる尿等の試料は、排出部529を介して、センサチップ520の外部に排出される。このような構造を有するセンサチップ520であっても、洗浄可能であるので繰り返し利用されることが可能である。 Further, in the sensor chip 520 described above, a discharge portion 529 that is a cavity formed in the substrate 521 is formed. In the case of the example in FIG. 24, the sample such as urine flowing through the flow paths 524 1 to 524 5 is discharged to the outside of the sensor chip 520 through the discharge unit 529. Even the sensor chip 520 having such a structure can be repeatedly used because it can be washed.
 また、図24に示した例において、測定制御部430は、絶対温度センサ522によって計測される環境温度に応じて、反応部525~525における発熱量、又は、反応部525~525に設けられる温度センサ526~526の出力電圧を補正してもよい。すなわち、宅内サーバ50の予測部55は、絶対温度センサ522によって計測される環境温度に応じて温度センサ526~526による計測結果が補正された後の値に基づいて、ユーザの体内に含まれる基質を予測する。この点について図26を用いて説明する。図26は、環境温度と出力電圧との関係の一例を示す図である。図26の横軸は時間経過を示し、図26の縦軸は温度センサ526~526からの出力電圧を示す。また、波形W21は、環境温度が高い場合における出力電圧の例を示し、波形W22は、波形W21よりも環境温度が低い場合における出力電圧の例を示す。なお、波形W21及びW22は、環境温度以外の条件(例えば、試料など)は同一であるものとする。図26に示すように、環境温度が低いほど出力電圧がピークとなる時間が遅くなり、かつ、そのピーク値は低くなる。上記の通り、測定制御部430は、温度センサ526~526からの出力電圧におけるピーク値、又は、出力電圧の波形の積分値に基づいて、各反応部における発熱量を測定する。このとき、測定制御部430は、図26に例示する関係と、絶対温度センサ522によって測定される環境温度とに応じて、出力電圧のピーク値、又は、出力電圧の波形の積分値を補正してもよい。すなわち、測定制御部430は、環境温度に応じて反応部525~525における発熱量を補正してもよい。これにより、宅内サーバ50の予測部55は、ユーザ体内に含まれる基質の量や濃度を高精度に予測することができる。 In the example illustrated in FIG. 24, the measurement control unit 430, depending on the environmental temperature measured by the absolute temperature sensor 522, the heating value in the reaction unit 525 1 to 525 4, or reaction part 525 1 to 525 4 The output voltages of the temperature sensors 526 1 to 526 4 provided in the above may be corrected. That is, the prediction unit 55 of the in-home server 50 includes in the user's body based on values after the measurement results by the temperature sensors 526 1 to 526 4 are corrected according to the environmental temperature measured by the absolute temperature sensor 522. Predict substrate This point will be described with reference to FIG. FIG. 26 is a diagram illustrating an example of the relationship between the environmental temperature and the output voltage. The horizontal axis of FIG. 26 shows the passage of time, and the vertical axis of FIG. 26 shows the output voltage from the temperature sensors 526 1 to 526 4 . A waveform W21 shows an example of the output voltage when the environmental temperature is high, and a waveform W22 shows an example of the output voltage when the environmental temperature is lower than the waveform W21. The waveforms W21 and W22 are assumed to have the same conditions (for example, a sample) other than the environmental temperature. As shown in FIG. 26, the lower the environmental temperature, the later the peak time of the output voltage and the lower the peak value. As described above, the measurement control unit 430 measures the amount of heat generated in each reaction unit based on the peak value of the output voltage from the temperature sensors 526 1 to 526 4 or the integrated value of the waveform of the output voltage. At this time, the measurement control unit 430 corrects the peak value of the output voltage or the integrated value of the waveform of the output voltage according to the relationship illustrated in FIG. 26 and the environmental temperature measured by the absolute temperature sensor 522. May be. That is, the measurement control unit 430 may correct the amount of heat generated in the reaction units 525 1 to 525 4 according to the environmental temperature. Thereby, the prediction unit 55 of the home server 50 can predict the amount and concentration of the substrate contained in the user's body with high accuracy.
 また、図24に示したセンサチップ520の排出部529には、流路524~524を移動する試料を、試料注入孔523から排出部529に向かう方向に吸引する吸引部が設けられてもよい。この場合、測定制御部430は、センサチップ520を洗浄する場合に、吸引部を制御することで、試料を素早く排出部529側に移動させることができる。 24 is provided with a suction unit that sucks the sample moving in the flow paths 524 1 to 524 5 in the direction from the sample injection hole 523 toward the discharge unit 529. The discharge unit 529 of the sensor chip 520 shown in FIG. Also good. In this case, when cleaning the sensor chip 520, the measurement control unit 430 can quickly move the sample to the discharge unit 529 side by controlling the suction unit.
〔変形例(ハンディタイプ)〕
 また、上述した第2の実施形態では、スマートトイレシステム4を例に挙げて説明した。しかし、上述したセンサチップ420は、持ち運び可能な小型タイプであるハンディタイプの測定装置に組み込まれてもよい。図27は、第2の実施形態に係るハンディタイプのセンサを説明するための図である。図27に示したハンディタイプのカロリメトリックセンサ500には、試料注入孔501が設けられ、上述したセンサチップ420(または、センサチップ520)及び測定制御部430が内部に搭載される。これに加えて、カロリメトリックセンサ500には、宅内サーバ50やPHR処理装置20と通信可能な通信部411が搭載されてもよい。また、カロリメトリックセンサ500には、排水部に対応する排水口が設けられてもよい。なお、カロリメトリックセンサ500に搭載される測定制御部430は、予測部55と同様に基質の種類や量や濃度の予測処理を行ってもよいし、宅内サーバ50やPHR処理装置20等の他のサーバ装置によって予測された予測結果を受信してもよい。
[Modification (Handy type)]
In the above-described second embodiment, the smart toilet system 4 has been described as an example. However, the above-described sensor chip 420 may be incorporated in a handy type measuring device that is a small portable type. FIG. 27 is a diagram for explaining a handy-type sensor according to the second embodiment. The handy-type calorimetric sensor 500 shown in FIG. 27 is provided with a sample injection hole 501, and the above-described sensor chip 420 (or sensor chip 520) and measurement control unit 430 are mounted inside. In addition, the calorimetric sensor 500 may be equipped with a communication unit 411 that can communicate with the home server 50 and the PHR processing device 20. Further, the calorimetric sensor 500 may be provided with a drain outlet corresponding to the drainage section. Note that the measurement control unit 430 mounted on the calorimetric sensor 500 may perform the process of predicting the type, amount, and concentration of the substrate in the same manner as the prediction unit 55, and may include other than the home server 50, the PHR processing device 20, and the like. The prediction result predicted by the server device may be received.
 カロリメトリックセンサ500は、上述した測定装置410と同様に、多項目の基質等を検出することができる。また、カロリメトリックセンサ500は、尿検査や血液検査等に用いることができる。このようなカロリメトリックセンサ500は、健康診断等の集団検診や、医療機関での検査に用いることができるだけでなく、家庭内で携帯用検査機として用いることができる。 The calorimetric sensor 500 can detect multiple items of substrates and the like, similar to the measurement device 410 described above. The calorimetric sensor 500 can be used for urinalysis, blood tests, and the like. Such a calorimetric sensor 500 can be used not only for group medical examinations such as medical examinations and examinations at medical institutions, but also as a portable inspection machine at home.
〔変形例(他のシステム)〕
 また、上述した第2の実施形態では、スマートトイレシステム4を例に挙げて説明した。しかし、上述した第2の実施形態は、スマートブラシシステムやスマートシンクシステムにも適用することができる。
[Modification (Other systems)]
In the above-described second embodiment, the smart toilet system 4 has been described as an example. However, the second embodiment described above can also be applied to a smart brush system or a smart sync system.
 例えば、上述した第2の実施形態がスマートブラシシステムに適用される場合、図3に示した測定装置103の代わりに測定装置410が採用される。すなわち、センサチップ420の試料注入孔423には、ユーザを洗浄する洗浄器具(歯ブラシ等)を洗浄した洗浄水が注入される。また、上述した第2の実施形態がスマートシンクシステムに適用される場合、図16に示した測定装置203の代わりに測定装置410が採用される。すなわち、センサチップ420の試料注入孔423には、ユーザから排出された物質(うがい後の水など)や、ユーザを洗浄した洗浄水(洗顔時の水など)が注入される。 For example, when the second embodiment described above is applied to a smart brush system, a measuring device 410 is employed instead of the measuring device 103 shown in FIG. That is, cleaning water that has cleaned a cleaning instrument (such as a toothbrush) that cleans the user is injected into the sample injection hole 423 of the sensor chip 420. Further, when the second embodiment described above is applied to a smart sync system, a measuring device 410 is employed instead of the measuring device 203 shown in FIG. That is, a substance discharged from the user (eg, water after gargle) and cleaning water (eg, water used when washing the face) discharged from the user are injected into the sample injection hole 423 of the sensor chip 420.
〔変形例(予測対象)〕
 また、第2の実施形態では、体内の生体物質と反応する反応物質として酵素を反応部425~425に固定する例を示した。しかし、反応部425~425には、酵素ではなく、特定の抗体や抗原が固定されてもよい。そして、宅内サーバ50は、測定装置410による発熱量の測定結果に基づいて、体内に含まれる酵素や抗原や抗体を予測してもよい。この場合、試料注入孔423に注入される体内物質は、上述した尿に限られず、唾液、血液、汗、人体を洗浄した洗浄水などであってもよい。
[Modification (Target for prediction)]
In the second embodiment, an example of fixing the reaction unit 425 1 to 425 3 enzymatic as a reactant that reacts with the body of the biological material. However, a specific antibody or antigen may be immobilized on the reaction units 425 1 to 425 3 instead of an enzyme. Then, the home server 50 may predict an enzyme, an antigen, or an antibody contained in the body based on the measurement result of the calorific value by the measurement device 410. In this case, the in-vivo substance injected into the sample injection hole 423 is not limited to the urine described above, but may be saliva, blood, sweat, washing water that cleans the human body, and the like.
〔効果〕
 上述してきたように、第2の実施形態によれば、酸化還元電流に基づくセンサと比較して、生体由来物質等の生体物質を精度良く検出することができる。この点について図28を用いて説明する。図28は、酸化還元電流による尿糖検査の例を示す図である。図28に示すように、従来の尿糖センサでは、例えば、酸化酵素であるグルコースオキシダーゼによりグルコースが酸化する際に生成される過酸化水素の酸化還元電流を計測することで、グルコースの量を検出する。しかし、尿に含まれる尿酸やアスコルビン酸や、酸化時に生成されるグルコン酸等の妨害物質も酸化還元電流に影響を与えるので、検出精度は高いと言えない。また、過酸化水素のみを透過させる選択透過膜を設けることで、妨害物質による酸化還元電流への影響を低下させることも考えられるが、センサの構造が複雑になるとともに製造コストの増大に繋がる。一方、第2の実施形態に係るセンサチップ420は、酵素や補酵素の触媒反応による熱反応を利用した温度変化を計測するが、この温度変化の計測に妨害物質の影響を受けることがない。このため、第2の実施形態に係るセンサチップ420では、センサの構造が複雑になることがなく、また、製造コストが増大することもない。
〔effect〕
As described above, according to the second embodiment, a biological material such as a biological material can be detected with higher accuracy than a sensor based on a redox current. This will be described with reference to FIG. FIG. 28 is a diagram illustrating an example of a urine sugar test using a redox current. As shown in FIG. 28, in the conventional urine sugar sensor, for example, the amount of glucose is detected by measuring the oxidation-reduction current of hydrogen peroxide generated when glucose is oxidized by glucose oxidase, which is an oxidase. To do. However, since the interfering substances such as uric acid and ascorbic acid contained in urine and gluconic acid generated during oxidation also affect the redox current, it cannot be said that the detection accuracy is high. In addition, by providing a selectively permeable membrane that allows only hydrogen peroxide to pass therethrough, it is conceivable to reduce the influence of the interfering substance on the oxidation-reduction current. However, the sensor structure is complicated and the manufacturing cost is increased. On the other hand, the sensor chip 420 according to the second embodiment measures a temperature change using a thermal reaction due to a catalytic reaction of an enzyme or a coenzyme, but the measurement of the temperature change is not affected by an interfering substance. For this reason, in the sensor chip 420 according to the second embodiment, the structure of the sensor does not become complicated, and the manufacturing cost does not increase.
 また、第2の実施形態に係るセンサチップ420によれば、注入された体内物質が排出部に排出されるので、洗浄できるとともに繰り返し利用されることが可能である。さらに、第2の実施形態に係るセンサチップ420によれば、異なる酵素が固定された各反応部において体内物質を触媒反応させるので、1回の処理で多項目の生体物質を検出することができる。上述してきた日常人間ドックでは、トイレの便器等にセンサが設けられるので、洗浄可能かつ繰り返し利用可能かつ多項目を検出可能なセンサチップ420を用いることで、この日常人間ドックを実現することが可能になる。 Also, according to the sensor chip 420 according to the second embodiment, the injected in-vivo substance is discharged to the discharge part, so that it can be washed and used repeatedly. Furthermore, according to the sensor chip 420 according to the second embodiment, the internal substance is catalyzed in each reaction part to which a different enzyme is immobilized, so that multiple items of biological substances can be detected in one process. . In the daily human dock described above, since a sensor is provided in a toilet bowl or the like, this daily human dock can be realized by using the sensor chip 420 that can be washed, can be repeatedly used, and can detect many items. .
(その他の実施形態等)
〔什器〕
 上記実施形態では、什器の例として、歯ブラシ洗浄機やトイレ(便器)やシンク(洗面台)等を例に挙げて説明したが、什器はこれらの例に限られない。例えば、什器としては、ユーザが尿等を排出するコップ等であってもよい。また、上記実施形態では、什器に設けられたセンサにより、什器から排水又は排出されるユーザの体内物質から、ユーザの生体物質の特性を示す情報を測定する例を示した。例えば、第1の実施形態では、洗浄機101に設けられた磁界センサ110により、ユーザの生体物質の特性を示す情報として、洗浄機101からの排水物質と抗体と磁気ビーズとが混合された混合物から発生する磁界を測定する例を示した。また、第2の実施形態では、便器401に設けられたセンサチップ420により、ユーザの生体物質の特性を示す情報として、便器401から排出される体内物質と所定の基質との熱反応に基づく温度変化を測定する例を示した。しかし、この例に限られず、上述した各実施形態は、什器から取り出される、又は、什器から採取されるユーザの体内物質から、生体物質の特性を示す情報を各種センサにより測定してもよい。例えば、病院や集団検診、更には、家庭などにおいて、ユーザや医師が、什器であるコップに排出した尿等を、測定装置103の第1の流路104や、センサチップ420の試料注入孔423に注入してもよい。
(Other embodiments, etc.)
[Furniture]
In the said embodiment, although the toothbrush washing machine, the toilet (toilet bowl), the sink (toilet) etc. were mentioned as an example as an example of a toilet bowl, a toilet bowl is not restricted to these examples. For example, the fixture may be a cup from which the user discharges urine or the like. Moreover, in the said embodiment, the example which measures the information which shows the characteristic of a user's biological material from the user's in-vivo material drained or discharged | emitted from a fixture with the sensor provided in the fixture was shown. For example, in the first embodiment, the magnetic field sensor 110 provided in the cleaning machine 101 uses a mixture of waste material, antibodies, and magnetic beads from the cleaning machine 101 as information indicating the characteristics of the biological material of the user. An example of measuring the magnetic field generated from the is shown. Moreover, in 2nd Embodiment, the temperature based on the thermal reaction of the internal substance discharged | emitted from the toilet bowl 401 and the predetermined | prescribed substrate as information which shows the characteristic of a user's biological substance with the sensor chip 420 provided in the toilet bowl 401 is provided. An example of measuring change was given. However, the present invention is not limited to this example, and each of the above-described embodiments may measure information indicating characteristics of a biological material from various types of sensors from a user's internal material taken out of the furniture or collected from the furniture. For example, urine discharged by a user or doctor in a cup, which is a fixture, in a hospital, a mass examination, or at home, for example, the first flow path 104 of the measuring device 103 or the sample injection hole 423 of the sensor chip 420. May be injected.
〔ハードウェア構成〕
 図29は、実施形態に係る宅内サーバ50のハードウェア構成を示す図である。宅内サーバ50は、CPU1100と、ROM1200と、RAM1300と、表示部1400と、入力部1500とを備える。また、宅内サーバ50では、CPU1100、ROM1200、RAM1300、表示部1400、及び入力部1500が、バスライン1010を介して接続されている。
[Hardware configuration]
FIG. 29 is a diagram illustrating a hardware configuration of the home server 50 according to the embodiment. Home server 50 includes CPU 1100, ROM 1200, RAM 1300, display unit 1400, and input unit 1500. In the home server 50, a CPU 1100, a ROM 1200, a RAM 1300, a display unit 1400, and an input unit 1500 are connected via a bus line 1010.
 宅内サーバ50による各種処理を実現するプログラムは、ROM1200内に格納されており、バスライン1010を介して、RAM1300へロードされる。CPU1100は、RAM1300内にロードされたプログラムを実行する。例えば、宅内サーバ50では、操作者による入力部1500からの指示入力に従って、CPU1100が、ROM1200内からプログラムを読み出してRAM1300内のプログラム格納領域に展開し、各種処理を実行する。CPU1100は、この各種処理に際して生じる各種データをRAM1300内に形成されるデータ格納領域に一時的に記憶させておく。 A program that realizes various processes by the home server 50 is stored in the ROM 1200 and loaded into the RAM 1300 via the bus line 1010. The CPU 1100 executes a program loaded in the RAM 1300. For example, in the home server 50, the CPU 1100 reads out a program from the ROM 1200 in accordance with an instruction input from the input unit 1500 by the operator, expands it in a program storage area in the RAM 1300, and executes various processes. The CPU 1100 temporarily stores various data generated during the various processes in a data storage area formed in the RAM 1300.
 宅内サーバ50で実行されるプログラムは、認証部53、受信部54、予測部55、表示制御部56、送信部57を含むモジュール構成となっており、これらが主記憶装置上にロードされ、これらが主記憶装置上に生成される。 The program executed in the home server 50 has a module configuration including an authentication unit 53, a reception unit 54, a prediction unit 55, a display control unit 56, and a transmission unit 57, and these are loaded on the main storage device. Are generated on the main memory.
〔構成〕
 上述した実施形態では、クラウド上にPHR処理装置20が構築される構成を説明したが、実施形態はこれに限られるものではない。PHR処理装置20は、その機能の全部若しくは一部を、例えば、データ信託会社内のネットワーク上に構築することもできる。また、PHR処理装置20は、必ずしも1つの拠点に構築されなければならないものではない。複数の拠点に分散配置された機能が連携することで、PHR処理装置20を実現してもよい。
〔Constitution〕
In the above-described embodiment, the configuration in which the PHR processing device 20 is built on the cloud has been described, but the embodiment is not limited to this. The PHR processing device 20 can also build all or part of its functions on, for example, a network within a data trust company. Further, the PHR processing device 20 does not necessarily have to be constructed at one base. The PHR processing device 20 may be realized by cooperation of functions distributed and arranged at a plurality of bases.
 また、上述した実施形態では、宅内サーバ50が予測処理を行う例を示したが、この例に限られない。例えば、PHR処理装置20が、予測部55を有し、上述してきた予測処理を行うことで、宅内の各ユーザに関する各種情報を管理する管理装置であってもよい。また、例えば、測定装置103、203、303、410が予測部55を有し、上述してきた予測処理を行ってもよい。 In the above-described embodiment, the example in which the home server 50 performs the prediction process is shown, but the present invention is not limited to this example. For example, the PHR processing device 20 may include a prediction unit 55 and may be a management device that manages various types of information regarding each user in the home by performing the above-described prediction processing. Further, for example, the measurement devices 103, 203, 303, and 410 may include the prediction unit 55 and perform the above-described prediction processing.
 また、実施形態は、上述した実施形態に限られるものではない。例えば、上述してきた各実施形態は、処理内容を矛盾させない範囲で適宜組み合わせることが可能である。 Further, the embodiment is not limited to the above-described embodiment. For example, the embodiments described above can be combined as appropriate within a range that does not contradict the processing contents.
 また、上述した実施形態で例示した物理的な構成は、あくまで一例に過ぎない。上述した実施形態で例示した各部は、運用の形態や負荷に応じて適宜統合若しくは分散される。 In addition, the physical configuration illustrated in the above-described embodiment is merely an example. Each unit illustrated in the above-described embodiment is appropriately integrated or distributed according to the operation mode and load.
 これまで説明してきた実施形態によれば、半導体・通信・エネルギー・素材・医療技術の創意を結集して、生きることへのモチベーションを取戻すための日常人間ドックを実現することができる。すなわち、実施形態によれば、図30に示すように、病気及び病気の萌芽をいち早く検出し、健康への回帰をサポートし、未病の人の健康への回帰、及び、病人の早期の社会復帰を助けることで、QOL(Quality of Life)の向上を図り、結果として医療費の削減が果たされ、かつ健康年齢の増加を図ることができる。 According to the embodiments described so far, it is possible to realize an everyday human dock to regain motivation to live by bringing together the originality of semiconductors, communication, energy, materials, and medical technologies. That is, according to the embodiment, as shown in FIG. 30, the disease and the sprouting of the disease are detected quickly, the return to health is supported, the return to the health of the unaffected person, and the early society of the sick person. By helping to return, QOL (Quality of Life) can be improved, resulting in a reduction in medical costs and an increase in healthy age.
 本発明のいくつかの実施形態を説明したが、これらの実施形態は、例として提示したものであり、発明の範囲を限定することは意図していない。これら実施形態は、その他の様々な形態で実施されることが可能であり、発明の要旨を逸脱しない範囲で、種々の省略、置き換え、変更を行うことができる。これら実施形態やその変形は、発明の範囲や要旨に含まれると同様に、請求の範囲に記載された発明とその均等の範囲に含まれるものである。 Although several embodiments of the present invention have been described, these embodiments are presented as examples and are not intended to limit the scope of the invention. These embodiments can be implemented in various other forms, and various omissions, replacements, and changes can be made without departing from the spirit of the invention. These embodiments and modifications thereof are included in the scope of the present invention and the gist thereof, and are also included in the invention described in the claims and the equivalent scope thereof.

Claims (24)

  1.  トイレ又は洗面所に設置される什器であってユーザが使用する什器から取り出される当該ユーザの体内物質を受け付ける受付部と、
     前記什器に設けられたセンサにより、前記受付部によって受け付けられた体内物質から、生体物質の特性を示す情報を測定する測定部と、
     前記測定部によって測定された情報に基づいて、前記ユーザの体内に含まれる生体物質を予測する予測部と、
     前記予測部によって予測された生体物質から前記ユーザの健康状態を判定する判定部と、
     前記判定部で判定された健康状態に基づいて、前記ユーザに対するアドバイスを表示する表示部と
     を備える生体管理システム。
    A reception unit that is a toilet installed in a toilet or a washroom and receives a user's in-vivo material taken out of the fixture used by the user;
    A measurement unit that measures information indicating characteristics of the biological substance from the in-vivo substance received by the reception unit by a sensor provided in the fixture,
    Based on the information measured by the measurement unit, a prediction unit for predicting the biological material contained in the user's body;
    A determination unit that determines the health state of the user from the biological material predicted by the prediction unit;
    A biological management system comprising: a display unit that displays advice for the user based on the health condition determined by the determination unit.
  2.  前記生体管理システムは、測定装置と、管理装置とを含み、
     前記測定装置は、前記測定部と、前記測定部によって測定された情報を前記管理装置に送信する送信部とを備え、
     前記管理装置は、前記予測部と、前記送信部によって送信された情報を受信する受信部を備え、
     前記予測部は、前記受信部によって受信された情報に基づいて、前記ユーザの体内に含まれる生体物質を予測する
     請求項1に記載の生体管理システム。
    The biological management system includes a measuring device and a management device,
    The measurement device includes the measurement unit, and a transmission unit that transmits information measured by the measurement unit to the management device,
    The management device includes the prediction unit and a reception unit that receives information transmitted by the transmission unit,
    The biological management system according to claim 1, wherein the prediction unit predicts a biological material contained in the user's body based on information received by the reception unit.
  3.  前記生体管理システムは、サーバ装置をさらに備え、
     前記サーバ装置は、前記ユーザの行動情報と前記予測部による予測結果とが関連付けられたライフログ情報を前記管理装置から収集し、収集したライフログ情報の解析結果を医療機関に提供する
     請求項2に記載の生体管理システム。
    The biological management system further includes a server device,
    The server device collects life log information in which the behavior information of the user is associated with a prediction result by the prediction unit from the management device, and provides a medical institution with an analysis result of the collected life log information. The biological management system described in 1.
  4.  ユーザが使用する什器から取り出される当該ユーザの体内物質を含む排水物質を受け付ける受付部と、
     前記受付部によって受け付けられた排水物質に、抗体又は抗原である反応物質と、磁気ビーズとが混合された混合物から発生する磁界を磁界センサによって測定する測定部と、
     前記測定部によって測定された磁界に基づいて、前記ユーザの体内に含まれる生体物質を予測する予測部と
     を備える生体管理システム。
    A reception unit that receives drainage material including the body material of the user to be taken out from the fixture used by the user;
    A measuring unit that measures a magnetic field generated from a mixture of a reactive substance that is an antibody or an antigen and a magnetic bead mixed with the waste material received by the receiving unit by a magnetic field sensor,
    A biological management system comprising: a prediction unit that predicts a biological substance contained in the user's body based on the magnetic field measured by the measurement unit.
  5.  前記受付部は、前記排水物質として、前記ユーザを洗浄するための洗浄器具を洗浄水により洗浄する什器から取り出される洗浄水、前記ユーザを洗浄水により洗浄する什器から取り出される洗浄水、又は、前記ユーザから当該ユーザの排出物が排出される什器から取り出される当該排出物を受け付ける、
     請求項4に記載の生体管理システム。
    The reception unit is, as the drainage substance, cleaning water taken out from a fixture that cleans a cleaning instrument for cleaning the user with cleaning water, cleaning water taken out from a fixture that cleans the user with cleaning water, or the Accepting the discharge from the user from the fixture from which the user's discharge is discharged;
    The biological management system according to claim 4.
  6.  前記予測部による予測結果を表示装置に表示させる表示制御部をさらに備え、
     前記予測部は、前記ユーザの体内に含まれると予測した所定の生体物質から、当該ユーザの健康状態を予測し、
     前記表示制御部は、前記予測部によって予測された健康状態を前記表示装置に表示させる
     請求項4又は5に記載の生体管理システム。
    A display control unit for displaying a prediction result by the prediction unit on a display device;
    The prediction unit predicts the health state of the user from a predetermined biological material predicted to be contained in the user's body,
    The biological management system according to claim 4, wherein the display control unit causes the display device to display the health state predicted by the prediction unit.
  7.  前記予測部は、前記什器から取り出される排水物質と前記反応物質と前記磁気ビーズとが混合されてから所定の時間が経過した後に、前記ユーザの体内に所定の生体物質が含まれるか否かを予測し、前記所定の時間よりも長い時間が経過した後に、前記ユーザの体内に含まれる前記所定の生体物質の量を予測する
     請求項4~6のいずれか一つに記載の生体管理システム。
    The prediction unit determines whether or not a predetermined biological material is contained in the user's body after a predetermined time has elapsed since the drainage material taken out from the fixture, the reaction material, and the magnetic beads are mixed. 7. The biological management system according to claim 4, wherein the biological management system predicts and predicts an amount of the predetermined biological material contained in the user's body after a time longer than the predetermined time has elapsed.
  8.  前記什器から取り出される排水物質が流れる流路と、
     前記流路を流れる排水物質に異なる反応物質を混合させる混合部とをさらに備え、
     前記測定部は、前記混合部によって混合された反応物質毎に、当該反応物質が混合された混合物から発生する磁界を測定し、
     前記予測部は、前記測定部によって測定された磁界に基づいて、前記混合部によって混合された反応物質毎に、当該反応物質との間で抗原抗体反応を起こす生体物質であって前記ユーザの体内に含まれる生体物質を予測する
     請求項4~7のいずれか一つに記載の生体管理システム。
    A flow path through which drainage material extracted from the fixture flows,
    A mixing section for mixing different reactants with the drainage material flowing through the flow path,
    The measurement unit measures a magnetic field generated from a mixture in which the reactants are mixed for each reactant mixed by the mixing unit,
    The predicting unit is a biological material that causes an antigen-antibody reaction with the reactant for each reactant mixed by the mixing unit based on the magnetic field measured by the measuring unit, and the body of the user The living body management system according to any one of claims 4 to 7, which predicts a biological material contained in the body.
  9.  前記流路は、前記排水物質が流れる第1の流路と、前記第1の流路から分岐した複数の第2の流路とを有し、
     前記混合部は、前記第2の流路毎に異なる反応物質を当該第2の流路に流れる排水物質と混合させ、
     前記測定部は、前記第2の流路毎に、当該第2の流路を流れる混合物から発生する磁界を測定する
     請求項8に記載の生体管理システム。
    The flow path includes a first flow path through which the drainage material flows, and a plurality of second flow paths branched from the first flow path,
    The mixing unit mixes different reactive substances for each second flow path with waste water flowing in the second flow path,
    The biological management system according to claim 8, wherein the measurement unit measures a magnetic field generated from the mixture flowing in the second flow path for each second flow path.
  10.  前記測定部は、前記混合物が流れた前記流路を洗浄する洗浄水から発生する磁界を測定し、
     前記予測部は、前記測定部によって測定された前記洗浄水からの磁界に基づいて、前記流路における洗浄状態を予測する
     請求項8又は9に記載の生体管理システム。
    The measurement unit measures a magnetic field generated from washing water for washing the flow path through which the mixture flows,
    The living body management system according to claim 8 or 9, wherein the prediction unit predicts a cleaning state in the flow path based on a magnetic field from the cleaning water measured by the measurement unit.
  11.  ユーザが使用する什器から取り出される当該ユーザの体内物質を受け付ける受付部と、
     前記受付部によって受け付けられた体内物質と所定の反応物質との熱反応に基づく温度変化を計測する温度計測部と、
     前記温度計測部によって計測された温度変化に基づいて、前記ユーザの体内に含まれる生体物質を予測する予測部と
     を備える生体管理システム。
    A reception unit for receiving the user's body substance taken out from the fixture used by the user;
    A temperature measurement unit that measures a temperature change based on a thermal reaction between the in-vivo substance and the predetermined reactant received by the reception unit;
    A biological management system comprising: a prediction unit that predicts a biological substance contained in the user's body based on a temperature change measured by the temperature measurement unit.
  12.  前記受付部は、前記ユーザから当該ユーザの排出物が排出される前記什器、又は、前記ユーザを洗浄するための洗浄器具を洗浄する洗浄装置である前記什器から取り出される前記体内物質を受け付ける
     請求項11に記載の生体管理システム。
    The said reception part receives the said in-vivo substance taken out from the said appliance which is the washing | cleaning apparatus which wash | cleans the said appliance from which the said user's discharge | emission is discharged | emitted from the said user, or the said user. The biological management system according to 11.
  13.  前記予測部による予測結果を表示装置に表示させる表示制御部をさらに備え、
     前記予測部は、前記ユーザの体内に含まれると予測した所定の生体物質から、当該ユーザの健康状態を予測し、
     前記表示制御部は、前記予測部によって予測された健康状態を前記表示装置に表示させる
     請求項11又は12に記載の生体管理システム。
    A display control unit for displaying a prediction result by the prediction unit on a display device;
    The prediction unit predicts the health state of the user from a predetermined biological material predicted to be contained in the user's body,
    The biological management system according to claim 11, wherein the display control unit causes the display device to display a health state predicted by the prediction unit.
  14.  前記受付部と、前記受付部から排出部へ前記体内物質が移動する流路と、前記流路のうち前記受付部と前記排出部との間に設けられる反応部と、前記温度計測部とを有するセンサをさらに備え、
     前記温度計測部は、前記流路を介して前記反応部へ移動した体内物質と、当該反応部に設けられた反応物質との熱反応に基づく温度変化を計測する
     請求項11~13のいずれか一つに記載の生体管理システム。
    The reception unit, a flow path through which the in-vivo substance moves from the reception unit to the discharge unit, a reaction unit provided between the reception unit and the discharge unit in the flow path, and the temperature measurement unit Further comprising a sensor having
    The temperature measurement unit measures a temperature change based on a thermal reaction between an in-vivo substance moved to the reaction unit via the flow path and a reaction material provided in the reaction unit. The biological management system according to one.
  15.  前記流路は、前記受付部から分岐した複数の分岐流路を有し、
     前記反応部は、前記分岐流路毎に設けられるとともに、当該分岐流路毎に異なる反応物質が設けられ、
     前記温度計測部は、前記反応部毎に前記温度変化を計測する
     請求項14に記載の生体管理システム。
    The flow path has a plurality of branch flow paths branched from the reception unit,
    The reaction section is provided for each branch channel, and a different reactant is provided for each branch channel,
    The biological management system according to claim 14, wherein the temperature measurement unit measures the temperature change for each reaction unit.
  16.  前記センサは、前記複数の分岐流路のうち少なくとも一部の分岐流路において、前記熱反応に基づく温度変化を計測する手法以外の他の手法によって、前記ユーザの体内に含まれる生体物質の特性を示す情報を計測する
     請求項15に記載の生体管理システム。
    The sensor is characterized by characteristics of the biological material contained in the body of the user by a method other than the method of measuring the temperature change based on the thermal reaction in at least some of the plurality of branch channels. The biological management system according to claim 15, wherein information indicating s is measured.
  17.  前記センサは、前記受付部と前記流路とが設けられる基板をさらに備え、
     前記温度計測部は、前記基板のうち前記流路以外の領域に設けられた第1の温度センサによる計測結果と、前記反応部に設けられた第2の温度センサによる計測結果とに基づいて、前記温度変化を計測する
     請求項14~16のいずれか一つに記載の生体管理システム。
    The sensor further includes a substrate on which the reception unit and the flow path are provided,
    The temperature measurement unit is based on a measurement result by a first temperature sensor provided in a region other than the flow path in the substrate and a measurement result by a second temperature sensor provided in the reaction unit, The living body management system according to any one of claims 14 to 16, wherein the temperature change is measured.
  18.  前記第1の温度センサは、環境温度を計測し、
     前記第2の温度センサは、前記反応部における温度変化を計測し、
     前記予測部は、前記第1の温度センサによって計測された環境温度に応じて前記第2の温度センサによる計測結果が補正された後の値に基づいて、前記ユーザの体内に含まれる生体物質を予測する
     請求項17に記載の生体管理システム。
    The first temperature sensor measures an environmental temperature;
    The second temperature sensor measures a temperature change in the reaction part,
    The predicting unit determines a biological material contained in the user's body based on a value after the measurement result by the second temperature sensor is corrected according to the environmental temperature measured by the first temperature sensor. Predicting the biological management system according to claim 17.
  19.  前記温度計測部は、前記体内物質が移動した前記流路が洗浄された後に、前記温度変化を計測し、
     前記予測部は、前記温度計測部によって洗浄後に計測された温度変化に基づいて、前記流路における洗浄状態を予測する
     請求項14~18のいずれか一つに記載の生体管理システム。
    The temperature measurement unit measures the temperature change after the flow path through which the body substance has moved is washed,
    The biological management system according to any one of claims 14 to 18, wherein the prediction unit predicts a cleaning state in the flow path based on a temperature change measured after the cleaning by the temperature measurement unit.
  20.  前記流路から前記排出部へ、前記流路内の物質を吸引するよう制御する制御部をさらに備える
     請求項14~19のいずれか一つに記載の生体管理システム。
    The biological management system according to any one of claims 14 to 19, further comprising a control unit configured to control the substance in the flow channel to be sucked from the flow channel to the discharge unit.
  21.  生体管理システムが、
     ユーザに用いられた歯ブラシを洗浄水により超音波洗浄し、
     前記超音波洗浄が行われた後の洗浄水に、抗体又は抗原である反応物質と、磁気ビーズとが混合された混合物から発生する磁界を磁界センサによって測定し、
     測定された磁界に基づいて、前記ユーザの体内に含まれる生体物質を予測する、
     生体管理方法。
    The biological management system
    The toothbrush used by the user is ultrasonically cleaned with cleaning water,
    The magnetic field generated from the mixture in which the reactive substance, which is an antibody or antigen, and magnetic beads are mixed in the washing water after the ultrasonic cleaning is performed, is measured by a magnetic field sensor,
    Predicting biological material contained in the user's body based on the measured magnetic field;
    Biological management method.
  22.  生体管理システムが、
     ユーザの口腔内から洗面台に排出された排出物質を排水し、
     排水された排出物質に、抗体又は抗原である反応物質と、磁気ビーズとが混合された混合物から発生する磁界を磁界センサによって測定し、
     測定された磁界に基づいて、前記ユーザの体内に含まれる生体物質を予測する、
     生体管理方法。
    The biological management system
    Drain the discharged substances discharged from the user's mouth to the sink,
    A magnetic field sensor measures the magnetic field generated from the mixture of the discharged waste material, the reaction material that is an antibody or antigen, and the magnetic beads,
    Predicting biological material contained in the user's body based on the measured magnetic field;
    Biological management method.
  23.  生体管理システムが、
     ユーザによって什器に排出された排出物質をセンサに注入し、
     注入された体内物質と、所定の反応物質との熱反応に基づく温度変化を前記センサにより計測し、
     計測された温度変化に基づいて、前記ユーザの体内に含まれる生体物質を予測する、
     生体管理方法。
    The biological management system
    Inject the exhaust material discharged into the fixture by the user into the sensor,
    The sensor measures a temperature change based on a thermal reaction between the injected body substance and a predetermined reactant,
    Predicting a biological material contained in the user's body based on the measured temperature change;
    Biological management method.
  24.  ユーザの体内物質を受け付ける受付部と、前記受付部によって受け付けられた体内物質から、生体物質の特性を示す情報をセンサにより測定する測定部とを有する、持ち運び可能な小型タイプの測定装置と、
     前記測定部によって測定された情報に基づいて、前記ユーザの体内に含まれる生体物質を予測する予測部と、
     前記予測部によって予測された生体物質から前記ユーザの健康状態を判定する判定部と、
     前記判定部で判定された健康状態に基づいて、前記ユーザに対するアドバイスを表示する表示部と
     を備える生体管理システム。
    A portable small-type measuring device having a receiving unit that receives a substance in the user's body, and a measuring unit that measures information indicating characteristics of the biological substance from the in-vivo substance received by the receiving unit,
    Based on the information measured by the measurement unit, a prediction unit for predicting the biological material contained in the user's body;
    A determination unit that determines the health state of the user from the biological material predicted by the prediction unit;
    A biological management system comprising: a display unit that displays advice for the user based on the health condition determined by the determination unit.
PCT/JP2015/053860 2015-02-12 2015-02-12 Living body management system and living body management method WO2016129087A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2015/053860 WO2016129087A1 (en) 2015-02-12 2015-02-12 Living body management system and living body management method
JP2016574584A JP6516229B2 (en) 2015-02-12 2015-02-12 Living body management system and living body management method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2015/053860 WO2016129087A1 (en) 2015-02-12 2015-02-12 Living body management system and living body management method

Publications (1)

Publication Number Publication Date
WO2016129087A1 true WO2016129087A1 (en) 2016-08-18

Family

ID=56614362

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/053860 WO2016129087A1 (en) 2015-02-12 2015-02-12 Living body management system and living body management method

Country Status (2)

Country Link
JP (1) JP6516229B2 (en)
WO (1) WO2016129087A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020509383A (en) * 2017-02-28 2020-03-26 ビドケア イノベーションズ プライベート リミテッド Methods and devices for analyte quantification

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06237902A (en) * 1993-02-18 1994-08-30 Shimizu Corp Health control system
JPH0978656A (en) * 1995-09-13 1997-03-25 Matsushita Electric Ind Co Ltd Human body private part washing device
JP2000081410A (en) * 1998-07-02 2000-03-21 Nec Corp Oxygen electrode, biosensor using it, and measurement apparatus
JP2003270241A (en) * 2002-03-12 2003-09-25 Omron Corp Health care apparatus
JP2003310560A (en) * 2002-04-19 2003-11-05 Yamatake Corp Health information management system and management method therefor
WO2005075997A1 (en) * 2004-02-03 2005-08-18 Asahi Kasei Kabushiki Kaisha Method of detecting analyte with use of magnetic bead
JP2009121922A (en) * 2007-11-14 2009-06-04 Canon Inc Concentration detecting apparatus and method
JP2012150130A (en) * 2006-04-26 2012-08-09 Nikkiso Co Ltd Biological component measuring apparatus and calibration method of biological component measuring apparatus
JP2012242244A (en) * 2011-05-19 2012-12-10 Tanita Corp Sugar concentration measurement instrument

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180418B1 (en) * 1998-01-20 2001-01-30 The United States Of America As Represented By The Secretary Of The Navy Force discrimination assay
BR112014010703A2 (en) * 2011-11-04 2017-04-25 Curtin Univ Of Tech apparatus and method for separating particulate matter

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06237902A (en) * 1993-02-18 1994-08-30 Shimizu Corp Health control system
JPH0978656A (en) * 1995-09-13 1997-03-25 Matsushita Electric Ind Co Ltd Human body private part washing device
JP2000081410A (en) * 1998-07-02 2000-03-21 Nec Corp Oxygen electrode, biosensor using it, and measurement apparatus
JP2003270241A (en) * 2002-03-12 2003-09-25 Omron Corp Health care apparatus
JP2003310560A (en) * 2002-04-19 2003-11-05 Yamatake Corp Health information management system and management method therefor
WO2005075997A1 (en) * 2004-02-03 2005-08-18 Asahi Kasei Kabushiki Kaisha Method of detecting analyte with use of magnetic bead
JP2012150130A (en) * 2006-04-26 2012-08-09 Nikkiso Co Ltd Biological component measuring apparatus and calibration method of biological component measuring apparatus
JP2009121922A (en) * 2007-11-14 2009-06-04 Canon Inc Concentration detecting apparatus and method
JP2012242244A (en) * 2011-05-19 2012-12-10 Tanita Corp Sugar concentration measurement instrument

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ISAO KARUBE: "Rinsho-yo Biosensor no Kaihatsu no Doko", NEW MEDICINE IN JAPAN THE FEBRUARY ISSUE, vol. 19, no. 2, 1 February 1992 (1992-02-01), pages 75 - 79 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020509383A (en) * 2017-02-28 2020-03-26 ビドケア イノベーションズ プライベート リミテッド Methods and devices for analyte quantification

Also Published As

Publication number Publication date
JP6516229B2 (en) 2019-05-22
JPWO2016129087A1 (en) 2017-11-24

Similar Documents

Publication Publication Date Title
Christodouleas et al. From point-of-care testing to eHealth diagnostic devices (eDiagnostics)
US9024766B2 (en) Beverage containers with detection capability
Schachtele et al. Comparison of methods for monitoring changes in the pH of human dental plaque
TW201038942A (en) Wireless monitoring bio-diagnosis system
JP5514442B2 (en) Human body fluid quantification and qualitative analyzer
JP2005230521A (en) Humor component detecting device and humor component detecting system
Popovtzer et al. Electrochemical detection of biological reactions using a novel nano-bio-chip array
CN1806252A (en) Vital data vtilization system, method, program and recording medium
CN105699449A (en) Multiple-analyte assay device and system
Woods et al. Spit: Saliva in nursing research, uses and methodological considerations in older adults
Hillman et al. Monoclonal antibody-based biosensor for point-of-care detection of type III secretion system expressing pathogens
Guo et al. Cyber–physical healthcare system with blood test module on broadcast television network for remote cardiovascular disease (CVD) management
Greene et al. The inside tract: The appendicular, cecal, and colonic microbiome of captive aye‐ayes
JP6516229B2 (en) Living body management system and living body management method
JPWO2019187018A1 (en) Health support system, sensor, and health support method
CN102224253A (en) Biosensor for detecting anti-hiv antibodies
Beteta Del Carpio Isolation of helicobacter pylori in dental plaque in patients with gastritis at" Angamos" clinic
Zingone et al. Myths and facts about food intolerance: a narrative review
JP2017192341A (en) Pre-treatment kit for gene analysis, nucleic acid analysis chip, and gene analysis system
Castán et al. Digestive anisakiasis: clinical manifestations and diagnosis according to localization.
US11881313B2 (en) Customized questions for user of analytical toilet
US20220022810A1 (en) Treatment Compliance Tracking by Measuring Symptoms with an Analytical Toilet
Wang et al. The clinical utility of string-PCR test in diagnosing Helicobacter pylori infection.
JP3120375U (en) Microchannel sensor test piece capable of simultaneously examining various types of human physiological information
US20190219512A1 (en) Device, procedure and system for detecting bacterial pathogens including methicillin-resistant staphylococcus aureus or clostridium difficile

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15881962

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2016574584

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15881962

Country of ref document: EP

Kind code of ref document: A1